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SUMMARY
The nAChR are ligand gated cation channels formed by the assembly of a variety of 
receptor subunits into a pentameric transmembrane structure permeable to both Na+ and 
Ca2+. Although a considerable amount of information has been gathered about the molecular 
structure, pharmacology and biophysical properties of nAChR, the role of nAChR in the 
modulation of various cellular processes of the nervous system has only become apparent in 
the last decade. The existence of multiple subtypes of neuronal nAChR, the non-uniform 
distribution in the nervous system and their localisation to both pre- and post-synaptic zones, 
imply diverse functions for the nAChR. In effect, the ability of nicotine to increase 
cytoplasmic Ca2+ concentrations should make the activation of nAChR an extremely 
sensitive tool for relying information from activity dependent inputs to the nucleus. The aim 
of this work was to investigate some of the intracellular signalling processes activated by the 
stimulation of nAChR in neuronal preparations.
The first part of the project analysed the putative neuroprotective properties of nicotine 
stimulation using cultures from the hippocampus, a brain region involved in memory and in 
the progression of Alzheimer’s disease. Stimulation with nicotine prevented the NMDA- 
evoked neuronal loss, an effect that was mediated by the a7 nAChR through a Ca2+- 
dependent cellular mechanism acting downstream to the Ca2+ overload generated by 
NMDA. Subsequently, the project focused on the analysis of the Ca2+ signals activated by 
the stimulation of nAChR. Using the human SH-SY5Y cell line as a model system it was 
demonstrated that, similar to hippocampal neurones, nicotine evoked sustained elevations of 
cytoplasmic Ca2+. The study of these Ca2+ signals indicated that besides the direct influx 
through the nAChR channel and the activation of VOCC, nAChR Ca2+ responses involved 
the activation of store dependent Ca2+-induced and IP3-mediated Ca2+ release.
The recruitment of intracellular Ca2+ stores provides further complexity to the Ca2+ signals 
activated by stimulation of nAChR. Eventually, much of the capacity to regulate intracellular 
mechanisms depends on the activation of specific signalling molecules. In the final part of 
the present work, it was established that in both SH-SY5Y cells and hippocampal neurones, 
the activation of a7 nAChR regulates the activity of the ERK cascade using a novel Ca2+ and 
PKA dependent signalling pathway. This mechanism, however, was not mediating the 
previously observed nicotine neuroprotection.
Although the a7 nAChR constitutes a precise tool for the activation of specific Ca2+ signals, 
we still do not know the exact function of the nAChR-mediated ERK signalling cascade. 
Probably, the activation of ERK following stimulation of the a7 nAChR is related to the 
proposed function of nAChR in memory processing. Considering the role that ERK has in 
synaptic plasticity, and the evidence showing the involvement of nAChR in memory, it is thus 
suggested that a7 nAChR and the ERK signalling cascade could mediate neuronal plasticity 
processes in the CNS.
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< GENERAL INTRODUCTION >
1.1 The Nicotinic Acetylcholine Receptor (nAChR)
1.1.1 nAChR and the development of Neuroscience
The elucidation of the role and function of nicotinic acetylcholine receptors (nAChR) has 
played a crucial part in the progress of modern neuroscience. A simple examination of the 
major contributions to the understanding of the mechanisms of neurotransmission shows 
how the nAChR figure prominently in many of the cornerstone advances that have occurred 
in the last 150 years.
It was in the mid nineteenth century that the existence of synaptic transmission and, 
indirectly, the presence of ligand gated ion channels (LGIC) was first suggested by Claude 
Bernard (1857) on the basis of the blockage of the neuromuscular junction by curare. In 
spite of these early studies, research on neuronal nAChR really started in the 1880’s with 
the experiments of Langley on the cat superior cervical ganglion, where nicotine was used 
as a tool to map the distribution of the sympathetic fibres. More than a decade and a half 
later, Langley discovered how the application of nicotine to ganglionic preparations 
generated “effects like those produced by brief stimulation of its preganglionic fibres”. 
Following these studies, experiments on the skeletal muscle allowed him to define the 
existence of “receptive substances”, now more commonly known as receptors, and establish 
them as specific physiological targets, capable of “receiving the stimulus” and “transmitting 
it” (Langley, 1914). Although for many years this newly defined “receptive substance” was 
considered almost as a “mythical” entity, Langley’s work allowed the formulation of receptor 
and signal transduction concepts, setting the foundation for modern neuropharmacology.
In 1914, Sir Henry Dale, one of Langley’s students, observed that the action of the esters of 
choline could be mimicked in some tissues by an alkaloid from Nicotiana tabacum (nicotine) 
and in other tissues by another alkaloid from Amanita muscana (muscarine). In doing so, 
Dale proved that the same substance (now known to be acetylcholine) could mediate 
distinctive responses in tissues through different molecules, therefore defining the existence 
of different receptor subtypes. Ironically, and in spite of all his major contributions to the 
understanding of neuronal function, Dale never used the term “receptor”.
14
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Almost fifty years later, the finding of a-bungarotoxin (a-Bgt) irreversible inhibition of 
neuromuscular transmission led to the isolation of the embryonic muscle nAChR (Changeux 
et al., 1970). In spite of this apparent delay in the isolation of the receptor itself, studies by 
Katz and colleagues in the 1950’s and throughout the 1970’s relied heavily on the amphibian 
and mammalian neuromuscular junction to uncover the principles of quantal release of 
transmitters (Fatt and Katz, 1952; Katz and Miledi, 1965), synaptic delay times and the 
deconvolution of synaptic noise to single channel events (Katz and Miledi, 1965; 1972), all of 
which involved the cholinergic synapse and nAChR. In effect, it can certainly be said that by 
nature’s ability to produce precise pharmacological tools targeting the nAChR, as well as 
due to the advances in experimental techniques applicable to the study of the endplate 
region of the neuromuscular junction, the nAChR has secured its position as one of the most 
studied of all receptors in the history of neuroscience.
At present, the research on nAChR has expanded into the study of the neuronal types of 
nAChR and their role in several processes affecting the function of the brain. The discovery 
that neuronal nAChR, unlike muscular ones, exist in a variety of subtypes and locations, 
along with the observation that they can affect several major brain processes like addiction, 
anxiety, synaptic plasticity, memory processing, neuronal survival, and the progression of 
neurodegenerative diseases, have been major driving forces in a field in continuous 
evolution. As part of this progress, a recent and unforeseen discovery emphasised the past 
and future role of nAChR in the understanding of neuronal transmission. In two consecutive 
papers, Sixma and colleagues (Smit et al., 2001; Brejc et al., 2001) revealed how in the 
Lymnea stagnalis snail, a glia-derived "releasable substance”, similar in sequence and 
structure to the extracellular domain of the nAChR, can interact with neuronally released 
acetylcholine, thereby modulating neurotransmission at cholinergic synapses. In fact, the 
finding of this unique mechanism for controlling synaptic transmission demonstrates that the 
role of the “nicotinic acetylcholine receptive substance” in the understanding of the novel 
fundaments of neuronal function is far from over yet.
1.1.2 The superfamily of ligand gated ion channels (LGIC)
Receptors that mediate vertebrate neurotransmission can be divided into two groups: the 
ionotropic and metabotropic receptors. The ionotropic receptors, which are able to mediate 
fast transmission, are usually defined as LGIC. Three main families are distinguished among 
the LGIC: the family of glutamate receptors (kainate/a-amino-3-hydroxy-5-methyl-4- 
isoxazole propionic acid, AMPA, and N-methyl-D-aspartate, NMDA), the family of the 
purinergic receptors and the family of the nAChR. This last one includes the inhibitory y-
15
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amino-butyric acid (GABAa and GABAC) receptors, glycine receptors, serotoninergic 5- 
hydroxy-tryptophan receptors (5-HT3) and the nAChR (Fig 1.1). Whilst the GABAa and 
glycine receptors are selectively permeable to anions and therefore usually inhibitory, the 
nAChR and 5-HT3 receptors are excitatory by being selective for cations.
Kainate




B1 ACh, GABA. and glycine 
receptors
Ligand binding
C O O H
C ytop lasm ic
side
C O O H '  C O O H
A C h G A B A a G lycine
Fig 1.1 Schematic representation of the ligand gated ion channel (LGIC) family members.
Three main groups are distinguished: the family of purinergic receptors (A), the family of the nAChR 
(Bi and B2), which also includes the GABAa and glycine receptors, and the family of glutamate 
receptors (Ci and C2), which include the kainate, AMPA and NMDA receptors. All members of the 
LGIC superfamily are multiprotein complexes forming an ion selective pathway across the membrane. 
The upper panels show the transmembrane structure of the typical subunit for each family. The lower 
panel shows the putative arrangement of the subunits in the formed channel. In the case of the 
nAChR (B^ the subunits are arranged in a pentameric structure, with the different subunits conferring 
distinctive functional and structural properties. Unlike the nAChR, glutamate receptors proved to have 
only three transmembrane domains, plus a cytoplasm-facing re-entrant membrane loop (M2). Also 
differing with the nAChR, the ligand binding site in glutamate receptors is formed by the N-terminal 
and the extracellular M3-M4 loop (Adapted from Kandel, 2000).
When studying a protein-complex as intricate as the LGIC, it is common to subdivide it on 
the basis of its functional domains into a ligand binding site and a channel domain. Although 
other sites where allosteric effectors, or any other compounds, may bind must also be 
considered, these two functional domains, which are thought to have evolved separately, 
constitute the minimal requirement for the existence of a LGIC. Accordingly, it should be 
possible to exchange functional domains from one ligand-gated channel with another one. 
The resulting chimera would display the pharmacological properties conferred by the binding 
site while the ionic pore selectivity and sensitivity would match those of the corresponding 
donor. The ensemble of these predictions was verified with the construction of the chimeric
16
CHAPTER 1
receptor that comprises the N-terminal domain of the a7 neuronal nAChR and the rest of its 
sequence from the 5-HT3 receptor (Eisele et al., 1993).
In evolutionary terms, the analysis of DNA sequences also supports the notion that the 
nAChR share a common ancestor, probably homomeric, with the GABAa, the glycine and 
the 5-HT3 receptors (LeNovere and Changeux, 1995; Ortells and Lunt, 1995). However, the 
most elegant evidence for the structural homologies found in this superfamily is revealed by 
the ability to change the selectivity of the nAChR ion channel from cation to anion by 
changing only three channel lining aminoacids to those characteristic of glycine and GABAa 
receptors (Galzi et al., 1992).
1.1.3 Structure of the nAChR
All nAChR subtypes are acetylcholine (ACh) -gated cation channels (Cooper et al., 1991; 
Unwin, 1993; Tierney and Unwin, 2000), organised around a pseudo 5-fold axis that 
delineates a cation-selective pathway across the membrane when the channel is open, but a 
robust barrier to the ions when it is closed (Fig 1.2b). As a group, the nAChR are part of a 
heterogeneous assembly of receptors, which are formed as pentamers from different 
combinations of various genetically distinct subunits. The differential association of these 
subunits confer distinctive functional and structural properties to the nAChR types that they 
form (Fenster et al., 1997). However, and with only few exceptions, the subunit composition, 
stoichiometry and arrangements of naturally expressed nAChR are not known with absolute 
certainty. The observed variety of known nAChR subunits is thought to have evolved from 
the primordial homomeric receptor subunits through repeated gene duplication and 
spontaneous mutations (LeNovere et al., 1995). To date, 17 receptor subunit genes (a1- 
a10, p1-p4, 5, e, y) have been cloned from vertebrates and initially classified according to the 
presence or absence of a pair of tandem cysteine residues in the putative N-terminal 
extracellular region. In the a subunits, these residues are near a site known to engage in 
agonist binding. None of the other subunits (i.e.: p1-p4, 8, e, y) have these tandem cysteines 
(Karlin, 1993).
In its amino acid sequence, each of the homologus nAChR subunits starts with a signal 
sequence cleaved during translation (Lindstrom, 1995; Sargent, 1993). The large hydrophilic 
N-terminal of the mature subunit consists of ~200 amino acids thought to form a large 
domain on the extracellular surface, which carries the multiple loops that participate in 
neurotransmitter binding site (Fig 1.2a). This is followed by ~90 aminoacids comprising three 
closely spaced hydrophobic sequences that form the transmembrane domains M1 to M3.
17
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The hydrophobic segments are thought to stack in the membrane with the amphiphilic M2 
helix orientated towards the channel lumen to form an ion permeant pathway.
COOH










Fig 1.2 Structure of the nAChR
The nAChR are multiprotein pentameric membrane complexes (B, D) that delineate a cation 
selective pathway across the membrane. The large hydrophilic N-terminal region (200 amino acids) 
forms a large domain that carries the multiple loops participating in ligand binding (A). Three closely 
spaced hydrophobic sequences form the M1-M3 transmembrane domains, with the amphiphilic M2 
helix orientated towards the channel lumen to form an ion permeant pathway (A, B). Following the 
M3 transmembrane segment is a large cytoplasmic domain of 100-200 amino acids (A), which 
constitutes the most variable part of the sequence between subunits, and has several putative 
phosphorylation sites relevant for signalling processes. An electron-density image of a section of the 
receptor molecule on the synaptic side of the membrane is shown in C. Arrows indicate the possible 
site of interaction with the neurotransmitter, and circles indicate the respective positions of the a-Bgt 
binding sites. In D, an image reconstruction of electron micrographs yielding a structure at 9 A 
resolution (Adapted from Kandel et al., 2000 and Unwin, 1993).
The predicted M2 region forms a rather non-selective channel, largely by virtue of 
hydroxylated serine and threonine residues, which line the internal face and are identical or 
highly homologous in excitatory (cation channels) and inhibitory (anion channels) receptors 
(Imoto et al., 1991; Villarroel and Sakmann, 1992; Bertrand, 1993). Ionic selectivity appears 
to be conferred by rings of fully charged amino acids just outside the bilayer plane (Bertrand 
et al., 1993). Following the M3 transmembrane segment there is a large cytoplasmic domain 
of ~100-200 aminoacids, which constitutes the most variable part of the sequence between 
subunits, and has several putative phosphorylation sites. Next to this large intracellular
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domain we find a fourth hydrophobic sequence (M4), finally leading to a small (~ 10-30 
aminoacids) extracellular domain at the C-terminus (Fig 1.2a).
Among the structural and functional features that define the LGIC, several structural motifs, 
which are absent or substantially different in members of the glutamate family in particular, 
help the characterization of the nAChR family:
- An extracellular N-terminal domain of approximately 200 aminoacids containing the 
agonist-binding site (Unwin, 1993; Fig 1.1). In glutamate receptors, the agonist- 
binding site is formed by part of the N-terminal domain and part of the M3-M4 
extracellular loop (Dingledine et al., 1999; Fig 1.1).
- A 15 residue cys-loop in the terminal domain (Ortells and Lunt, 1995), which is 
absent in glutamatergic subunits (Hollman et al., 1994).
- Conserved residues in the second transmembrane segment (M2), proposed to form 
a primarily a-helical structure lining the ion channel and gating ion-flow (Ortells and 
Lunt 1995; Unwin et al 1995). Evidence gained using N-glycosylation site tagging 
(Hollman et al., 1994) and prolactin reporter epitopes (Bennett and Dingledine, 1995) 
suggests that the “M2” sequence identified in glutamatergic subunits does not 
traverse the cell’s membrane completely, forming instead a re-entrant loop similar to 
that seen in e.g. K+ channels. Consequently, the large M3-M4 loop is extracellular 
and appears to form part of the ligand-binding site, with a C-terminus in the 
cytoplasmic side (see Fig 1.1c).
At the pentameric structural level, the nAChR are undoubtedly the best characterised of any 
LGIC. This is largely due to the thorough study of nAChR from skeletal muscle and fish 
electric organs, whith the latter providing a homogeneous and accessible preparation for 
electron microscopy studies. In particular, it was the analysis of postsynaptic membranes 
from the Torpedo electric fish that gave extremely detailed pictures of the pentameric cation 
channel structure (Fig 1.2d). In these studies, the channel pathway has been reported to 
narrow across the membrane, but widen into a 20 A diameter cylinder that extends ~65 A 
into the synaptic cleft and ~15 A into the interior of the cell (Unwin, 1993; Fig 1.2d). The 
narrow portion of the pore, lined by five a-helical structures from the M2 segment, appears 
to come together near the middle of the membrane and form the gate of the channel (Unwin, 
1993). At the molecular level, it has been proposed that by bending towards the central axis, 
the helices would allow the leucine-251 large side chains to project inwards and associate in 
a tight ring, preventing the ions from crossing the membrane (closed channel). In addition, 
details of the activated receptor suggest that by bending tangentially to the central axis and 
associating side-to-side, the helices would allow the polar surfaces to become more fully
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exposed, while at the same time moving the large side-chains away from the ion path, 
therefore opening the gate (open channel; Unwin, 1995). The weakening of the “leucine- 
ring” mode of association of the helices, allowing their side-to-side association around the 
barrel, must be triggered by localised disturbances at the binding sites in the two a subunits 
(Fig 1.2c). At the level of the cytoplasmic wall, the receptor was shown to contain openings 
wide enough for the ions to pass through, made by the spaces between -30 A long rods that 
protrude from each of the subunits towards the cell interior. It was therefore proposed that 
cations leaving the cell interior are “filtered” through narrow openings in the channel wall. 
Framing these narrow pores are lines of negatively charged residues, which may help to 
exclude anions from the vicinity of the transmembrane pore (Miyazawa et al., 1999).
Knowledge about the ligand-binding site comes largely from biochemical studies using high 
affinity ligands or photo-affinity labelling (reviewed in Galzi and Changeux, 1995) and from 
functional investigations of receptors engineered by site-directed mutagenesis (reviewed in 
Bertrand and Changeux, 1999). Most of the evidence obtained up to now indicates that a 
minimum of two a subunits are present per receptor, forming the ligand binding pockets at 
the interface with its adjacent subunit (Corringer et al., 1995; Karlin, 1993; Sugiyama et al., 
1998; Fig 1.3a). As a result, aminoacid residues from both subunits form the ligand binding 
structure of the receptor, indicating that the presence of both a and non-a subunits 
contribute to the physiological and pharmacological properties of nAChR (Couturier et al., 
1990; Figl et al., 1992; see review by Bertrand and Changeux, 1995). A particular exception 
to this rule is given by the a7, a8 or a9 nAChR subunits, which can reconstitute functional 
homomeric receptors (Schoepfer et al., 1990; Elghoyen et al., 1994; Seguela et al., 1993, 
Peng et al., 1994). Accordingly, these subunits must possess in their sequences both the 
principal and complementary components that form the ACh binding pocket, conferring a 
functional structure probably responsible for the particular characteristics of receptor 
activation and desensitisation observed with a7, a8 and a9 homomers (see later).
Numerous analyses have identified that the ACh binding pocket results from the contribution 
of at least six loops. The three loops (A, B, C) of the a subunit are often referenced as the 
major binding component while the other loops (D, E, F) present on the adjacent subunit are 
called the complementary component (Bertrand and Changeux, 1995; Galzi and Changeux, 
1995; Fig 1.3b). Initial site-directed mutagenesis had highlighted the contribution of aromatic 
residues in the principal component of the agonist-binding site (Galzi et al., 1991). The 
participation of these loops has been further documented in several studies where the 
exchange of short aminoacid sequences has been performed between different subunits 
(Corringer et al., 1998; Figl et al., 1992). In particular, the introduction of residues between 
positions 183-191 of the a4 subunit into the a7-5-HT3 receptor chimera was found to be
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sufficient to increase the receptor apparent affinity and equilibrium binding. From these and 
other microchimera it was concluded that the transfer of residues 151-155 and 183-191 
confers typical pharmacological properties of the a4|32 nAChR to the a7-5-HT3 receptor 
(Corringer et al., 1998).
No ACh bound: 
Channel closed
Two ACh molecules bound: 
Channel open
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Fig 1.3 nAChR channel and agonist binding site
The upper panel shows the pentameric structure of the nAChR transmembrane channel and the 
corresponding agonist binding sites in the interfaces between the a and adjacent subunits. In the 
lower panel, the left picture shows a model of the ACh binding site of nAChR, which summarises the 
results from photoaffinity labelling experiments. These results revealed that the agonist binding 
domain is composed of two main components of the N-terminal domain that overlaps the boundary 
between subunits. The “principal component” is carried by the a subunit and consists of three loops: 
loop A (Trp-86, Tyr-93), loop B (Trp-149, Tyr 151) and loop C (Tyr-190, Cys-192, Cys-193, Tyr-198), 
whereas the “complementary component” is carried by the non-a subunits and comprises at least 
three loops: loop D (Trp-55, Trp-57), loop F (Asp 180, Asp 182) and loop E (Tyr 111, Tyr 117). On 
the right lower panel, a schematic representation of the transmembrane a7 nAChR channel is 
shown. The channel pathway has been reported to narrow across the membrane and to widen into a 
20 A diameter cylinder at the synaptic cleft (Adapted from Kandel 2000, and Changeux and 
Edelstein, 2001).
Additional confirmation for these structural observations of the nAChR came from a totally 
unexpected source, when the crystal structure of a glia-derived ACh-binding protein was 
determined with a 2.7 A resolution (Brejc et al., 2001). This ACh binding molecule is a 
soluble protein found in the snail Lymnaea stagnalis, which is produced and stored in glial
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cells, and released in an ACh-dependent manner into the synaptic cleft. The mature ACh- 
binding protein is 210 aminoacids long and forms a stable homopentamer, although lacking 
the transmembrane and intracellular domains present in the LGIC superfamily. Of the 
extracellular portion, nearly all the residues that are conserved within the nAChR family are 
present in the ACh-binding protein, including those that are relevant for ligand binding. The 
analysis of this releasable glial protein confirmed many previous assumptions of the nAChR 
structure. Moreover, it also supported the elaboration of new hypotheses for the subunit 
assembly and functional structure of the nAChR receptor. The ligand-binding site in this ACh 
binding protein is found in a cleft or cavity formed by a series of loops from the principal face 
of one subunit and a series of p-strands from the complementary face of the adjacent 
subunit. Present at each interface between the subunits and close to the outside of the 
pentameric ring, the cavity is lined by residues that were biochemically shown to be involved 
in ligand binding in nAChR (see above). The study of this protein has also shown that the 
most likely access route to the ligand binding sites are from above or below the double 
cysteine containing loop that bury the region from the solvent and prevents access from the 
outside. Although access from the central pore has been previously suggested (Miyazawa et 
al., 1999) this would require major structural rearrangements at the interface, which are less 
likely to occur. In spite of the major breakthrough in the understanding of nAChR structure 
provided by studies of this ACh binding molecule, a cautionary note must arise when 
studying its binding domain. In fact, it is still unclear whether this ACh binding protein 
performs the allosteric conformational changes that are important for pentameric LGIC. This 
apparently minor consideration might, however, have produced a lack of evolutionary 
restraints necessary for the maintenance of the channel allosteric mechanisms. In the end, 
this could have diverted the strucutural architecture of the ligand-binding domain in the ACh 
binding protein, making it different from the ligand-binding site in the nAChR.
1.1.4 Classification of nAChR
In evolutionary terms, muscle nAChR a1, p1, 8, s, y subunits are thought to represent one 
branch of the gene family while neuronal nAChR a2, a3, a4, a5, a6, p2, p3, p4 subunits are 
thought to form another branch that normally form heteromeric subunit receptors. The third 
branch consists of neuronal nAChR composed of a7, a8, a9, or a10 subunits, with the first 
three capable of forming homomeric pentamers. In the case of muscle nAChR, their diversity 
can be summarised in just two different subtypes, the foetal (a1)2p5y and the adult (a1)2p5s. 
In effect, the e  subunit replaces y in adult muscle, altering both single channel conductance 
and channel kinetics (Mishina et al 1986; Camacho et al., 1993). This lack of subtype 
diversity, together with their specific segregation to neuromuscular synapses, makes muscle
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nAChR an easy target for receptor classification. On the contrary, the classification of 
neuronal nAChR, with their subtype diversity and specific localisation, is a more daunting 
task. In addition to the evolutionary studies, several approaches have been taken in an 
attempt to illuminate relationships between nAChR subunits and their genes, in order to 
allow a rational classification of neuronal nAChR subtypes. However, any protein structure 
or genomic sequence comparison between different subunits lacks functional significance, 
as knowledge of the contribution of particular subunits to specific nAChR subtypes is still far 
from complete. An alternative approximation is given by the use of pharmacological tools for 
the segregation of particular neuronal nAChR subtypes. Specifically, neuronal nAChR can 
be divided according to their high affinity binding to the curaremimetic toxin a-bungarotoxin 
(a-Bgt), which defined a nAChR population independent of the one with high affinity for 
nicotine (for review see Lindstrom, 2000). Although not totally adequate, the use of 
pharmacological, functional and anatomical data serves a useful purpose, differentiating the 
family of nAChR subtypes in three branches:
- The muscle nicotinic acetylcholine receptors (heteromeric).
- The neuronal nAChR with high affinity for nicotine (heteromeric).
- The neuronal nAChR with high affinity for a-Bgt (mainly homomeric).
Thanks to their easier accessibility and straightforward functional role, the synthesis, 
structure, and function of muscle-type nAChR are known in relatively great detail. On the 
other hand, the more diverse function, location, structure and roles of neuronal nAChR are 
much less well characterised. In effect, the functional properties of diverse neuronal nAChR 
subtypes in vivo, and the actual functional roles in the nervous system of many of the real 
and potential subtypes of neuronal nAChR remain to be determined. However, it is 
increasingly apparent that many neuronal nAChR are likely to have functional roles that 
differ from the clear-cut postsynaptic type of critical link in neurotransmission exemplified by 
muscle nAChR. Actually, a rapid overview of the suggested functions of neuronal nAChR 
reveals a molecule involved in such diverse processes as ganglionic neurotransmission in 
the autonomic nervous system and synaptic plasticity, learning and memory, modulation of 
transmitter release, addiction, neuroprotection and progression of neurodegenerative 
diseases in the CNS. The ability to fulfil such a variety of functional roles is, very likely, a 
result of several interrelated factors. First, the known diversity of neuronal nAChR subtypes 
can selectively influence their molecular properties (i.e.: desensitisation rates and ligand 
binding affinity), therefore shaping the actual cellular responses triggered by the activation of 
particular nAChR subtypes. Secondly, the precise cellular localisation of neuronal nAChR 
can also determine the activation of different neuronal mechanisms after receptor 
stimulation. In this regard, the recognised presynaptic location of neuronal nAChR allows the
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control of particular neurotransmitter systems, thus affecting a variety of CNS functions 
(Wonnacott, 1997). Last but not least, the fact that neuronal nAChR are highly permeable to 
Ca2+, opens the possibility for triggering a variety of intracellular signalling processes with 
diverse functional outcomes (Role and Berg, 1996).
1.1.4.1 Neuronal nAChR with high affinity for nicotine
A particular population of nAChR can be pharmacologically defined by their high affinity 
binding to the nAChR specific agonist [3H]-epibatidine, which is weakly displaced, if at all, by 
a-Bgt (Houghtling et al., 1995). These neuronal nAChR comprise combinations of a2, a3, 
a4, a5, a6, p2, p3 and p4 subunits, forming heteromeric nAChR with alternate a and p 
subunits. The functional properties of various subunit combinations expressed in 
heterologous systems are relatively well known, although the precise nAChR subtypes 
present in vivo are not specifically defined yet. In Xenopus oocytes, functional receptors 
were obtained with paired combinations of a2, a3, or a4 with p2 or p4 (Papke et al., 1991, 
1993). The a6 subunit has been also shown to form functional receptors in combination with 
p2 or p4 (Gerzanich et al., 1997; Fucile et al., 1998), even though it seems to function more 
effectively when is combined with another a and p subunit (Fucile et al., 1998). Although the 
a5 and p3 subunits are incapable of forming a functioning nAChR in pair wise combination 
with any other subunit and do not contribute to the ACh binding site (Boulter et al., 1990; 
Groot-Kormelink et al., 1998), they can have an effect on the efficacy and potency of 
agonists by participating in the overall conformational changes involved in activation and 
desensitisation, while also contributing to the channel properties by forming one fifth of the 
channel lining (Groot-Kormelink et al., 1998). This role as a 3rd subunit type is consistent 
with the suggested a3a5a4 nAChR reported to exist in avian brain (Conroy et al., 1992) and 
the a3a4a5(p2)2 inferred in midbrain dopaminergic nuclei in rats (Klink et al., 2001).
Among the various heteromeric nAChR, most of the attention has focused on the a3* and 
a4* subtypes. The a3* nAChR, although expressed in some particular brain regions 
(Sargent, 2000), are better-known as the most abundant subtype in the peripheral 
autonomic nervous system, where they play a postsynaptic role in ganglionic 
neurotransmission. However, this is frequently complicated by the presence of perisynaptic 
a7 nAChR, which can also participate in ganglionic transmission (Zhang et al., 1996; Shoop 
et al., 1999).
The a4* nAChR are the most prominent subtype with high affinity for nicotine in the CNS. 
Experiments performed in rodent brain have suggested that more than 90 % of the
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mammalian high affinity binding sites for nicotine and the nicotinic ligand cytisine are 
composed of a4 and p2 subunits alone (Flores et al., 1992; Lindstrom, 2000). Confirming 
evidence for this observation was given by the loss of nicotine high affinity binding sites 
reported in p2 null mice (Piccioto et al., 1995). Although when expressed in Xenopus 
oocytes the subunit stoichiometry has been interpreted to be (a4)2(p2)3 (Anand et al., 1991; 
Cooper et al., 1991), a small fraction of the a4p2 nAChR subtype may have a5 subunits 
associated with it (Conroy et al., 1992), and the a4-a3/a6-a5-p2 combination has been also 
proposed to exist in midbrain dopaminergic neurones (Klink et al., 2001).
Unlike their functional role in ganglia and skeletal muscle, where nAChR are the main 
excitatory LGIC receptor, in the CNS they are outnumbered by several orders of magnitude 
by the glutamate receptors (Clarke et al., 1985). At present, there is still only limited 
evidence for heteromeric nAChR with postsynaptic functions in the brain (Clarke 1995; 
Jones et al., 1999). Nonetheless, numerous reports demonstrate that heteromeric nAChR 
can function pre-synaptically to modulate the release of various neurotransmitters 
(Wonnacott, 1997), while they can also fulfil a modulatory role when present on cell bodies 
and/or dendrites (Blaha and Winn, 1993).
1.1.4.2 Neuronal nAChR with high affinity for a-Bgt
Like muscle nAChR, but unlike the other neuronal nAChR, this set of nAChR can bind with 
high affinity with the snake venom toxins a-cobratoxin and a-Bgt. Several nAChR subunits 
are part of this group, including the a7 subunit, and the closely related a8 (Schoepfer et al., 
1990), a9 and a10 (Elgoyhen et al., 1994 and 2001), which are mainly associated with 
sensory organs. Although capable of forming functional homomeric nAChR in heterologous 
expression systems, it is not certain that the a7 nAChR are always present as homomers, 
and in avian brain much of a8 (which is not found in mammals) is normally present in 
heteromeric nAChR with a7 (see Lindstrom, 2000).
In terms of localisation, the highly abundant a7 containing nAChR subtype can be found in 
many brain regions, being especially concentrated in the hippocampus (Dominguez-Del 
Toro et al., 1994). In addition, it is also present in peripheral ganglionic neurons along with 
the a3* nAChR (Conroy and Berg, 1995). The a9 containing nAChR are only expressed in 
limited neuronal areas, and most notably in the cochlear hair cells (Elgoyhen et al., 1994).
Apart from their ability to function as homomers and bind a-Bgt, the a7, a8 and a9 nAChR 
exhibit other particular properties, like an exceptionally high Ca2+ permeability and very fast
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desensitisation kinetics. Rapid desensitisation might intrinsically result from homomeric 
structure, if the presence of five rather than the typical two ACh binding sites capable of 
initiating nAChR activation results in faster desensitisation. The exceptionally high Ca2+ 
permeability of a7 (and also a8 and a9/a10) nAChR can have direct functional 
consequences, as Ca2+ entering through these nAChR can facilitate transmitter release 
when presynaptic a7 nAChR are activated (Gray et al., 1996). In addition, it was also 
suggested that the a7 nAChR mediated Ca2+ influx could initiate intracellular mechanisms 
leading to the modulation of signalling processes and gene expression (Role and Berg,
1996). In fact, many of the functional properties of a7 nAChR, like fast desensitisation and 
inward rectification, make them ideal cellular tools for the activation of precise Ca2+ signalling 
pathways.
1.1.5 Ca2+ permeability of nAChR
The potential relevance of nAChR in neuronal function has been pressed further by the 
demonstration of their high relative permeability to Ca2+. As illustrated above, the capacity to 
modulate intracellular Ca2+ concentrations has prompted the suggestion that nAChR 
regulate many neuronal mechanisms in a Ca2+ dependent manner.
Although the report of the nicotine-evoked activation of Ca2+ dependent neuronal functions 
has been a relatively recent development (for review see Role and Berg, 1996), the ability of 
muscle nAChR to permeate not only monovalent but also divalent cations has been known 
for some time (Bregestovski et al., 1979). However, at the neuromuscular junction, activation 
of muscle nAChR yields primarily Na+ entry and subsequent depolarisation of the muscle 
cells. As a result, intracellular Ca2+ increases during neuromuscular synaptic activation will 
be a primary consequence of the activation of VOCC and Ca2+ release from the 
sarcoplasmic reticulum (Martonosi et al., 1984). For some time, this mechanism for the 
generation of Ca2+ signals after nicotine activation was also translated to neuronal nAChR, 
which were not considered as direct mediators of significant changes in intracellular Ca2+ 
concentrations.
This assumption has dramatically changed in the last decade, when an increasing amount of 
studies have demonstrated the relative Ca2+ permeability of nAChR in neuronal 
preparations. In freshly dissociated neurones from the medial habenula nucleus, Mulle et al. 
(1992) unequivocally demonstrated that Ca2+ permeates nAChR channels. Nicotine 
application after extracellular cations were replaced by 100 mM Ca2+ resulted in an inward 
current representing a significant fraction of that recorded in standard medium, suggesting
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that the single channel conductance in the pure CaCL external solution was comparable to 
that of NMDA receptors (see below).
Following these initial studies, several reports suggested that the Ca2+ permeability of 
nAChR could be directly related to their subunit composition, therefore proposing different 
patterns of nicotine evoked Ca2+ signals depending on the variable expression of nAChR 
subtypes. Accordingly, Ragozzino et al. (1998) demonstrated that a3p4 receptors have a 
slightly higher fractional Ca2+ conductance than a4 containing receptors, while Gerzanich et 
al. (1998) indicated that functional incorporation of the a5 subunit in heterologously 
expressed a3 containing human nAChR receptors significantly increased Ca2+ permeability.
Although selective Ca2+ permeability is a common property of all nAChR, the homomeric a7 
subtype of nAChR appears to be the most highly permeable for Ca2+. An elegant study by 
Seguela et al. (1993) examined the relative Ca2+ permeability of the a7 nAChR by 
measuring changes in the reversal potential of the nicotine-induced current while changing 
the external Ca2+ concentration from 1 mM to 10 mM. A reversal shift of +3, +7 and +29 mV 
was observed for muscle nAChR, a3p4 and a7 nAChR respectively. Since the relative 
permeability of these cation-selective channels to Ca2+ versus Na+ is a function of the 
magnitude of the shift of the reversal potential, these results indicate that the relative 
permeability of the a7 nAChR to Ca2+ is greater than that of the other nAChR (Sands and 
Barish, 1991; Vernino et al., 1992), and corresponds to a permeability ratio (PCa:PNa) of 
approximately 20 (i.e. ~ 20 % of the fractional current is carried by Ca2+). Other studies of 
heterologously expressed a7 receptors by Sands et al (1993), in which barium was 
substituted for Ca2+ to minimise any contaminating influence of Ca2+-activated chloride 
currents, reported a similar PBa:PNa ratio of 17. In addition, studies carried out by 
Lindstrom and coworkers (1995) demonstrated that 11 % of the a7 fractional current was 
carried by Ca2+, compared to 3 % and 1 % of a4p2 and muscle nAChR respectively. 
However, it should also be noted that studies of a7 responses in cultured hippocampal 
neurones indicated that Ca2+ carried approximately 6 % of the current (Albuquerque et al.,
1997). In spite of these apparent discrepancies in the reported permeability, probably due to 
differences in experimental preparations, it is widely accepted that a7 nAChR are highly 
permeant to Ca2+, with a relative permeability of Ca2+ over Na+ similar or even higher than 
that of the NMDA glutamate receptor (Seguela et al 1993; Albuquerque et al 1997). It should 
be considered however, that the combination of rapid desensitisation and inward rectification 
in the a7 nAChR could lessen the sustained ion flux through these channels. As a result, the 
overall relative permeability cannot be taken as a direct index of the amplitude of evoked 
Ca2+ responses (further illustrated in Chapters 2 and 3).
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At present, the concept that nAChR are predominantly permeant to monovalent ions and 
serve mainly for the control of membrane potential, has been replaced by a more complex 
hypothesis, in which nAChR channels with significant Ca2+ permeability would also be 
capable of functioning as direct regulators of intracellular signal transduction pathways (see 
Chapter 4). Consistent with this theory, it has been shown that Ca2+ entry through nAChR 
channels can increase intracellular Ca2+ concentration up to the micromolar range, a level 
sufficient for the activation of Ca2+-dependent regulatory processes (Mulle et al., 1992).
1.1.6 Cellular localisation of nAChR
Functional neuronal nAChR can be located on a cholinergic cell or a cholinergic target (i.e., 
a cholinoceptive cell). Both types of neuronal nAChR can be present on membranes of the 
cell body, dendrites, axon or nerve terminals, while functional studies have suggested that 
neuronal nAChR may also occur in “preterminar membranes, i.e., on the axon before the 
spread of nerve terminals (see Wonnacott, 1997). In fact, on the basis of both 
electrophysiological and transmitter release studies, it has become a common notion that 
neuronal nAChR are often presynaptic, meaning that they are modulators of the release of 
various transmitters, including ACh itself (McGehee and Role 1995; Wonnacott 1997). As a 
result, this terminal or presynaptic location makes possible the modulation of several brain 
functions, possibly underlying several of the behavioural consequences of neuronal nAChR 
activation.
In the peripheral nervous system, neuronal nAChR located on terminals, cell bodies and 
dendrites of autonomic ganglionic neurons are well characterised from a morphological and 
functional standpoint (Ullian et al., 1997; Zhang et al., 1996). In the CNS, the demonstration 
of functional neuronal nAChR on cell body/dendrite membranes comes mainly from 
electrophysiological studies, and although nicotinic responses are less easy to detect than 
for instance, glutamate responses, much evidence has accumulated for neuronal nAChR on 
cell bodies/dendrites in a number of CNS regions, including the thalamic nuclei (Lena and 
Changeux, 1997), cerebral cortex (Roerig et al., 1997; Xiang et al., 1998), ventral tegmental 
area (Blaha and Winn, 1993; Calabresi et al., 1989), hippocampal pyramidal cells and 
intemeurons (Alkondon and Albuquerque, 1993; Alkondon et al., 1998; Frazier et al., 1998), 
and locus coeruleus (Egan and North, 1986).
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1.1.7 Distribution of nAChR in the nervous system
Several methodologies, including high affinity ligand binding and immunolabelling, have 
been used to detect and study the distribution of nAChR in the nervous system. However, it 
was the availability of subunit specific complementary RNA probes that has permitted the 
analysis of the distribution of nAChR subunit mRNAs in different areas of the nervous 
system.
In autonomic ganglia neurones, where ACh mediates rapid synaptic transmission, nAChR 
have been characterised extensively (Conroy and Berg, 1995). Neonatal rat sympathetic 
ganglia contain mRNAs for a3, a5, a7, 02 and 04, but no mRNA for a2, a4 or 03 (see 
Sargent, 2000). In the CNS, distribution studies of specific molecular probes have shown 
that expression of nAChR subunit mRNAs is widespread, with most regions of the brain 
expressing significant quantities of at least one subunit. The patterns of expression differ, 
with some subunits being much less common than others. For example, high concentrations 
of a2 transcripts were only found in the interpeduncular area of the rat, with small amounts 
detected at limited number of other sites. On the other hand, the a4 mRNA is strongly 
expressed in a large number of brain regions, although its distribution is less widespread 
than that of 02 (Wada et al., 1989). Among the 0 subunits, 02 mRNA expression was found 
in almost all parts of the brain, including sites with no high affinity [3H]-nicotine binding, 
where they are presumably assembled with a subunits other than the a4 (Wada et al., 
1989). The 04 subunit was found in the medial habenula (Duvoisin et al., 1989), with lower 
expression at other loci (Dineley-Miller and Patrick, 1992). Finally, a7 mRNA is found in 
most regions of the brain, but particularly high levels are found in the amygdala, olfactory 
regions, and distinct layers of the hippocampus and cerebral cortex (Seguela et al., 1993).
Although providing very useful information, in situ hybridisation techniques can only identify
cells which express mRNAs for particular subunits, but cannot predict the quantity of that
subunit present on the cell surface nor the composition of the receptor and its distribution
along the neuron. For that reason, additional mapping studies have been carried out in the
CNS using high affinity ligand binding and immunocytochemical detection. The extensive
expression of a7, a4 and 02 mRNAs fits well with studies showing the wide distribution of
high affinity [125l]-a-Bgt and [3H]-nicotine binding sites. High affinity [3H]-nicotine or [3H]-ACh
binding is highest within the interpeduncular nucleus, all thalamic nuclei except the posterior
group and intralaminar nucleus, the superior colliculus and the medial habenula. Binding
was also noted in the substantia nigra pars compacta, the ventral tegmental area, the
molecular layer of the dentate gyrus, the presubiculum and in layers I and 11 I/I V of the
cerebral cortex (although not equally in all parts of the cerebrum). When specific antibodies
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for the p2 subunit were used, they produced a pattern of binding that is generally similar to 
that seen with [3H]-nicotine (Swanson et al., 1987; Hill et al., 1993), which is consistent with 
the fact that virtually all high affinity nicotine binding to rat brain extracts is 
immunoprecipitated by an antibody against the p2 subunit (Flores et al., 1992; Lindstrom, 
2000). The pattern of [125l]-a-Bgt binding is distinct from that seen with [3H]-nicotine, and is 
highest in the cerebral cortex (especially layers I, IV, V and VI), olfactory bulb, hypothalamus 
and hippocampus (Clarke et al., 1985).
1.1.8 Brain cholinergic pathways
The study of the neuronal nAChR ditribution constitutes a fundamental question in the 
process of understanding the role of nAChR in the CNS. In pursuing this objective, the 
investigation of the cholinergic source responsible for the activation of nAChR is, in many 
cases, left unattended. In fact, acetylcholine is one of the most ubiquitous neurotransmitters 
in the mammalian nervous system, and a cholinergic neuron (i.e., a neuron that utilises ACh 
as a neurotransmitter) has several specific neurochemical features: a releasable pool of 
ACh; the enzyme necessary for ACh synthesis, i.e., choline acetyltransferase; the uptake 
site for choline; and the vesicular ACh transporter. The cholinergic innervation of a given 
brain structure can be intrinsic or extrinsic. The innervation of the striatum, for example, is 
almost exclusively intrinsic and arises from cholinergic interneurons. In contrast, the 
cholinergic innervation of limbic structures, neocortex, thalamus and superior colliculus is 
predominantly extrinsic. The anatomical studies of cholinergic pathways has defined several 
cholinergic systems, capable of inervating various brain regions:
The Basal Telencephalic System is comprised of several large clusters of cholinergic 
neurons, present in the ventral part of the telencephalon, where, intermingled with different 
proportions of non-cholinergic neurons, they are detected in a more or less continuous strip. 
This series of nuclei comprises (from rostral to caudal levels) the medial septum (MS), the 
nucleus of the vertical (VDB) and horizontal limb (HDB) of the diagonal band of Broca, the 
magnocellular preoptic area (MPA), the ventral pallidum (VP), the globus pallidus (GP), the 
substantia innominata (SI), the basal nucleus of Meynert (MY) and the nucleus of the ansa 
lenticularis (AL). Four principal clusters are distinguished among this basal telencephalic 
system, which gives origin to four main projection pathways:
- From MS and VDB to the hippocampal formation
- From VDB, HDB, MPA and SI to medial neocortex
- From MPA, SI, MY and AL to lateral neocortex, limbic cortex and amygdala
- From HDB to alfactory bulb
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The connectivity of basal telencephalic cholinergic neurons has important functional 
consequences, as it has been shown that single cholinergic neurons innervate a relatively 
restricted zone of the cortex. At the level of cell bodies, cholinergic neurons are densely 
interconnected via dendro-dendritic synapses and functional studies show that even sparse 
projections to the basal telencephalic system can cause global release of ACh in the cortex 
(see Butcher, 1992).
In the striatum, a population of cholinergic intemeurons that constitute the striatal system 
represent one of the two main populations of interneurons, although only corresponding to a 
small percentage (1-2 %) of the overall striatal neuronal population. In spite of its size, the 
population of striatal cholinergic interneurons produces the densest network of cholinergic 
terminals in the brain (Contant et al., 1996). Other cholinergic systems have been also 
described, including the mesopontine tegmental system, with the highest density of 
neurones located in the pedunculopontine tegmental, laterodorsal tegmental and 
parabigeminal nuclei. Their projections are rather widespread, including several thalamic 
nuclei, the basal ganglia (substantia nigra and ventral tegmental area), basal telencephalic 
cholinergic nuclei and catecholaminergic brain stem nuclei. Notably, projections of the 
mesopontine tegmental system are not overlapping with those of the basal telencephalic 
system. Cholinergic systems have been also described at the brain stem and spinal cord 
motor nuclei, the medullary tegmentum, the peripheral ganglia and the retina, while it 
continues to be debated whether or not cholinergic interneurons exist in the cerebral cortex, 
hippocampus, olfactory bulb and anterior olfactory nucleus of the rat.
In spite of their widespread distribution, the density of cholinergic fibers in neocortex and 
thalamic nuclei shows major regional variations (Descarries et al., 1997). For example, 
limbic and paralimbic areas of the cerebral cortex contain a far denser concentration of 
presynaptic cholinergic markers than immediately adjacent sensory association areas. 
These limbic and paralimbic areas also seem to be the only parts of the cerebral cortex that 
have substantial projections back into the basal forebrain cholinergic cell groups. Some of 
these characteristics may reflect the importance of cholinergic innervation to learning and 
memory processes. In fact, acetylcholine plays a special role in the cellular events that 
underlie learning, as demonstrated by the direct role of cholinergic transmission in the 
establishment of hippocampal long-term potentiation (Matsuyama et al., 2000). Because of 
this selective concentration, cholinergic agonists may have a relatively greater impact on 
limbic and paralimbic parts of the brain, areas that are known to play a major role in the 
organisation of memory and learning.
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1.1.9 Neurotransmission in cholinergic synapses
In physiological conditions neuronal nAChR are activated by ACh binding, although the <x7 
subtype of nAChR may, in addition, be activated by choline (see Chapter 1, part 1.3.2.5). In 
both cases, it is assumed that activation of neuronal nAChR depends on signals deriving 
from cholinergic cells at synaptic contacts. However, almost none of the ultrastructural 
investigations on cholinergic terminals were designed for measuring the frequency with 
which cholinergic axon terminals, boutons or varicosities are engaged in synaptic contact. 
Results obtained from more recent ultrastructural studies showed that in several key areas 
involved in cholinergic transmission, cholinergic terminals presented a low frequency of 
junctional specialisation (Descarries et al., 1997). These observations imply that rather than 
a brief pulse of a high concentration (mM) of ACh delivered across the synaptic cleft, ACh 
may be required to diffuse to adjacent terminals, achieving a lower concentration (^M-nM) 
but for a longer duration. This hypothesis must assume that sufficient ACh will escape 
hydrolysis by acetylcholinesterase, while the sensitivity of particular neuronal nAChR 
subtypes to ACh, and their propensity to desensitise may become important factors in 
shaping their responsiveness.
Following the above-mentioned observations, the relevance of assessing the spatial 
relationships between cholinergic neurons and neuronal nAChR is manifestly obvious. 
Double immunolabelling with choline-acetyltransferase and nAChR subunit antibodies would 
be the technique of choice for this assessment. Unfortunately, most of the data regarding 
precise subunit localisation derives from in situ hybridisation, a technique that gives no 
information on the subcellular distribution of the receptor protein.
1.1.9.1 Wiring versus Volume transmission
In the last decade, the concept that other types of interneuronal, and in general intercellular,
communication besides synaptic transmission exist in the CNS is gaining consensus (Agnati
et al., 1995; Agnati and Fuxe, 2000). Communication between cells following migration of
the transmitter in the cerebral extracellular space has been defined as volume transmission,
as opposed to the synaptic communication, which is defined as wiring transmission. Much
structural evidence points to the fact that cholinergic transmission in several CNS nuclei is
mostly of the volume type. As an example, in both target areas of the basal telencephalic
system (neocortex and hippocampus) as well as in the neostriatum of the rat, the
percentage of cholinergic varicosities (i.e.: release sites of ACh) that make synaptic contact
is only around 10 % (Descarries et al., 1997). This observed asynaptic character and high
density of innervation by ACh neurons in many CNS regions has led to the proposal that a
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continuous cholinergic tone exists in some brain regions. According to this hypothesis, there 
would exist, at least in brain regions densely innervated by cholinergic neurons, an ambient 
level of extracellular ACh to which all tissue elements would be continually exposed 
(Descarries et al., 1997). This ambient level would be maintained by the spontaneous or 
evoked release from non-junctional cholinergic varicosities and ACh spill-over beyond the 
synaptic interfaces of the few junctional ones. In this context, enzymatic degradation by 
acetylcholinesterase (AChE) would primarily serve to keep the ambient level of ACh within 
certain limits, rather than totally eliminate ACh from the extracellular space. Supporting the 
ultrastructural evidence, an increasing amount of microdialysis data seems to indicate the 
presence of a steady state, resting or basal level of ACh in the extracellular space of 
different CNS regions. Spontaneous ACh dialysis outputs in the nanomolar range have been 
repeatedly measured in cerebral cortex, hippocampus or neostriatum of freely moving rats 
(Damsma et al., 1988; Nilsson et al., 1990; Messamore et al., 1993). In addition, a series of 
studies performed in rodents have provided strong evidence for the localisation of the CNS 
predominant molecular form of acetylcholinesterase (G4) in a distinct compartment separate 
from the junctional area (see Descarries, 1997), leading the belief that this form of the 
enzyme primarily serves to eliminate ACh molecules which spill over from the synaptic cleft.
Experimental and theoretical models have been proposed to evaluate the diffusion of 
transmitter molecules in living CNS tissue, which take into account physical factors such as 
re-uptake, degradation and loss at blood-brain boundaries (Descarries et al., 1997 and 
references therein). Much of the current work is devoted to dopamine (DA) and nitric oxide 
and unfortunately little is known about ACh. In the case of neostriatal DA however, it has 
been calculated that transmitter molecules should be found 10 ^m away from release site 
within 50 msec. In a region as densely innervated as the neostriatum, 10 |xm is not a short 
distance, at least at the scale of axon varicosities. Based on currently available quantitative 
data on dopamine and ACh innervation density (Doucet et al., 1986; Contant et al., 1996), it 
may be calculated that a sphere of neostriatal neuropil 10 p.M in radius comprises about 400 
dopamine and at least as many ACh terminals, five to ten times more unidentified axon 
terminals and at least several thousand dendritic spines!
The realisation that a significant part of the cholinergic transmission in the CNS may be 
composed of non-classical synaptic contact fits well with the proposed role of nAChR as 
modulators of neuronal function. In theory, both terminal and/or somatodendritic nAChR 
could be regulated by relatively low levels of acetylcholine, able to sustain a basal tone 
stimulation, or even desensitisation, of nAChR. This may have even further significance in 
the case of a7 nAChR, which can be activated by the metabolite of acetylcholine, choline. 
Overall, the integration of classical and non-classical interneuronal contacts may constitute a
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1.2 nAChR and Disease
1.2.1 Tobacco smoking and nAChR stimulation: the bad, 
the ugly, and the good?
In the process of investigating the function of nAChR in the brain, the study of the effects of 
tobacco smoking has played a significant role. A clear example of this interrelation is given 
by the examination of the addictive and anxiolitic properties of tobacco consumption, which 
are closely related with the neuronal consequences of nAChR activation. In general, nicotine 
is regarded as a toxic and addictive substance, and this negative perception certainly stems 
from nicotine’s presence in tobacco and the many adverse consequences associated with 
cigarette smoking. In reality, it is generally accepted that the well-known adverse effects of 
smoking are largely not attributed to nicotine, as cigarette smoke contains many toxic 
bioactive substances that are sought to be more harmful than nicotine. There is no doubt, 
however, that nicotine has some major liabilities, which include its addictive properties and 
adverse effects on the cardiovascular and gastrointestinal systems (for review see Decker 
and Americ, 1999).
Although a significant part of human nicotine research has focused on the understanding of 
nicotine addiction, it has become increasingly accepted in the last 15 years that nicotine can 
have some beneficial effects on human illness, including neurological disorders such as 
Alzheimer’s (AD) and Parkinson’s disease (PD; Donnelly-Roberts and Brioni, 1999). 
Unexpectedly, some of the initial evidence came from studies of tobacco consumption. In 
the case of PD, the epidemiological findings suggested that cigarette smoking was 
negatively correlated with the progression of the disease and, although part of the 
epidemiological evidence has been controversial, a series of studies by Morens et al. (1994,
1995) demonstrated that tobacco smoking reduces the risk of developing PD and, more 
important, that this relationship is not due to any obvious confounding factors (Morens et al.,
1996). In addition, an inverse correlation between tobacco smoking and the progression of 
other neurodegenerative diseases of the brain, like AD, has also been reported. 
Epidemiological studies show that smokers have a lower risk of developing AD than non- 
smokers, even when other factors (i.e.: age) are controlled (Tyas, 2000). In addition, Van 
Duijn and Hof man (1991), showed how tobacco smoking might be positively correlated with 
the delayed onset of AD, while a more recent retrospective case-control autopsy study by 
Ulrich and colleagues (1997) suggested that an apparent protective action against senile 
plaque formation could be demonstrated. As a result, the findings reported from 
epidemiological investigations indicated a potential role for nicotine in the therapy of
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neurodegenerative diseases. AD, in particular, has been the foremost therapeutic objective, 
partly because epidemiological reports have been complemented with studies linking 
activation of the nAChR with hippocampal function and the process of cognition (this will be 
further discussed in Chapter 2), but also for the more prosaic reason that substantial 
economic rewards will surely follow a “successful” therapy for AD.
In addition to AD and PD, nAChR have been also associated with schizophrenia, which 
constitutes one of the most disturbing disorders of neurological function. Similar to the 
situation with the neurodegenerative diseases, part of the evidence for the involvement of 
nAChR came from epidemiological studies of tobacco smokers, which showed how 
schizophrenic patients are particularly heavy smokers, even when compared with other 
psychiatric patients (for review see Stitzel et al., 2000). It was therefore suggested that this 
heavy tobacco use might reflect an attempt at self-medication of an endogenous neuronal 
deficit. When considering the actual experimental data, much of the support for the role of 
nAChR in shizophrenia came from studies of paired pulse inhibition, a method developed for 
the analysis of neuronal mechanisms related to the filtering of sensory inputs to higher brain 
centers. Clinical evidence suggested that the apparent attention to extraneous stimuli in their 
surroundings, which is observed in schizophrenics but ignored in normal individuals, is 
related to the inability to filter sensory stimuli (Waldo et al., 1991). Using an electrically 
positive evoked potential occurring 50 ms after an auditory stimulus, it was established that 
both normal humans and rodents showed similar decreased responses to a repeated 
auditory stimulus (Adler et al., 1986; Freedman et al., 1991). This function was shown to be 
deficient in schizophrenic patients (Adler et al., 1998). More precise neuronal recordings 
identified the pyramidal neurones of the hippocampus as a major source of the rat evoked 
potential in auditory stimulus, and showed that these pyramidal neurones have a 
decremented response to repeated auditory stimuli that parallels the decrement in the 
evoked potential (Bickford-Wimer et al., 1990). This observed decrement is lost after 
transection of the fimbria-fornix, a fibre tract that includes afferents to the hippocampus from 
cholinergic neurones in the basal forebrain. Moreover, nicotine normalises the inhibition of 
response (Bickford and Wear, 1995). The inhibition is also selectively blocked by a-Bgt 
(Luntz-Leybman et al., 1992), which suggests that the a7 nAChR receptor mediates 
nicotine’s effects. Consistent with this apparent involvement of nAChR function in some of 
the neuronal processes affected in schizophrenia, a report by Freedman et al. (1997) has 
indicated that the auditory sensory deficit observed in schizophrenic patients is genetically 
linked to the locus of the a7 nAChR gene on chromosome 15q14.
At present, it is widely recognised that nAChR are involved in a variety of diseases affecting 
both the nervous system and non-neuronal tissue. These alterations can be divided into
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those occurring during development (Tourette’s syndrome and schizophrenia), those 
occurring at any stage of life (epilepsy or depression), and those associated with aging 
(Alzheimer’s and Parkinson’s disease, and dementia). The evidence for an involvement of 
nAChR is supported, in some cases, by direct results showing the nAChR role in the 
affected brain, while in many others, clinical improvement after nicotine consumption or even 
tobacco smoking is the sole indicator for a nAChR role. Although it should be considered 
that the therapeutic benefits might not imply the specific involvement of nAChR in the cause 
or symptoms of the disease, increasing evidence suggests that abnormalities in nAChR 
neurotransmission can be associated to various human diseases. Some of the possible 
mechanisms behind the apparently wide scope of nAChR action in neuronal disease will be 




Although the functional role of nAChR in the CNS is far from being resolved, some of the 
physiological implications of nAChR stimulation appear to be related to the 
regulation/modulation of synaptic plasticity and cognitive processes (see below). In addition, 
the putatively protective properties of nAChR activation can also help in preventing the 
neuronal loss observed in neurodegenerative disorders, like Alzheimer’s, while at the same 
time, contribute to the cognitive function. Considering that the hippocampus is a key area for 
memory processing in the brain and one that is affected in the progression of AD, it 
constitutes a relevant model for the study of nAChR function in the CNS (see Chapters 2, 4 
and 5).
1.3.1 The hippocampal region
It was back in the sixteenth century that the anatomist Arantius introduced the term 
hippocampus, which literally means “horse-caterpillar”, to describe a particular area of the 
brain. In actual fact, the hippocampal region presents, perhaps more than any other part of 
the brain, many highly formalised and instantly recognisable neuronal assemblages, “so 
distinctive that cytoarchitectonic boundaries are unmistakable” (Angevine, 1965).
The hippocampal region has been subdivided into the hippocampal and retrohippocampal 
formation, with the latter being divided in the pre- and para-subiculum, the parahippocampal 
cortex and the enthorhinal cortex, which is continuous with the neocortex (Fig 1.4). The 
hippocampal formation itself is probably the one most thoroughly studied, and can be 
divided into dentate gyrus (area dentate), hippocampus proper (cornu ammonis, CA) and 
subiculum. Each area is defined by individually distinct cell layers, which are summarised in 
Fig 1.4.
The hippocampus proper has been divided in CA1, CA2 and CA3 regions, areas that play a 
crucial part in the understanding of hippocampal neuronal circuitry. These CA fields form a 
large flap of tightly packed pyramid-shaped neurones that is folded and tucked under the 
edge of the neocortex. Pyramidal neurons in the hippocampus proper exhibit a large primary 
apical dendrite with numerous higher order branches and many radially orientated basal 
dendrites. Their axons arise either from the perikaryon or from a proximal segment of a 
basal dendrite. Different anatomical layers have been described in the hippocampus proper, 
which give rise to its lamellar neuroarchitecture. The stratum moleculare contains dendritic 
processes from pyramidal cells projecting from other layers. Next to this layer is the stratum
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lacunosum with many irregularly spaced cells and a rather large number of fibers projected 
from other layers. Some fibers end in this layer, while others project into the stratum 
moleculare. Then follows the stratum radiatum, populated with few non-pyramidal neurons 
and containing many fiber systems coursing through it from various points of origin. Also 
present is a dense network of dendritic arborisations characteristic of the pyramidal 
neurones from the stratum pyramidale situated next to it. The stratum oriens, with its densely 
packed polymorphic cells that project to other parts of the hippocampus, lies adjacent to the 
stratum pyramidale from which receive fibers. Then follows the alveus, which for the most 






























Fig 1.4 The anatomy of the Hippocampus
The description of the defining components of the hippocampus is based on the appearance of the 
region in horizontal sections. The hippocampal region has been divided into two main formations and 
various regions and layers. The hippocampal formation itself can be divided into the dentate gyrus 
(Area dentata), hippocampus proper and subiculum. The general organisation of the hippocampal 
region in relation to other brain areas is shown in the lower panel. In the case of the hippocampus 
proper, it has been divided in the CA1, CA2 and CA3 regions, which play a crucial role in the 
hippocampal neuronal circuitry (Adapted from Angevine, 1975 and Kandel, 2000).
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The second sheet of neurones in the hippocampal formation is the dentate gyrus, which 
contains round and also tightly packed neurons called granule cells. These cells extend two 
or more primary dendrites from one pole of the cell body, while their axons present a dense, 
mossy appearance, therefore called mossy fibers. The dentate gyrus is separated into three 
different layers. The stratum moleculare presents many fibers and a few neurones bearing 
short processes. Next to it is the densely packed granule cell layer (stratum granulosum) 
followed by a polymorphic zone (hilus fasciate dentate) composed of pyramidal, stellate and 
bipolar cells. These other morphological cell types (i.e., bipolar, multipolar and aspiny cells) 
largely correspond to local circuit neurons or interneurons (Milner and Bacon, 1989a, b; 
Banker and Goslin, 1991). The stratum moleculare of the dentate gyrus blends into the 
stratum lacunosum-moleculare of the hippocampus proper, while the stratum radiatum of the 
hippocampus fades out beneath the stratum moleculare-granulosum.
The relatively simple layered structure of the hippocampal region, together with its well- 
defined connections, made it a model area for the general study of synaptic mechanisms. 
The axons of pyramidal neurones from many neocortical association areas project into the 
entorhinal cortex, and information from this area is projected to the dentate gyrus of 
hippocampal formation via the subicullum, in the so called perforant pathway. This cortical 
information is processed in the hippocampus through a network of synaptic connections that 
is not yet completely understood. Three major pathways, called the trisynaptic loop, 
comprise the thoroughly studied and most important part of the hippocampal synaptic 
network:
- Perforant pathway, which projects from the enthorhinal cortex and makes synapses 
onto the granule cells of the dentate gyrus.
- Mossy fiber pathway, which contains the axons of granule cells and runs to the 
pyramidal cells in the CA3 region of the hippocampus proper. The pyramidal cells of 
the CA3 field produce branched axons, in which one leaves the hippocampus 
through the fimbria.
- The Schaeffer collateral pathways consist of the excitatory branches of the pyramidal 
cells in the CA3 region and ends on the pyramidal cells in the CA1 region of the 
hippocampus proper.
Axons of the CA1 pyramidal neurones project to dendrites of neurones in the subicullar 
complex and, to complete the circuit, these neurones send axons back to the entorhinal 
cortex. However, it has to be noted that apart from the trisynaptic loop described so far, all 
areas of the hippocampal formation, except the dentate gyrus, contain neurones that project
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to various other parts of the brain, mainly through the enthorinal cortex (Lavenex and 
Amaral, 2000).
1.3.2 nAChR in the hippocampal region
The hippocampus receives rich cholinergic innervation, mainly via the fimbria-fornix, from 
the medial septum-diagonal band complex (Woolf, 1991). Electron microscopy reveals 
choline-acetyltransferase-positive terminals synapsing on pyramidal neurones, intemeurons, 
granule cells and their dendrites (Frotscher, 1992). Those cholinergic afferents provide the 
main source of acetylcholine that activates endogenous nicotinic-cholinergic mechanisms. 
Indeed, mapping studies indicate that neuronal nAChR are present throughout the 
hippocampus, and in situ hybridisation experiments show that the strongest labelling by far 
corresponds to a7 nAChR subunits along with p2, with weaker labelling for a3, a4, a5, and 
P4 (Seguela et al., 1993; Zarei et al., 1999, and references therein). Immunocytochemical 
studies by Dominguez-del Toro et al. (1994) demonstrated that the a7 nAChR was the main 
subunit in the hippocampus. In accordance with this hippocampal high labelling of a7 
nAChR subunits, [125l]-a-Bgt binding has also been shown to be high in the hippocampus 
(Clarke, 1995). Additional evidence for the presence of a7 nAChR in the hippocampus came 
from the observed loss of [125l]-a-Bgt binding in a7 defficient mice (Orr-Urtreger et al 1997). 
A more recent study by Fabian-Fine et al. (2001) has reported the ultrastructural distribution 
of a7 nAChR subunits in the hippocampus. Light microscopic immunolabelling revealed 
diffuse a7 nAChR immunoreactivity throughout the cell bodies and cell processes of 
neurones in the dentate gyrus and CA3 and CA1 regions. Immunoreactivity was also visible 
in the dendritic fields of CA3 and CA1, and ultrastructural data revealed a widespread 
presynaptic and postsynaptic labelling (Fabian-Fine et al., 2001).
1.3.2.1 Nicotine-evoked ionic currents in hippocampal neurones
Hippocampal neuronal cultures
Much of the existing data on the nAChR function in the hippocampus has been carried out
using neuronal hippocampal cultures from rats. This approach allows the easy manipulation
of the neuronal environment, permitting also the detailed study of nAChR dependent ionic
currents (further analysis of different experimental preparations for the study of hippocampal
neurones is given in Chapter 2). Nicotine stimulated currents can be recorded in
hippocampal primary cultures from rats, and as Albuquerque and collaborators have
demonstrated, hippocampal neurones respond to nicotinic agonists with one of three types
of nicotinic whole-cell currents, named type IA, type II and type III (Fig 1.5). These nicotine-
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evoked currents are distinguished from one another on the basis of their kinetic and 
pharmacological properties. Type IA currents are by far the predominant response of 
hippocampal neurones to nicotinic agonists, and are characterised by fast desensitisation 
and blockade by a-Bgt, a-cobratoxin and methyllycaconitine (MLA; Alkondon and 
Albuquerque, 1993; Albuquerque et al., 1997). The fast kinetics of inactivation and the short 
lived open time of the nAChR channels subserving type IA currents accounts for the unique 
kinetic properties of these currents (Castro and Albuquerque, 1993). Type II and III currents 
desensitise more slowly and can only be recorded from a small population of the 
hippocampal neurones (Albuquerque et al., 1997). Aproximately 10 % of the hippocampal 
neurones in culture respond to nicotinic agonists with type II currents, whereas no more than 
2 % of neurones respond to the agonists with type III currents. Type II and III currents are 
differentiated from one another on their sensitivity to nicotinic antagonists. The activation of 
type II currents is inhibited by dihydro-p-erythroidine (DHpE, 10 nM), while type III currents 
are inhibited by low concentrations of mecamylamine (1 pM), as shown in Fig 1.5.






Fig 1.5 Nicotinic currents recorded from the hippocampus
The figure shows the typical family of whole-cell currents evoked by application of ACh to 
hippocampal neurones, and their sensitivity to blockade by nicotinic antagonists (Albuquerque et al., 
1997). Short pulses of ACh (3 mM; 1-2 s) were applied via a U-tube to hippocampal neurones at the 
time indicated by the arrows. Red traces represent the agonist evoked currents, whereas black traces 
correspond to currents recorded in the presence of different antagonists (applied by bath 
superfusion). Type IA currents are by far the predominant response, characterised by fast kinetics 
and short-lived open time. Type II and III currents desensitise more slowly and can only be recorded 
from a small population of hippocampal neurones in culture.
A comparison of the kinetic and pharmacological properties of the nicotine-evoked currents 
in hippocampal neurones to those elicited in oocytes by heterologously expressed nAChR 
led to the suggestion that an a7 bearing nAChR sub serves type IA currents, while an a4p2 
and an a3p4 subserve type II and III currents respectively (Albuquerque et al., 2000). These 
suggestions are in agreement with mRNA expression studies and with the proportion of 
cultured hippocampal neurons binding a-Bgt (see above, section 1.3.2). Although it is not 
completely clear if a7 containing nAChR are functional homomeric receptors in the brain, 
some recent evidence on the basis of Western blot analysis of neuronal a-Bgt binding
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receptors suggests that the rat neuronal a-Bgt binding nAChR is a homo-oligomer of a7 
subunits (Chen and Patrick, 1997).
The distribution of nAChR on the surface of hippocampal neurones was addressed by 
recording whole cell currents evoked by focal application of ACh (Alkondon et al., 1996). In 
brief, by using an infrared camera and computer-enhanced contrast images of the neuron it 
was possible to visualise precise areas of the neuronal surface and to estimate distances 
with a precision of 0.5-1 pm. The focal application of the agonist to well defined areas of the 
neuronal surface of hippocampal neurones and the exact location of recording electrode 
allowed the estimation of receptor density distribution (Alkondon et al., 1996). In effect, 
assuming that the peak amplitude of the current evoked by activation of a single receptor 
subtype is proportional to the number of individual receptors activated by the agonist, an 
estimate of the current density at different areas of the neuronal surface can provide 
important information about the receptor density distribution in such neuronal areas. From 
these estimations, Albuquerque and collaborators have shown that the density of type IA 
currents is substantially higher on the apical and basal dendrites of pyramidal neurones and 
on the dendrites of bipolar neurones than on the soma of these neurones (Albuquerque et 
al., 1997). The localisation of a7 nAChR in the hippocampus was also detected with the use 
of specific antibodies, where they were shown to be present along neuronal processes 
(Zarei et al., 1999). In effect, a correlation of a7 nAChR and the presynaptic marker 
synaptotagmin provided support for a synaptic location of the receptor (Zarei et al., 1999).
Hippocampal slices
Taking advantage of the knowledge made available by the studies carried out in cultured 
neurones, electrophysiological studies were also performed in conventional hippocampal 
slices. Evidence has been provided that in addition to functional a7 nAChR (Alkondon et al., 
1997; Frazier et al 1998; Jones and Yakel 1997), functional a4p2 nAChR are also present in 
CA1 interneurones, and that a single CA1 interneuron can express both a7 and a4p2 
nAChR (Alkondon et al., 1999).
Although functional a7 nAChR are also expressed by interneurones of the dentate gyrus 
(Jones and Yakel 1997), some reports have shown that these receptors are apparently not 
present in the soma and/or proximal dendrites of the principal (glutamatergic) neurones in 
the dentate gyrus and in the CA1 field of the hippocampus (Alkondon et al., 1997; Frazier et 
al., 1998; Jones and Yakel, 1997). It has been also reported that CA1 pyramidal neurones 
do not respond to ACh with currents that have typical characteristics of responses mediated 
by a7 nAChR (Alkondon et al., 1997; Frazier et al., 1998; Jones and Yakel, 1997). A more 
recent study showed that approximately 50 % of the CA1 pyramidal neurones recorded
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showed no response to ACh, whereas the other 50 % responded to ACh with slowly 
decaying currents that were insensitive to blockade by MLA (Alkondon et al., 1999). These 
results are in apparent discrepancy with the functional a7 nAChR reported to be present in 
the soma and proximal neurites of hippocamal neurones in culture (see above). However, 
the existence of nicotine-evoked a7-nAChR mediated post-synaptic currents in CA1 
pyramidal neurones after stimulation of the Schaffer collaterals was indeed demonstrated by 
Hefft et al. (1999) in organotypic hippocampal cultures and slices. In addition, a7 nAChR 
dependent currents were also detected in most of the CA1 pyramidal neurones after local 
application of acetylcholine in hippocampal slices (Ji et al., 2001). On the whole, these 
results are in agreement with the recent study by Fabian-Fine et al. (2001), describing the 
presence of a7 nAChR immunoreactivity in nearly all synapses in the CA1 stratum radiatum.
1.3.2.2 Functional characteristics of a7 nAChR in the hippocampus
The nAChR present on hippocampal neurones differ from one another not only with respect 
to their kinetics and pharmacology, but also with respect to single-channel properties, 
rectification, ion permeability and modulation by Ca2+. The type IA currents generated by a7 
nAChR show fast desensitisation in the presence of the agonist, intense rundown and 
inward rectification dependent on the presence of intracellular Mg2+ (Albuquerque, 1997). 
The a7 nAChR are also distinctive because of their brief open time (~100 ps at -80  mV) and 
high channel conductance (~73 pS). In addition, most of the important clues about the 
possible physiological roles of the a7 containing nAChR in the CNS were obtained from 
studies showing that these receptors have a very high permeability to Ca2+ (Seguela et al., 
1993; Castro and Albuquerque, 1995). By the analysis of reversal potentials of ACh-induced 
currents under various ionic conditions it was estimated that, close to the resting potential 
(~-50 mV) and in the presence of 1 mM extracellular Ca2+, approximately 6 % of the type IA 
current was carried by Ca2+ (Albuquerque et al., 1997). As illustrated previously (section 
1.1.5), this estimation is only slightly lower than the one calculated for a7 nAChR expressed 
in oocytes (Lindstrom, 1995), which was shown to be 11 %. In hippocampal measurements 
in particular, the Ca2+ entry through a7 nAChR appears to be equivalent to approximately 60 
% of that through the NMDA receptor. However, considering that the mean opening time and 
kinetics of inactivation of the NMDA receptor channel are much slower than those of the a7 
nAChR in hippocampal neurones (Castro and Albuquerque, 1993; Nelson and Albuquerque,
1994), the Ca2+ influx through the NMDA receptor should be longer lasting than that through 
the a7 nAChR. It is therefore likely that NMDA receptors and native neuronal a7 nAChR 
mediate qualitatively different Ca2+ signals (Teyler et al., 1994). This will be further discussed 
in Chapter 2 of this thesis.
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1.3.2.3 a7 nAChR-mediated synaptic transmission
Direct evidence for the mediation of synaptic transmission by neuronal nAChR in the 
mammalian CNS is very limited (for review see Albuquerque et al., 2000). The scattered 
distribution throughout the CNS of cholinergic projections and nAChR-containig targets and 
the rapid desensitisation of nAChR in general and a7 nAChR in particular have made 
difficult the isolation of nAChR mediated synaptic transmission in the brain. In fact, it was the 
development of rapid drug delivery systems and visualised recording techniques in slice 
preparations that allowed the detection of <x7 post-synaptic currents in the hippocampus 
(Albuquerque et al., 2000). In addition, only the use of precise pharmacological tools made it 
possible to isolate the a7 nAChR evoked currents from the variety of EPSCs that can be 
elicited by electrical stimulation.
Two reports, appearing almost simultaneously, described how the stimulation of afferent 
fibres in the stratum radiatum or stratum oriens of area CA1 of the hippocampus produced 
a7 nAChR mediated excitatory postsynaptic currents recorded on hippocampal interneurons 
(Alkondon et al., 1998; Frazier et al., 1998). These postsynaptic currents had their frequency 
and amplitude reversibly reduced by the selective a7 nAChR antagonists MLA and a-Bgt, 
and were desensitised by the application of nicotine.
The activation of hippocampal GABAergic interneurons by cholinergic afferents from the 
medial septum could result in the inhibition of pyramidal neurones. Interestingly, it has been 
previously shown that EPSPs can be mediated by muscarinic receptors in CA1 pyramidal 
neurones (Cole and Nicoll, 1983). Altogether these findings may indicate that the transient 
inhibitory effect mediated by a7 nAChR stimulated GABA neurones, would be opposed by 
slow cholinergic EPSPs in the pyramidal cells. The combination of a slow excitatory potential 
(Cole and Nicoll, 1983) with synchronised transient IPSPs might provide a mechanism that 
could underlie theta rhythm activity. Such patterns of firing have been hypothesised to be an 
important component of the endogenous patterns of activity that can induce long-term 
potentiation (LTP) at hippocampal CA1 synapses. In addition, Albuquerque and 
collaborators proposed a more complex picture of the nAChR role in the hippocampal 
circuitry. In effect, the finding that treatment of hippocampal slices with nAChR antagonists 
(MLA and DHpE) causes an increase in the frequency and amplitude of the GABA-mediated 
post-synaptic currents (Alkondon et al., 1999) led to the suggestion that in the CA1 field of 
the hippocampus there should be a neuronal network composed of the following circuitry: 
cholinergic neuron-nAChR bearing interneuron-interneuron-intemeuron. This could result in 
the nAChR-mediated stimulation of the first intemeuron and the disinhibition of the activity of 
the third intemeuron. Consequently, nAChR activation in interneurones that synapse directly
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onto pyramidal neurones is likely to inhibit the activity of the latter, whereas activation of 
nAChR in intemeurones that innervate other intemeurones would cause disinhibition of the 
pyramidal neuron.
1.3.2.4 Presynaptic a7 nAChR in the hippocampus
The initial difficulty in detecting excitatory nicotinic postsynaptic responses evoked by 
nAChR stimulation or electrical stimulation of nerve fibres in the brain led to the hypothesis 
that nAChR may play a role in modulating rather than mediating transmission.
In hippocampal preparations, CA3 pyramidal neurones respond to nicotine with an increase 
in the rate of spontaneous miniature excitatory postsynaptic currents (mEPSCs) and in the 
amplitude of evoked EPSCs (Radcliffe and Dani, 1998). Evidence for this effect being 
mediated by presynaptic nAChR is given by the fact that the nicotine-evoked effect on 
miniature-EPSCs frequency can be blocked by glutamate receptor antagonists and is absent 
in the presence of Ca2+ free buffer (Gray et al., 1996). Presynaptic a7 nAChR were shown to 
be responsible for nicotine’s effect and a7 nAChR were indeed capable of directly mediating 
the presynaptic terminal Ca2+ influx responsible for the enhanced glutamate release 
(Radcliffe and Dani, 1998). These findings indicate that properly timed nicotinic activation 
can alter the output signal of pyramidal neurones excited by glutamate released from 
presynaptic glutamatergic afferents. When considering the previously illustrated role of 
nAChR in GABAergic intemeurones, it is possible to speculate that the activation of 
cholinergic fibers synapsing onto GABAergic and glutamatergic neurones can take the full 
control of timing inhibitory and excitatory signals to hippocampal pyramidal neurones (for 
review see Albuquerque et al., 2000)
1.3.2.5 Activation of the a7 nAChR by choline
Studies of the efficacy and potency of various agonists in activating different subtypes of 
neuronal nAChR have led to the discovery that choline, the metabolic product of ACh 
degradation in vivo, is able to act as a very efficacious agonist at a7 nAChR in hippocampal 
neurones (Albuquerque et al., 1997). Choline evokes no response in neurones that respond 
to ACh with type II currents, which indicates that it does not activate the a4p2 subtype of 
nAChR. Thus, the concept that ACh hydrolysis is the means by which cholinergic activity 
ends in vivo appears to be true for the cholinergic functions mediated by most nAChR 
subtypes, with the exception of the a7 nAChR.
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There has been no experimental determination of the concentrations of ACh and choline in 
the synaptic cleft. However, it has been demonstrated that the a7 nAChR is sensitive to 
activation by a choline concentration as low as 200 pM and it can be desensitised with a 
concentration of 35 pM (Alkondon et al., 1997). Overall, considering that choline uptake into 
the presynaptic terminal is a slow process, the concentration of choline in the synaptic cleft 
during synaptic activity could be sufficient to lead to the activation and/or desensitisation of 
a7 nAChR. In fact, levels of choline may subserve a tonic basal modulation on both synaptic 
and non-synaptic sites, which is in agreement with the postulated existence of volume 
transmission in cholinergic systems.
1.3.3 Memory processing and synaptic plasticity
The hippocampus is well known as a critically important structure for attention and memory 
processing (for review see Jarrard, 1995). As illustrated above, stimulation of nAChR 
facilitates hippocampal synaptic activity, and behavioural pharmacology studies of nicotinic 
agonist and antagonist effects on cognitive performance have shown that nicotine 
stimulation can improve performance on cognitive tasks, while nicotinic antagonists such as 
mecamylamine can impair it (Levin and Simon, 1998).
Learning and memory processes are the most important mechanisms by which the 
environment alters behaviour. Learning being the process of acquiring knowledge about the 
world, and memory the process by which that knowledge is encoded, stored, and later 
retrieved. Enduring memories appear to be stored, at least in part, as structural changes at 
specific synapses within neuronal networks, which encode and connect the sensory 
impressions associated with each memory. These structural changes are thought to occur in 
the neocortex. As an example, extensive bilateral lesions of the limbic association areas 
produces devastating memory deficits characterised by the inability to transfer new short­
term memory into long-term memory. Lesion models have also provided insights into the 
nicotinic involvement in hippocampal cognitive function. In effect, nicotine reverses attention 
and memory impairments caused by basal forebrain lesions in rats, while ablation of the 
pathway from the septum to the hippocampus causes significant deficits in memory 
processes (Levin and Simon, 1998).
The theory that information storage is related to changes in synaptic efficacy has been 
established for a long time. Although derived from early studies of Cajal and Sherrington, 
Hebb further developed this concept in the late 1940’s, suggesting the existence of activity 
dependent changes in synaptic efficiency. At present, it is widely recognised that the
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strength of the connection between a presynaptic and postsynaptic neuron exhibits a 
remarkable degree of plasticity. The first of such synapses to be identified in the mamallian 
brain was the excitatory connection made by perforant path fibres onto granule cells of the 
hippocampus (Bliss and Lomo, 1973; Bliss and Gardner-Medwin, 1973). Brief trains of high 
frequency stimulation to monosynaptic excitatory pathways in the hippocampus cause an 
abrupt and sustained increase in the efficiency of synaptic transmission, an effect called 
LTP. Since then, changes in the efficacy of synaptic transmission have been associated with 
short-term adaptation to sensory inputs, changes in behavioural states associated with 
arousal and short-term memory. More lasting changes have been associated with neuronal 
development in the immature nervous system and with long-term memory in the mature 
nervous system. At present, it is possible to say that synaptic transmission can be either 
enhanced or depressed, and these alterations could span a wide range of time scales, from 
a transient few milliseconds to enduring modifications that persist for days, weeks and 
maybe longer (Malenka and Siegelbaum, 2000).
When considering the diverse functions and time scales observed in synaptic plasticity 
phenomena, it is not surprising that a large number of mechanisms have been described. 
These include a large set of pre- and post-synaptic mechanisms extensively described in 
invertebrate organisms (Kandel, 2000). However, perhaps no other form of synaptic 
plasticity has generated more interest than the LTP in the hippocampal formation. In 
particular, several aspects of hippocampal LTP have made it a suitable model for memory 
processing in mammalian brain:
- Evidence from lesion studies in rodents and higher primates, including humans, 
shows that the hippocampus is a critical component of a neural system involved in 
the initial storage of certain forms of long-term memory (Zola-Morgan and Squire, 
1993).
- Several properties of LTP make it, in theory, an attractive cellular mechanism for 
information storage (for review see Bliss and Collingridge, 1993). Like memories, 
LTP can be generated rapidly and be prolonged and strengthened with repetition. It 
exhibits input specificity (Andersen et al., 1977), such that LTP is elicited primarily at 
the synapses stimulated by afferent activity, but not at adjacent synapses on the 
same postsynaptic cell. This may increase dramatically the storage capacity in 
neuronal circuits.
- LTP is also associative (McNaughton et al., 1978), meaning that temporally pairing 
activity in a “weak” input (incapable of generating LTP by itself) with activation of a 
strong input (capable of generating LTP at adjacent synapses on the same
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postsynaptic cell) results in the LTP of the ‘Weak” input. This associative property is 
reminiscent of classical behavioural conditioning.
- LTP is readily triggered in in vitro slice preparations of the hippocampus, making it 
accessible to rigorous experimental analysis. Indeed much of what is known about 
the detailed cellular mechanisms of LTP derives from studies on two types of 
excitatory synapses in hippocampal slices: synapses between the Schaffer collateral- 
commisural axons and the apical dendrites of CA1 pyramidal cells; and synapses 
between the mossy fiber terminals of dentate granule cells and the dendrites of CA3 
pyramidal cells.
- Finally, LTP has been observed at virtually every excitatory synapse in the 
mammalian brain that has been studied. This includes excitatory synapses in 
different regions of the hippocampus; all areas and layers of the cortex, including 
visual, somatosensory, motor, and prefrontal; the amygdala; the thalamus; the 
neostriatum and nucleus accumbens, the ventral tegmental area; and the 
cerebellum. Thus, LTP appears to be a ubiquitous property of mammalian excitatory 
synapses and may subserve a variety of functions in addition to its postulated role in 
learning and memory (for review see Malenka and Siegelbaum, 2000).
1.3.3.1 Induction of LTP: role of LGIC and Ca2+
Bliss and his colleagues first described LTP at glutamatergic excitatory synapses in the 
dentate gyrus in vivo in the early 1970’s (Bliss and Gardner-Medwin, 1973; Bliss and Lomo, 
1973). It is now well established that during low-frequency synaptic transmission the 
neurotransmitter glutamate can bind to different subtypes of ionotropic receptors that are 
often, but not always, co-localised at individual dendritic synapses. AMPA receptors (kainate 
receptors can also be localised at some excitatory synapses) have a channel predominantly 
permeable to monovalent cations (Na+ and K+, although some permeability to Ca2+ is also 
observed), which provides the majority of the inward current responsible for generating 
synaptic responses when the cell is close to its resting membrane potential. NMDA 
receptors are blocked at negative potentials by extracellular Mg2+ and therefore contribute 
little to the postsynaptic response during low-frequency synaptic activity. When the cells are 
depolarised sufficiently for the Mg2+ to dissociate from its binding site within the NMDA 
receptor channel, Ca2+, as well as Na+, can enter the dendritic spine. The resultant rise in 
intracellular Ca2+ is a necessary step in the triggering of LTP. In support of this model for the 
initiation of LTP, specific antagonists of the NMDA receptor can block the initiation of LTP, 
while having minimal effects on basal synaptic transmission (Bliss and Collingridge, 1993). 
In addition, preventing the rise in Ca2+ by loading postsynaptic cells with Ca2+ chelators also 
blocks LTP (Lynch et al., 1983; Malenka et al., 1988). Imaging studies have demonstrated
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that NMDA receptor activation causes a large increase in the Ca2+ level within dendritic 
spines (Alford et al., 1993; Yuste and Denk, 1995), whereas direct increases in the level of 
postsynaptic Ca2+ can mimic LTP (Malenka et al., 1988).
NMDA receptor activation and increases in postsynaptic Ca2+ that do not reach the threshold 
for eliciting LTP can generate either short term potentiation (Malenka and Nicoll, 1993) that 
decays to baseline over the course of 5-20 min or even long term depression (Bear and 
Linden, 2000). Thus, any experimental manipulation that influences the magnitude or 
dynamics of the postsynaptic Ca2+ signal within dendritic spines may have an effect on the 
form of the synaptic plasticity caused by a given pattern of synaptic activation.
Another relevant issue that remains not entirely resolved is whether an NMDA receptor- 
dependent rise in Ca2+ alone is sufficient to trigger LTP or if additional factors provided by 
synaptic activity are required. For example, it is clear that various neurotransmitters found in 
the hippocampus, such as ACh, can modulate the ability to trigger LTP (Matsuyama et al., 
2000; Malenka and Siegelbaum, 2000). It has been indeed reported that nicotine enhanced 
tetanus-induced LTP in the presence of GABA antagonists in hippocampal slices (Sawada 
et al., 1994) and that a nicotinic agonist facilitated induction of LTP in hippocampal slices 
(Hunter et al., 1994). In the ventral tegmental area it was demonstrated that activation of 
presynaptic nAChR increases glutamatergic transmission and could induce LTP of the 
excitatory inputs (Mansvelder and McGehee, 2000). A direct role for a7 nAChR in the 
generation of LTP was also suggested in the hippocampus after the demonstration that 
nicotinic agonists by themselves can induce LTP in vivo (Matsuyama et al., 2000). However, 
perhaps due to the different subcellular localisation of Ca2+ channels, the LTP due to 
activation of voltage operated Ca2+ channels or nAChR may utilise mechanisms distinct from 
those involved in NMDA receptor-dependent LTP (Cavus and Teyler, 1996).
A large number of signalling molecules have been suggested to play a role in the Ca2+ signal 
that is required to trigger LTP. In fact, the Ca2+ influx through NMDA receptors initiates the 
persistent enhancement of synaptic transmission by activating at least two Ca2+-dependent 
serine threonine protein kinases, the Ca2+/calmodulin dependent protein kinase (CaMKII) 
and protein kinase C (PKC). CaMKII is found in high concentrations in the postsynaptic 
density and has the interesting biochemical property that, when autophosphorylated on 
threonine 286, its activity is no longer dependent on Ca27calmodulin, thus allowing its 
activity to outlast the Ca2+ signal that originally activated the enzyme (Braun and Schulman, 
1995). Inhibiting the activity of CaMKII, by directly loading CA1 pyramidal cells with inhibitors 
of CaMKII, blocks the ability to generate LTP (Malenka et al., 1989). PKC may play a role 
analogous to that of CaMKII, as PKC inhibitors have been reported to block LTP and loading
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of PKC into CA1 pyramidal neurones can enhance synaptic transmission (Hu et al., 1987; 
Klann et al., 1991). Several other protein kinases have also been suggested to play 
important roles in the triggering of LTP. As an example, the initial activation of protein kinase 
A (PKA), perhaps by activation of calmodulin dependent adenylyl cyclase, has been 
suggested to boost the activity of CaMKII indirectly by decreasing competing protein 
phophatase activity (Makhinson et al., 1999). In addition, the mitogen activated protein 
kinase/extracellular signal-regulated kinase (MAPK/ERK) has been also addressed as an 
important mediator of synaptic plasticity events in neuronal preparations (see Chapter 4).
The phenomenon of LTP most probably involves pre- and post-synaptic processes. 
However, the seemingly simple issue of whether LTP is due primarily to a pre- or post­
synaptic modification has generated a lot of controversy over the past decade. In fact, 
although the postsynaptic model can account for much of the experimental literature, it does 
not preclude the occurrence of significant presynaptic modifications contributing to LTP. 
Because of the possibility that NMDA receptor dependent LTP involves presynaptic 
changes, much effort has been directed towards the putative retrograde messenger that 
must exist. Pharmacological and genetic experiments have identified nitric oxide, a gas that 
diffuses readily from cell to cell, as one of the possible candidates. Inhibitors of the enzyme 
responsible for its synthesis (nitric oxide synthase) block the generation of LTP, while NMDA 
receptor activation can stimulate the activity of nitric oxide synthase through Ca2+/calmodulin 
(see Malenka and Siegelbaum, 2000).
1.3.3.2 NMDA receptor independent LTP
Although most of the effort toward understanding long lasting forms of synaptic plasticity has 
focused on NMDA receptor-dependent LTP, it is clear that at certain synapses a robust form 
of LTP can be generated independent of NMDA receptor activation. The one most 
extensively examined occurs at mossy fiber synapses in the hippocampus, which are formed 
between the axons of dentate gyrus granule cells and the proximal dendrites of CA3 
pyramidal cells (Nicoll and Malenka, 1995). The first indication of a different mechanism was 
that LTP could be triggered in the presence of NMDA receptor antagonists (Harris and 
Cotman, 1986). This finding suggested either that mossy fiber LTP was triggered 
presynaptically or that a post synaptic rise in Ca2+ was required, but that this was achieved 
via some other source other than NMDA receptors. However, some authors postulate that 
mossy fiber LTP can be triggered by postsynaptic Ca2+ increases due to activation of either 
voltage dependent Ca2+ channels or metabotropic glutamate receptors that release Ca2+ 
from intracellular stores (Yeckel et al., 1999).
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1.3.3.3 Late phase LTP
As with memory storage, LTP has phases. One stimulus train produces an early, short-term 
phase of LTP (early LTP: 1-3 hours), in a process that does not require new protein 
synthesis. However, four or more trains induce a more persistent phase of LTP (called late 
LTP) that lasts at least for 24 hours and requires new RNA and protein synthesis (see 
Malenka and Siegelbaum, 2000). In addition, it has been demonstrated that the late phase 
LTP recruits several signalling molecules, including the cyclic-AMP (cAMP)-PKA-MAPK- 
cAMP response element binding protein (CREB) pathway, and may involve the activation, 
perhaps the growth, of additional presynaptic machinery for transmitter release and the 
insertion of new clusters of postsynaptic receptors.
In summary, it is presently accepted that the phenomenon of LTP entail a series of inter and 
intracellular events that can be modulated by quite a few interacting factors. Among the 
several signalling molecules that are known to participate in these processes, Ca2+ has 
emerged as the pivotal messenger, able to trigger most of the cellular responses associated 
with the initiation and maintenance of LTP. The Ca2+ permeability of nAChR provides a 
putative molecular basis for the behavioural data showing a role of nAChR in learning and 
memory. In effect, the study of the Ca2+-mediated signalling mechanisms activated by 




1.4 Neuronal Ca2* Signalling
1.4.1 The ubiquitous messenger
The importance of ion fluxes in fast synaptic transmission and in modulating the biophysical 
properties of neuronal membranes is well established. However, it has become increasingly 
clear over the past decade that the presynaptic release of neurotransmitter can have long 
lasting consequences for the postsynaptic neuron. These long lasting adaptations normally 
involve the elaboration of complicated intracellular signals, which can modulate a variety of 
cellular processes, including neuronal differentiation, survival, axon outgrowth and changes 
in synaptic strength (Ghosh and Greenberg, 1995). Much of the attention upon intracellular 
messengers in the CNS has been focused on the role played by intracellular Ca2+ signals. It 
has been demonstrated that Ca2+ can play a role in the cell survival of developing neurones 
and in the subsequent mediation of their activity. In the mature nervous system, it is critical 
for the processing of neuronal responses that could, among others, be a major mechanism 
of information storage in the brain (Franklin and Johnson, 1992; Bliss and Collingridge,
1993). Interestingly, Ca2+ is not only implicated in most of the cellular mechanisms of a living 
neuron, but it is also invariably involved in their death (Berridge et al., 1998). This incredible 
versatility is given by its capacity to act in the different contexts of space, time and 
amplitude. Accordingly, different cell types with particular developmental stages, may 
integrate Ca2+ signals with the precise parameters that fit their physiology.
1.4.2 Extracellular sources of Ca2+
There are several ways of increasing intracellular Ca2+ in neurones, which, like other cells, 
use both extracellular and intracellular sources of Ca2+ to mediate cytoplasmic Ca2+ signals. 
The mechanisms responsible for regulating the influx of external Ca2+ are well established, 
and include several Ca2+ permeable transmembrane channels. Perhaps the most thoroughly 
studied way of Ca2+ influx to the cells is the activation of the Ca2+ permeable glutamate 
receptor subtypes NMDA and AMPA. However, Ca2+ can also enter the cell through other 
selective channels, including voltage operated Ca2+ channels (VOCC) (Catterall, 1995) or 
the nAChR ligand gated channel.
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1.4.2.1 Voltage operated Ca2+ channels (VOCC)
VOCC are widely distributed in the animal kingdom and are an essential part of many 
excitable and non-excitable mammalian cells. The opening of theses channels is primarily 
regulated by the membrane potential, but is also modulated by a wide variety of hormones, 
protein kinases, protein phosphatases, toxins and drugs. VOCC have been subdivided into 
several classes by biophysical and pharmacological criteria. The low voltage activated 
channels are defined by the T-type current, while the high voltage activated channels are 
classified into L (long lasting)-type, P (Purkinje)-type, N (neither L nor T channel)-type, Q- 
type and R (remaining)-type. The P-, Q-, N-, and R-type currents have been mainly identified 
in neuronal and endocrine tissues, whereas L-type currents have been found in skeletal, 
heart and smooth muscles, in fibroblasts, and also in neuronal and endocrine cells 
(Hofmann et al., 1999). The high voltage activated Ca2+ channels are heterooligomeric 
complexes of five proteins from four genes: the a1 subunit, the intracellularly located p 
subunit; the a2S subunit, a disulphide-linker dimer, and the transmembrane y subunit (for 
details see Catterall, 1995).
The functional roles of VOCC are rather diverse. In skeletal muscle the L-type channels are 
crucial for excitation-contraction coupling; in heart they are necessary for the generation of 
electrical impulses and for the initiation of contraction, while in smooth muscle they are 
involved in tension development (Hoffman et al., 1999). In neurones, L-type channels 
provide the Ca2+ for activation of small conductance Ca2+ activated K+ channels (Marrion and 
Tavalin, 1998). In addition, the fact that L-type VOCC have a relatively high activation range, 
a slow inactivation rate and a high single channel conductance, makes them ideal 
transducers for the passing of large amounts of Ca2+ (Catterall, 1995). The N- and P/Q-type 
channels appear to be linked in many neuronal cells to neurotransmitter secretion (Hofmann 
et al., 1999).
Most of the prominent features of the Ca2+ channel complex can be assigned to the a1 
subunit, which contains the ion conducting pore, the selectivity filter of the pore, the voltage 
sensor and the interaction sites for the p subunits, the a25 subunit, the Ca2+ channel 
blockers and activators. Nine individual genes have been identified for the a1 subunit, which 
are homologous to each other and encode proteins of predicted molecular masses of 212 to 
273 kDa. They belong to the same multigene family as voltage-activated Na2+ and K+ 
channels and share a common ancestral protein with them. Hydrophobicity analysis of the 
a1 subunit predicts a transmembrane topology with four homologous repeats, each 
containing five hydrophobic putative a helices and one amphiphatic segment. An early 
evolutionary event separated the a1 subunit into the electrophisiolgically distinct low-voltage
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activated and high voltage activated Ca2+ channels, which share less than 30 % sequence 
identity (Hofmann et al., 1999).
1.4.2.2 Glutamate receptors
The ionotropic glutamate receptors are LGIC that mediate the vast majority of excitatory 
neurotransmission in the brain. Three pharmacologically defined classes of these receptors 
have been described, named according to the selective agonists that identified them: NMDA, 
AMPA and kainate receptors. The receptor subunits for the different glutamate receptors are 
encoded by at least six gene families as defined by sequence homology: a single family with 
four different subunits for AMPA (GluR1-4), two families with 5 subunits for kainate (GluR5-7 
and KA1-2) and three families with 6 subunits for NMDA (NR1, NR2A-D, NR3A) (Dingledine 
et al., 1999). Sequence similarity suggests a common evolutionary origin for all of the 
ionotropic glutamate receptor genes. With respect to their transmembrane structure, 
glutamate receptors proved to have only three transmembrane domains (M1, M3 and M4) 
plus a cytoplasm-facing re-entrant membrane loop (M2). As a result, the N-terminus is 
located extracellularly and the C-terminus intracellularly (Fig 1.1). The ligand binding site is 
formed by a conserved amino acid-binding pocket (Sun et al., 1998), proposed to exist in all 
glutamate receptors, and which would be formed from two globular domains (S1 and S2) 
drawn from the sequence adjacent to the M1 domain and the M3-M4 loop. It is speculated 
that the closure of the S1 and S2 lobes places a torque on the receptor that is transmitted to 
the channel region, and generates the opening.
Early evidence suggested a pentameric structure for glutamate receptors, based on the size 
of chemically cross-linked NMDA receptor proteins (Brose et al., 1993). However the 
conclusions from at least six functional evaluations of receptor subunit mixtures are divided 
between the structure being a tetramer or a pentamer (Dingledine et al., 1999 and 
references therein). Although the number of subunits composing a receptor is still a matter 
of dispute, it is generally accepted that a given subunit will only assemble with others within 
its own family. The precise subunit composition of native glutamate receptors is still not 
known, but it is apparent that multiple subtypes exist within the AMPA and NMDA receptor 
families based on subunit composition. In addition to the functional diversity provided by the 
existence of different genes, ionotropic glutamate receptors are subject to posttranscriptional 
alterations, which give rise to added structural and functional diversity.
The endogenous transmitter L-glutamate activates both NMDA and non-NMDA receptors, 
whereas the putative transmitter candidate L-aspartate appears to activate NMDA receptors 
exclusively (Patneau and Mayer, 1990). In addition, glycine has been shown to be an
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essential co-agonist at NMDA receptors (Dingledine et al., 1999). Gating of AMPA and 
kainate receptors by glutamate is extremely fast, and contrasts with the slow gating of 
NMDA receptors. In addition, both AMPA and kainate receptors possess a low-affinity 
binding for the endogenous transmitter glutamate, and are thus thought to deactivate quickly 
because of the brief mean bound time of the agonist. The rapid activation and brief open 
time of AMPA facilitates unblock of NMDA receptors by Mg2+, and therefore participation of 
the more slowly activating and deactivating NMDA receptors in synaptic currents. In effect, 
one unique feature of the NMDA receptor compared to other LGIC, is the dual dependence 
of function on agonist binding and membrane potential. This property renders the Ca2+ flux 
through NMDA receptors a coincidence detector for depolarisation and synaptic release of 
glutamate. The NMDA receptor’s voltage dependence follows directly from channel block by 
submillimolar concentrations of extracellular Mg2+, rather than from the voltage dependence 
of conformational changes (Nowak et al., 1984). Binding of extracellular Mg2+ within the pore 
is strongly voltage dependent, a property that dominates the physiological role of NMDA 
receptors. At resting membrane potentials, most subtypes of NMDA receptor undergo rapid 
channel block by extracellular Mg2+, which reduces the NMDA component of synaptic 
currents considerably. However, when neurones are depolarised, for example by activation 
of colocalised AMPA receptors, the voltage dependent block by Mg2+ is partially relieved.
All glutamate ionotropic receptors are permeable to cations, and sodium and potassium are 
thought to be nearly equally permeable. Recombinant NMDA receptors appear to be more 
permeable to Ca2+ than non-NMDA glutamate receptor subtypes. The combination of 
AMPA/Kainate and NMDA glutamate receptors constitutes a finely tuned association, crucial 
for glutamate transmission.
As stated in sections 1.1 and 1.3 of this chapter, nAChR can also mediate cytoplasmic 
changes in Ca2+ concentrations due to their high permeability to Ca2+. Interestingly, their 
specific location and functional properties allows them to activate precise Ca2+ signals, not 
necessarily overlapping with those evoked by other sources of Ca2+ influx.
1.4.3 Intracellular Ca2+ stores
While much is known about the extracellular Ca2+ influx pathways, there is less information 
on the mechanisms and role of the intracellular supply of Ca2+ stored within the endoplasmic 
reticulum of neurones. The endoplasmic reticulum is a continuous tubular structure 
composed of distinct heterogeneous subunits with different Ca2+ transport characteristics 
(Golovina and Blaustein, 1997). Perhaps the most remarkable aspect of this endoplasmic
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reticulum network is that it appears to be a continuous membrane system (Terasaki et al.,
1994), which has a number of regional specialisations of particular significance with regard 
to Ca2+ signalling
The endoplasmic reticulum neuronal network contains inositol 1,4,5-triphosphate receptors 
(IP3R) and ryanodine receptors (RyR), both of which are capable of regenerative Ca2+ 
release, enabling the endoplasmic reticulum to play an active role in neuronal Ca2+ signalling 
(Berridge, 1998; Fig 1.6). These two intracellular channels integrate information from the 
cytoplasm and the lumen, and they are both capable of displaying the phenomenon of Ca2+ 
induced Ca2+ release (CICR). It is this regenerative process that is responsible for amplifying 
Ca2+ signals coming from the outside and for setting up Ca2+ waves (Berridge, 1998). The 
Ca2+ sensitivity of these receptors can be influenced by a variety of intracellular factors, 
including IP3 in the case of IP3R and cyclic ADP ribose in the case of RyR. In addition, and 
through a mechanism that has yet to be defined, a buildup of Ca2+ within the lumen of the 
endoplasmic reticulum can exert a positive feedback effect by increasing the Ca2+ sensitivity 
of both the RyR and IP3R.
1.4.3.1 Ca2+ release from IP-3 receptors
The phosphoinositide system is particularly well developed in the brain, where a large 
number of receptors respond by stimulating the hydrolysis of phosphatidylinositol 4,5- 
biphosphate to form the second messenger’s diacylglycerol and IP3. The latter, can act by 
modulating Ca2+ release from IP3R, which are widely distributed through the brain. The study 
of Ca2+ release from IP3R is complicated by their sensitivity to a variety of factors; the most 
effective activation being when Ca2+ and IP3 are presented together. In addition, IP3 
receptors can be regulated by PKA, PKC and by tyrosine kinases, as well as by the Ca2+ 
dependent phosphatase, calcineurin (for review see Meldolesi, 2001). This may suggest that 
the IP3R act as a coincidence detector during integration of synaptic signals (Simpson et al
1995).
1.4.3.2 Ca2+ release from ryanodine receptors
RyR resemble the IP3R in that they are sensitive to Ca2+ entering the cytoplasm from outside 
the neuron or from neighbouring internal stores receptors. Therefore, Ca2+ entering from 
extracellular sources can directly induce Ca2+ release from intracellular stores, producing an 
amplification of the influx signal (Fig 1.6). The extent to which this internal amplification 
process operates varies considerably between neurones, and internal release can be 
triggered by either a single action potential (Cohen et al., 1997) or by trains of action
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potentials (i.e. hippocampal cells; Jacobs and Meyer, 1997). In addition to the modulation by 
intracellular Ca2+, a specifc messenger, cyclic ADP ribose, exists for RyR. Although the 
precise mechanism of receptor regulation by cyclic ADP ribose is not known, it has been 
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Fig 1.6 Neural Ca2* signalling
The cytoplasmic levels of Ca2+ can be regulated bv extracellular or intracellular sources, which are 
operated by various mechanisms. The entry of Ca via ion channels can activate release of Ca2+ 
from internal stores via activation of RyR, which can also be modulated by cyclic ADP ribose. In 
addition, many metabotropic receptors couple to activation of phosphoinositol specific phospholipase- 
C (PLC) and consequent production of IP3. In turn, IP3 can activate the release of Ca2+ from IP3 
sentitive internal stores. The influx of Ca2+ through plasma membrane ion channels can also increase 
activation of IP3R via potentiation of the activity of PLC or via direct sensitisation of IP3R. Thus, 
ionotropic receptors or VOCC might induce Ca induced Ca2+ release via either or both types of 
intracellular Ca channel. This process of Ca2* induced Ca2+ release can subsequently initiate the 
propagation of Ca2+ waves. Although the capacitative Ca2+ entry (CCE) constitutes another potential 
source of cytoplasmic Ca2+, its regulation and physiological function is still uncertain.
1.4.3.3 Ca2* spikes and waves
The neuronal endoplasmic reticulum is an excitable organelle capable of regenerative 
release to produce repetitive Ca2* spikes and waves (Berridge, 1998). These Ca2* waves 
may function to spread Ca2* signals bidirectionally throughout the cytoplasm (i.e., 
transferring Ca2* signals from the cell periphery to the nucleus). In addition, it could function 
much more locally to spread a localised signal between synaptic spines. However, the 
existence of such Ca2* waves is very dependent on the progressive loading of the 
endoplasmic reticulum, which thus reflects its dual role as a source and a sink for Ca2*. This 
faculty gives the potential for integrating not only spatial Ca2* signals, but also temporal 
ones, as the loading of the endoplasmic reticulum is highly dependent on the previous 
activity of the neuron (Miller et al., 1996). Thus, the temporal and spatial conjunction of CICR
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and IP3 elicited Ca2+ release might play a role in several neuronal processes, like LTP, LTD, 
transmitter release and neurotoxicity (Simpson et al., 1995). In chapter 4, I will present and 
discuss evidence regarding the role of intracellular Ca2+ stores in the intracellular Ca2+ 
signals activated by nAChR.
1.4.4 Ca2+ dependent signalling
The complexity of Ca2+signals is not only associated to the various sources of Ca2+ influx to 
the cell. Once Ca2+ reaches the cytoplasmic compartment it can activate numerous 
signalling mechanisms, capable of modulating almost every aspect of neuronal physiology. 
Ca2+ influx through NMDA receptors and/or VOCC has been extensively studied with regard 
to the Ca2+ dependent neuronal responses. In this chapter I will concentrate on both of them 
in order to review some of the key components involved on the Ca2+ signalling pathways. 
The role that specific nAChR-evoked Ca2+ signals may have on neuronal function will not be 
discussed here, as it will be extensively examined in Chapters 2, 3 and 4.
Synaptic stimulation that leads to the activation of NMDA receptors and/or VOCC is followed 
by a series of dramatic Ca2+ dependent cellular responses. Stimulation of the NMDA 
receptor and the activation of VOCC lead to the activation of a variety of distinct protein 
kinases, including CaMK (l-V), PKC, various components of the Ras/ERK signalling pathway 
and tyrosine kinases (Greenberg and Ziff, 2000). There is increasing evidence that functions 
such as LTP and LTD are at least partially mediated by the protein kinase catalysed 
phosphorylation of specific ion channel subunits, leading to ion channel modulation or 
changes in the cell surface expression of ion channel subunits (Greenber and Ziff, 2000).
In addition to inducing rapid cellular responses, such as ion channel modulation, the Ca2* 
evoked signals can have a more long lasting effect that is associated with the activation of 
down stream signalling effectors, which ultimately lead to induction of new gene expression 
(Finkbeiner and Greenberg, 1998). However, the way in which changes in gene expression 
can selectively alter the efficacy of only a few of many synapses is still a matter of 
discussion. One possibility is the so-called “tagging” of the synapse, which leads to the 
mutually selective recognition of the new gene products by the “tagged” synapse (Frey and 
Morris, 1997). On the other hand, another possibility that has gained more recent support is 
that neurotransmitters modulate gene expression post-transcriptionally by regulating the 
translation stability of specific mRNA that are localised and translated within the dendritic 
region of the postsynaptic neuron (Huang, 1999).
59
CHAPTER 1
The first indication that activation of ionotropic neurotransmitter receptors could lead to the 
activation of new gene expression came from studies of the c-fos proto-oncogene 
(Greenberg et al., 1986). It is presently known that its transcription can indeed be rapidly and 
transiently activated in response to a wide variety of extracellular stimuli, including 
neurotransmitters and other agents that can lead to membrane depolarisation and the 
activation of L-type VOCC (Sheng and Greenberg, 1990). The c-fos gene is a member of a 
family of 50-100 genes termed immediate early genes, which are activated rapidly after 
stimulation. The best characterised of these genes are the transcription factors, like c-fos 
and c-jun, that can regulate subsequent programs of late responses. However, some 
immediate early genes do not represent transcriptional regulators, but encode either soluble 
factors or receptors that affect neuronal function and enzymes mediating the synthesis of 
neurotransmitters (Sheng and Greenberg 1990). These immediate early genes, in contrast 
to the ones that encode transcriptional regulators, are selectively activated in neurons, being 
capable of modulating synaptic function. One of the best characterised of these neuron 
specific, Ca2+ regulated, immediate early genes is the brain-derived neurotrophic factor 
(BDNF), which is a member of the neurotrophin family that plays a critical role in regulating 
the survival and differentiation of selective populations of neurones during development. 
Activation of VOCC and NMDA receptors could lead to a significant rise in the level of BDNF 
mRNA and also stimulates the release of BDNF protein, while BDNF has also been shown 
to be an important mediator in neuronal adaptive responses (Kang and Schuman, 1995).
1.4.4.1 CREB
Promoter deletion analysis in cultured cells revealed the DNA regulatory elements within the 
c-fos promoter that mediate Ca2+ induction of c-fos transcription (Sheng and Greenberg,
1990). One key regulatory sequence described (5’-TGACGTT-3’) and designated the Ca2+ 
response element (CaRE), is located 60 nucleotides 5’ of the initiation site for c-fos mRNA 
synthesis. The c-fos CaRE is similar in sequence to the cAMP regulatory element CRE, a 
DNA regulatory element that mediates the transcriptional responses to elevated levels of 
cAMP. CRE and CaRE were shown to be functionally indistinguishable, which suggested 
that the same DNA regulatory element mediates both Ca2+ and cAMP responses (Sheng et 
al., 1991). A member of the basic leucine zipper family of transcription factors, CREB can 
regulate gene transcription by binding to the CaRE or CRE DNA sequence. When activated 
by phosphorylation of ser-133, CREB can act as a regulator of immediate early genes that 
encode transcription factors (i.e., c-fos, c-jun, egr-1) and neuron specific early genes (i.e., 
BDNF), which made it one of the most studied of the Ca2+ regulated transcription factors. At 
present, CREB has been implicated in several neuronal functions, including long term
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memory in flies, long lasting LTP in mice, differentiation and survival (Greenberg and Ziff, 
2000).
1.4.4.2 Ca2+-regulated CREB kinases
Considering the clear importance of Ser-133 phosphorylation for CREB activation and 
function in mature neurones, it is relevant to understand the kinase cascades that may 
trigger this critical event. In fact, there are multiple Ca2+ regulated kinase cascades that 
catalyse CREB Ser-133 phosphorylation in membrane-depolarised cells (Finkbeiner and 
Greenberg, 1996). They include CaMK I, II and IV, the ribosomal S6 kinases (pp90Rsk1-3), 
PKC, PKA, the serine/threonine kinase Akt, and the MAPK-activated protein kinase. These 
kinases are part of a complex structure of intracellular signalling molecules capable of 
regulating several aspects of neuronal function, including CREB activation. The Ras/MAPK 
signalling cascade in particular, has been shown to be activated by Ca2+ influx and to trigger 
the sequential phosphorylation of the kinases MEK/MAPK and Rsk, which can then 
translocate into the nucleus and phoshporylate transcription factors, including CREB 
(Greenberg and Ziff, 2000). A more detailed study of the Ras/MAPK cascade and its 
dependence on nAChR activation will be reviewed on Chapter 4 of this thesis.
1.4.4.3 Importance of Ca2* entry routes
The incredible versatility of Ca2+-activated neuronal responses has suggested that particular 
neuronal types, or even neuronal compartments, may have precise and unique ways of 
integrating Ca2+ signals. It has been demonstrated that Ca2+ influx through VOCC is much 
more effective at inducing CREB dependent transcription than is Ca2+ influx through the 
NMDA receptors channels (Hardingham and Bading, 1999). These results suggest that the 
location, duration and amount of intracellular Ca2+ concentration may account for the 
specificity of the Ca2+ evoked responses. However, it should be also possible for Ca2+ to 
activate specific signal transduction molecules that are localised in close proximity to its site 
of entry, therefore conferring specificity towards the influx path. More recent evidence 
indicates that Ca2+ mediated specificity is achieved, in part, by the use of scaffolding and/or 
anchoring proteins which facilitate the regulation of signal transduction pathways. A more 
detailed account on the role of Ca2+ entry, specificity of Ca2+ signalling routes, and 




Although a considerable amount of information has been gathered about the molecular 
structure, pharmacology and biophysical properties of nAChR, the role of neuronal nAChR in 
the modulation of various cellular processes of the nervous system has only become 
apparent in the last decade. The existence of multiple subtypes of neuronal nAChR, the non- 
uniform distribution throughout the nervous system and their localisation to both pre- and 
post-synaptic zones, imply diverse functions of nAChR and indicate that several neuronal 
mechanisms can be triggered as a result of nAChR stimulation. In spite of the increasing 
amount of evidence suggesting a functional role for the nAChR, not much is known about 
the overall cellular mechanisms involved. The aim of this work was to investigate some of 
the intracellular signalling processes activated by the stimulation of nAChR in neuronal 
preparations.
The first part of the project was designed to study the putative neuroprotective actions of 
nicotine stimulation. As a model system we utilised primary cultures from rat hippocampus, a 
brain region involved in learning and memory processes and one that is affected in the 
progression of Alzheimer’s disease. The specific aims of this part were:
- The analysis of the excitotoxic actions of glutamate and NMDA stimulation in 
hippocampal primary cultures.
- To demonstrate if nicotine stimulation and nAChR activation, in particular, can 
prevent the neuronal loss.
- The characterisation of the nAChR subtypes involved and the cellular mechanisms 
implicated in the observed responses.
The results obtained suggested that the stimulation of neuronal nAChR was capable of 
protecting hippocampal neurones through the activation of precise and sustained Ca2+ 
signals. Therefore, we decided to centre the attention on the analysis of the Ca2+, and Ca2+ 
dependent, signals evoked after activation of nAChR. As a first approach, experiments were 
conducted to study the Ca2+ sources mediating nicotine evoked Ca2+ responses in neurones. 
In order to do so, we utilised the human neuroblastoma SH-SY5Y cell line as a model 
neuronal system. In particular, the aims of this part included:
- The replication in SH-SY5Y cells of the sustained Ca2+ responses shown to occur in 
hippocampal primary cultures.
- The analysis of the nAChR subtypes involved in nicotine evoked Ca2+ signals.
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- The determination of the role of voltage operated Ca2+ channels and intracellular 
Ca2+ stores in the nicotine evoked increases in cytoplasmic Ca2+.
Although Ca2+ has been suggested as the main candidate for the mediation of nAChR 
modulated actions, not much is known about the precise cellular mechanisms activated by 
nicotine evoked Ca2+ signals. For that reason, we decided to use both hippocampal primary 
cultures and SH-SY5Y cells to explore some of the putative signalling pathways activated 
after nAChR stimulation The particular objectives of this part of the work were:
- The analysis of ERK1/2 activity after nAChR stimulation in both SH-SY5Y cells and 
hippocampal neurones.
- The study of the nAChR subtypes involved and the Ca2+ dependence of nicotine’s 
actions.
- To establish the precise cellular pathways connecting the stimulation of nAChR with 
the modulation of ERK1/2 activity.
- To determine the relevance of this pathway in the overall processes regulated by 




< nAChR and Neuroprotection >
2.1 Introduction
2.1.1 Alzheimer’s disease and neurodegeneration
Although the cellular bases of neurodegeneration are complex and not completely 
understood, it is generally assumed that a series of genetic and ambient factors act in 
combination to trigger the cellular mechanisms leading to neuronal impairment and 
subsequent loss of brain function. In the case of Alzheimer’s disease (AD), the progressive 
loss of cognitive ability is the result of a neurodegenerative process classically characterised 
by the extracellular deposition of the p-amyloid (Ap) peptide in deposits termed senile 
plaques, and the formation of neurofibrillary tangles in neurones (Kawahara and Kuroda, 
2000; Neve et al., 2000). Additional pathological hallmarks of AD include granulovacular 
degeneration and the overall loss of synaptic contacts and cell density in distinct regions of 
the brain. AD does not have a simple aetiology. It can occur as a “sporadic” event; it can 
result from the possession of an extra copy of the chromosome 21 (Down’s syndrome); or it 
can be caused by mutations in the amyloid precursor protein (APP) gene on chromosome 
21 or by mutations in the preselinin genes on chromosome 1 and 14 (Neve et al., 2000).
Numerous mechanisms for the neuronal degeneration observed in AD have been proposed, 
but perhaps the most widely accepted theory is the amyloid hypothesis, in which the 
deposition of Ap peptides derived from the APP precursor has been implicated in the 
pathological cascade that leads to neuronal loss (Kawahara and Kuroda, 2000). This 
argument is based on in vitro studies showing that Ap is toxic to neurones, and on the 
measurement of increased release of Ap by cells carrying familial AD mutant genes (Neve et 
al., 2000). The Ap peptide exists in two major carboxy-terminal variants. APi^0 is the major 
species secreted from cultured cells and found in cerebrospinal fluid, while Api^2 is the 
major component of amyloid deposits (for review see Younkin, 1995). Cells expressing 
familial AD mutants of APP and the preselinins are reported to secrete increased amounts of 
APi^, thus suggesting a link of this variant of Ap to AD pathogenesis (Younkin, 1995). 
Overall, these mechanisms are linked in some way to the APP, which is the source of Ap. 
However, perhaps the most convincing piece of evidence linking AD neurodegeneration to 
APP and/or its Ap derivatives is the early finding that the APP gene is located on
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chromosome 21, as virtually all individuals trisomic for this chromosome show AD-like 
neurophatology by the age of 40. In addition, it has been discovered that specific mutations 
in the APP can be the cause of some forms of familial AD mutants (Neve et al., 2000). 
These data have raised the possibility that AD may result from an alteration in the normal 
function of APP (Neve and Robakis, 1998; Nishimoto 1998), and much of the attention has 
refocused on the delineation of the function that APP subserves in the CNS. It has been 
shown that in the brain, a percentage of APP is present on the cell surface (Perez et al.,
1997) and it is proposed that this cell surface APP mediates the transduction of extracellular 
signals into the cell via its intracellular C-terminal tail (Perez et al., 1997; Nishimoto, 1998). 
In addition, APP can also exist in a soluble releasable form that has been associated with 
promotion of cell survival, neurite outgrowth, synaptogenesis and synaptic plasticity (for 
reviews see Mattson, 1997). The processing and release of APP can be regulated by a 
variety of factors, including stimulation of receptors for acetylcholine, serotonin, glutamate 
and neuropeptides (Nitsch and Growdon, 1994). In particular, it has been shown that the 
nicotine-evoked increase in soluble APP was inhibited by the a7 nAChR antagonist 
methyllycaconitine, suggesting that activation of a7 nAChR is sufficient to enhance this 
secretion (Seo et al., 2001). The a7 nAChR has been also shown to bind selectively and 
with high affinity with the Ap peptide in cerebral cortex and hippocampus (Wang et al., 
2000). At present, the physiological effect of this interaction is still unclear, as the Ap peptide 
has been shown to block nicotine-evoked currents from hippocampal intemeurones (Pettit et 
al., 2001; Liu et al., 2001), but also to activate the ERK cascade via a7 nAChR in an 
organotipic slice preparation from the hippocampus (Dineley et al., 2001).
The actual mechanisms of Ap peptide toxicity in vitro might involve the excessive Ca2+ influx 
to the cells (Mattson et al., 1993). It has been reported that antigenic changes of cytoskeletal 
elements typical of AD are mimicked by excessive Ca2+ influx into cultured hippocampal 
neurones (Mattson, 1990), and when neurones were treated with actin depolymerising 
agents, known to block receptor-mediated Ca2+ entry, Ap-induced toxicity was prevented 
(Furukawa and Mattson, 1995). In fact, it may be speculated that the pathology of AD is 
related to a very protracted chronic form of excitotoxicity (Mattson et al., 1993; see below) 
caused by a conversion of APP to Ap. Accordingly, the unprocessed APP protein seems to 
have a dampening effect on the physiology of cellular Ca2+ by hyperpolarizing neurons 
through the opening of potassium channels (Furukawa et al., 1996). Interestingly, and in 




2.1.2 Ca2+ and excitotoxicity
As illustrated above, the precise cellular causes of cell death in neuronal degenerative 
disorders are still being actively investigated. Although it is increasingly accepted that 
triggering mechanisms might vary according to the particular neurodegenerative disorder, 
the cellular process of neurodegeneration in the CNS may share some common 
mechanisms. In particular, the excessive increase in intracellular Ca2+ concentrations has 
been addressed as a fundamental player in the progression of neurodegenerative cell death. 
One of the most common mechanisms of neuronal death by excessive Ca2+ accumulation is 
initiated by a pathological condition known as excitotoxicity. This is a phenomenon typically 
encountered in neurones, and follows a stimulation that exceeds the physiologic range with 
respect to duration or intensity. In general, it describes the supra-physiological activation of 
glutamate receptors, and in particular the NMDA receptors subtype. A large variety of 
chronic neurodegenerative diseases seem to have an excitotoxic component (Meldrum and 
Gathwaite, 1990), while a causal contribution of excitotoxicity to neuronal damage has also 
been established in stroke or head trauma (Lipton and Rosenberg, 1994) and in acute 
poisoning phenomena, like 1-methyl-4-phenyl-1,2,3,5-tetrahydopyridine (MPTP; Turski etal.,
1991). The excessive increase in intracellular Ca2+ observed in excitotoxic processes could 
then lead to impaired energy metabolism, mitochondrial dysfunction and oxidative stress, 
resulting in neuronal loss (Meldrum and Garthwaite, 1990; Leist and Nicotera, 1998).
In spite of its recognised role as a contributor mechanism to neuronal death, excitotoxic 
processes are probably not the initial trigger of the observed neuronal degeneration. In fact, 
a number of cellular processes could lead to the generation of excitotoxic cell death. For 
example, an initial insult like the blockade of the mitochondrial respiratory chain, or the 
perturbation of intracellular Ca2+, could cause a limited disturbance of cellular homeostasis, 
mitochondrial dysfunction and subsequent energy depletion. This would result in the 
reduced activity of ion pumps, membrane depolarisation and the opening of VOCC, which 
consequently leads to hyperexcitability and the increased probability of glutamate release. 
Subsequent to the increase in glutamate, all subtypes of glutamate receptors can initiate the 
excitotoxic processes, although is the prolonged activation of the Ca2+-permeable NMDA 
subtype of glutamate receptor that constitutes the key mediator of excitotoxicity in the CNS 
(Leist and Nicotera, 1998).
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2.1.3 nAChR involvement in cognitive disorders and 
Alzheimer’s disease
ACh is an important participant in the maintenance of cognitive functions, as lesions of 
forebrain cholinergic nuclei and pathways alter memory and, more specifically, working 
memory and attentional processes that rely on the integrity of the prefrontal cortex and are 
deeply affected in patients with AD (Winkler et al., 1995). Although some of these 
contributions are mediated by muscarinic receptors, nicotine is also able to selectively 
improve attention, learning and memory through activation of nAChR (Levin and Simon,
1998). These nicotine-induced memory improvements do not diminish with continued 
treatment and appears to be specific to working memory, with little or no effect on reference 
memory (Levin et al., 1997; Rezvani and Levin 2001). In addition, studies with transgenic 
mice lacking functional p2 subunits, demonstrated that the lack of high affinity nAChR leads 
to an impairment in spatial learning and memory (for review see Changeux et al., 1998).
Additional evidence for the role of nAChR in cognitive processes has been provided by the 
observed loss of cortical nAChR in AD (Nordberg 1994; Whitehouse and Au, 1986). Studies 
using neuroimaging techniques also support the involvement of nAChR in AD, as a 
significant correlation between the temporal cortex labelling of [11C]-nicotine and cognitive 
function scores in AD patients has been found (Nordberg, 1993). However, epidemiological 
studies and studies of receptor changes in post-morten or living tissue constitute only 
indirect evidence that the loss of nAChR is relevant to the cognitive disorder of AD. In 
particular, they will not demonstrate if the observed nAChR loss is either a cause or a 
consequence of the neurodegenerative process. On the other hand, studies using nAChR 
antagonists serve a more direct purpose, by producing a temporary “chemical lesion”, which 
may uncover some of the functional roles of nAChR activation in memory processes. In a 
series of studies by Newhouse and colleagues (1992; 1994) it was shown that the non- 
selective nAChR antagonist mecamylamine could produce cognitive impairment, resembling 
in many cases that seen in AD. Consistent with this proposed role of nAChR in cognitive 
disorders, symptomatic benefits, such as improvement in attentional functioning, have been 
reported in patients with AD after nicotine administration (Sahakian et al., 1989; Parks et al.,
1996). In addition, the use of cholinesterase inhibitors has been applied as a therapy in the 
treatment of AD, their positive effects associated not only with an increase of cholinergic 
transmission, but also with a direct modulation of nAChR function (Maelicke et al., 2001). In 
fact, galanthamine (Reminyl), a cholinesterase inhibitor with known properties as an 
allosteric modulator of the nAChR, is administered as a therapeutical treatment for AD 
(Maelicke et al., 2001).
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nAChR have been a recent target for the development of cognitive disorder therapies 
(Arneric et al., 1995). However, the symptomatic relief produced by cholinergic agents in the 
treatment of AD are not dramatic, possibly because the treatment is administered at a late 
stage, when the neuronal degeneration is already advanced. At present, ongoing 
investigations of the molecular structure and pharmacology of neuronal nAChR are actively 
used in the development of novel nicotinic agents as potential therapeutic means (Lloyd and 
Williams 2000). Ideally, the fulfilment of these therapeutic objectives should be intimately 
associated with the understanding of the cellular mechanisms activated by nAChR in the 
nervous system. Nonetheless, the true significance of many of the neuronal actions of 
nicotine stimulation is still far from being resolved.
2.1.4 nAChR mediated cytoprotection
As discussed earlier, epidemiological and clinical data initially suggested the use of nicotinic 
agonists as therapeutic agents in the treatment of cognitive disorders. In most cases, the 
rationale behind this clinical conduct was based on the apparent involvement of cholinergic 
systems in the processing of brain cognitive functions, and was mainly associated with a 
symptomatic relief rather than neuronal restoration. However, as the results from the clinic 
prompted the investigation of nicotine actions in neuronal preparations, an initially 
unexpected observation was unravelled. In effect, in vitro and in vivo work carried out 
primarily in the last ten years provided direct evidence to support the belief that nicotine 
stimulation could be acting as an important factor in neuroprotection.
2.1.4.1 In vitro neuroprotection with nAChR ligands
The majority of in vitro models utilised in the study of nicotine neuroprotection try to mimic 
some of the cellular processes occurring in the onset and/or progression of various 
neurodegenerative disorders, such as PD, AD and cerebral ischemia (Lipton and Rosenberg 
1994; Donnelly-Roberts and Brioni, 1999). In particular, several laboratories have 
investigated neuronal models associated with the overstimulation of glutamatergic receptors 
and/or Ap derived toxicity. These studies have shown that in vitro, nAChR activation can 
protect neuronal cultures against excitotoxic cell death (Marin et al., 1994; Donnelly-Roberts 
et al., 1996; Kaneko et al., 1997) and Ap toxicity (Kihara et al. 1997; Zamani et al., 1997; 
Wang et al., 2000; Kihara et al 2001), while also preventing the dexamethasone potentiation 
of kainic acid toxic effects (Semba et al., 1996). In addition, nicotine has been reported to 
protect PC12 cells against nerve growth factor deprivation (Yamashita and Nakamura, 1996; 
Li, et al., 1999) and to reduce apoptosis in chick cilliary ganglion neurons (Pugh and
68
CHAPTER 2
Margiotta, 2000). It is also relevant to mention that the neuroprotective effects observed after 
stimulation with nicotine in different neuronal preparations are mediated by nAChR, since 
nAChR antagonists attenuated or completely eliminated the neuroprotection.
In general, nicotine neuroprotection has been demonstrated in various types of neuronal 
preparations, including cortical and striatal primary cultures (Marin et al., 1994; Kihara et al., 
1997; Prendergast et al., 2001). However, previous reports also demonstrated that in certain 
neuronal models activation of nAChR can produce deleterious effects, such as neurotoxicity 
in the axons of the medial habenula (Carlson et al., 2001), naturally occurring cell death in 
motoneurones (Hory-Lee and Frank, 1995) and apoptosis in HC2S2 immortalised 
hippocampal progenitor cells (Berger et al., 1998). Interestingly, the ability of nicotine to 
induce apoptosis in undifferentiated HC2S2 cells was associated with the lack of adequate 
endogenous Ca2+ buffering systems. Accordingly, differentiated HC2S2 cells that, unlike 
their undifferentiated counterparts, have strong expression of the Ca2+ binding molecule 
calbindin, showed no apoptosis after nicotine stimulation (Berger et al., 1998). These results 
suggest that the capacity of neurones to integrate complex Ca2+ signals constitutes a critical 
factor in the final outcome of nAChR activation. Altogether, the effects of nicotine on cell 
survival probably depends on a number of factors such as specific gene expression, cell 
cycle phase, developmental stage and Ca2+ buffering capabilities of neuronal populations. 
As a result, a critical part in the study of nicotine neuroprotection is the understanding of the 
role of intracellular Ca2+ in the mechanisms of neuroprotection and the identification of the 
nAChR subtypes involved. In fact, although most of the reports have proposed Ca2+ as the 
intracellular mediator of neuroprotection, the actual experimental evidence showing the Ca2+ 
dependence of nicotine protection is scarce (Donnelly-Roberts et al., 1996). Similarly, 
although most of the studies have not definitively addressed the nAChR subtypes involved, 
both a7 (Donnelly-Roberts et al., 1996; Kaneko et al., 1997; Carlson et al., 1998; Li et al 
1999; Kihara et al 2001) and a4p2 (Kihara et al., 1998) nAChR have been proposed to 
mediate in vitro neuroprotection. The issues of Ca2+ dependence and nAChR subtypes will 
be further addressed in the Results and Discussion of this Chapter.
2.1.4.2 In vivo neuroprotection with nAChR ligands
In vivo studies showed that nicotine could be protective against MPTP induced 
neurodegeneration (Maggio et al., 1998), quinolinic acid evoked neuronal death (O'Neill et 
al., 1998) and systemic kainic acid toxicity (Borlongan, et al., 1995). Nicotine was also 
shown to reduce the loss of tyrosine hydroxylase immunoreactive neurones after partial 
transection of the nigrostriatral dopaminergic pathway (Janson et al., 1988) and to delay the 
ageing process of nigrostriatal neurons (Prasad et al., 1994). However, several studies
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assessing nicotine protection in toxically induced parkinsonism reported that chronic 
continuous nicotine did not prevent the dopamine loss, and even worsened it (Behmand and 
Harik, 1992; Fung et al 1991a, b). In fact, it seems that the delivery-protocol of nicotine plays 
a key part in achieving the in vivo neuroprotective actions. This assumption is supported by 
several studies where acute intermittent nicotine application, in contrast with most of the 
chronic studies, protected substantia nigra neurones in experimental models of Parkinson’s 
disease (Janson et al., 1992; Maggio et al., 1998; Costa et al., 2000). In vivo, the observed 
difference between chronic versus intermittent treatments would suggest that nicotine 
desensitisation of nAChR might be responsible for the lack of protection observed in most 
chronic studies. Although experimental evidence for the role of nAChR activation in in vivo 
models of nicotine neuroprotection is largely missing, more recent studies with the nAChR 
antagonists mecamylamine and chlorisondamine (Maggio et al., 1998; Costa et al., 2000) 
demonstrate that functional activation of the nAChR is indeed necessary for the 
achievement of nicotine protection in vivo.
Similar to results obtained in vitro, nicotine effects are also dependent on the neuronal 
population studied. Consequently, it has been shown that in the septum, nicotine actually 
has a deleterious effect, producing an increase in the loss of cholinergic neurones (Fuxe et 
al., 1994). In the hippocampal region however, the reactivity of hippocampal neurones to 
nicotine’s neuroprotective effects has been different compared to the septal counterparts. In 
an in vivo study of quinolinic induced neurodegeneration, hippocampal pyramidal and 
granule cells were protected after sub-chronic treatment with nicotine (O’Neill et al., 1997). 
Quinolinic acid is an endogenous substance that activates the NMDA subtype of glutamate 
receptor, and it is significantly increased in the cerebrospinal fluid of patients suffering from 
Huntington’s disease and AIDS dementia (Heyes et al., 1993; Lipton and Gendelman, 1995). 
The finding that in vivo nicotine protects against quinolinic-mediated neurotoxicity supports 
the notion that the activation of nAChR could be useful to ameliorate the neurodegenerative 
process associated to NMDA excitotoxicity.
2.1.5 General Aims of this chapter
Taking into account its crucial role in the progression of neurodegenerative processes, the
over stimulation of the NMDA receptor is widely used as a model of neurodegenerative-like
cell death (Meldrum and Garthwaite, 1990; Stuiver et al., 1996). The high levels of glutamate
receptors in the CNS and the vulnerability of the hippocampus to neurodegeneration in
Alzheimer’s disease have resulted in numerous studies documenting glutamate or NMDA
neurotoxicity in hippocampal preparations. As illustrated in the General Introduction, the
hippocampus has a particularly high expression of a7 nAChR (Seguela et al., 1993) and
70
CHAPTER 2
primary hippocampal cultures are predominantly labelled by a-bungarotoxin, indicative of a7 
nAChR (Barrantes et al., 1995a). Although the role of nicotine protection has been observed 
in several preparations, studies on hippocampal neurones are scarce (O’Neill et al 1998; 
Semba et al 1996; Zamani et al 1997). Even more surprising is the fact that the possible 
protective role of nicotine activation against NMDA-evoked excitotoxicity was never explored 
in hippocampal preparations.
Considering its role in the progression of AD, and the high densitiy of both nAChR and 
NMDA receptors, the hippocampus is an attractive brain region for examining the role of a7 
nAChR against NMDA-mediated excitotoxicity. Although both nicotine and NMDA act 
through ligand gated ion channels with high permeability to Ca2+, their differences in 
localisation, voltage dependence and magnitude of Ca2+ influx may differentiate the 
intracellular signals activated after receptor stimulation (Rogers and Dani, 1995; Role and 
Berg, 1996). In fact, both the differences and similarities in the molecular and biochemical 
properties of NMDA and nAChR may confer interesting insights into the specificity of 
neuronal Ca2+ signalling.
The particular aims of this part of the project were:
- To establish an experimental model for the study of NMDA-evoked excitotoxicity in 
hippocampal preparations.
- To explore the putative neuroprotective properties of nAChR activation against 
excitotoxicity in the hippocampus.






Tissue culture media were purchased from ICN Pharmaceuticals Ltd. (Basingstoke, Hants, 
UK). Culture media supplements, 3-[4,5-dimethylthiazol-2-y]-2,5-diphenyltetrazolium 
bromide (MTT), ethylene glycol-bis (p-aminoethyl ether)-N,N,N’,N’-tetraacetic acid (EGTA), 
N-methyl-D-aspartate (NMDA), 7-chlorokynurenic acid and nicotine were obtained from The 
Sigma Chemical Co. (Poole, Dorset, UK). 45Ca2+ was from Amersham Pharmacia Biotech 
(Little Chalfont, Bucks, UK). a-Bgt was obtained from RBI/Sigma (Poole, Dorset, UK). Fura- 
2 AM was from Molecular Probes (PoortGebouw, Leiden, The Netherlands). 
Methyllycaconitine and MK-801 were purchased from Tocris Cookson Ltd. (Bristol, UK). All 
other chemicals used were of analytical grade and obtained from standard commercial 
sources. Time-mated Wistar rats were obtained from the University of Bath Animal House 
breeding colony.
2.2.2 Cell Culture
High density hippocampal primary cultures were prepared from the hippocampi of E18
Wistar rat foetuses and maintained in serum free conditions as previously described (Goslin
and Banker, 1991; Barrantes et al. 1995). In brief, rats were sacrificed by cervical dislocation
and the entire uterus containing the foetuses was removed; each foetus was separated one
at a time by cutting the umbilical cord. The foetuses were decapitated, the brains being
immediately removed and immersed into fresh culture medium. Microdissection was carried
out under 20x magnification, separating the cerebral hemispheres from the diencephalon
and brainstem utilising fine spring scissors and style forceps. After the thalamus was
removed, the hippocampus could be seen on the posterior half of the hemisphere. At this
stage, the meninges were removed in one piece and the hippocampi were dissected by
cutting the boundaries between the hippocampus and the adjoining cortex. For further cell
dissociation, the dissected hippocampi were placed into a 35 mm Petri dish containing
Dulbecco’s Modified Eagle’s Medium (DMEM), cut into pieces and transferred into a 12 ml
test tube. The tissue pieces were washed twice with 10 ml of PBS, centrifuged and the
supernatant discarded after each wash. Subsequently, tissue was incubated at 37° in 2 ml of
PBS, plus 100 \i\ of trypsin and D-glucose 20 %. The enzyme reaction was finished after
adding 8 ml of serum supplemented defined medium and centrifuging, then tissue was
resuspended in the exact volume of serum supplemented media for further plating (1 ml for
each well). Cell suspensions were obtained by triturating the tissue with a Pasteur pipette
and once a cloudy suspension was obtained cells were ready to be plated in
polyethyleneimmine-coated dishes at a plating density of 1.5 x 10s cells/cm2, in serum
supplemented (10% fetal calf serum) chemically defined DMEM medium (consisting of
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DMEM and Nutrient Mixture F-12 Ham, 3:1), supplemented with 2 mM L-glutamine, 50 fig/ml 
gentamicin, 100 pM putrescein, 100 pg/ml human transferrin, 5 pg/ml insulin, 30 pM sodium 
selenite and 20 pM progesterone). After two h to allow cell attachment, the medium was 
changed to serum-free chemically defined medium (see above). This procedure resulted in 
viable cultures of neurons with less than 5 % glial contamination. For the long-term survival 
of neurons, cultures were fed every 3-4 days by replacing half of the medium with fresh 
medium.
General characteristics of dissociated cell cultures
In the appropriate conditions primary cell cultures develop distinct axons and dendrites, form 
synapses with one another, and are electrically active. Importantly, neurones in dissociated 
cultures appear to retain their individual identity, presumably because they are post-mitotic 
and committed in their differentiation. In general, the morphological and physiological 
characteristics of the cell populations present in culture correspond closely to the 
characteristics of the cell populations in the tissues of origin (Goslin and Banker, 1991 and 
references therein).
Primary dissociated neuronal cultures are particularly useful to study morphological and 
physiological properties, which can be applied on a cell-by-cell basis. In most cases, they 
are less well suited to traditional biochemical approaches, mainly because the quantity of 
material obtainable from these cultures is usually limited and they often contain a 
heterogeneous population of cells. In effect, developing approaches to deal with the 
heterogeneity of cell types is integral to the successful use of primary cultures. In the CNS, 
the presence of single dominant cell types in the hippocampus (pyramidal neurones) and the 
cerebellar cortex (granule cells) help to overcame this problem, in particular when culture 
conditions prevent the growth of unwanted glial cells. In the case of the hippocampus, the 
generation of pyramidal neurones, which begins in the rat at about embryonic day 15 (E15), 
is essentially complete, while the generation of dentate granule cells, which largely occurs 
postnatally, has scarcely begun (Bayer, 1980) and the number of glial cells is still relatively 
modest. The culture protocol previously developed in our laboratory by Barrantes et al. 
(1995a) avoided the need for glia (a common requirement for neuronal populations) by 
culturing neurones in a relatively high density. As stated above, this method produces fairly 





Fig 2.1 Hippocampal neurones in culture.
Hippocampal primary cultures, prepared as described in the methods section, are shown at different 
stages (1 day, 3 days, or 9 days after dissection and plating). Neuronal processes start to appear on 
day 2 and extended neurite networks can be seen from day 5-6. In addition to the typical pyramidal 
cells, stellate, bipolar, and cells with a single dominant process can also be observed. Neurones 
were cultured for 8 to 10 days before experiments.
In the hippocampal neuronal cultures immunoreactivity to a7 nAChR was observed in the 
cell body of almost all neurones (95 %) and its localisation paralleled that of a-Bgt binding 
sites. Using Rhodamine-a-Bgt labelling it was possible to determine that surface a-Bgt sites 
were on 60 % of neurones, while almost all neurones (95 %) labelled rhodamine-a-Bgt after
74
CHAPTER 2
permeabilisation (Barrantes et al., 1995a). Therefore, most of hippocampal neurones in 
culture (10 day old) have the potential to express a7 nAChR, although only 60 % of 
neurones do so. Studies carried out by Albuquerque and collaborators (1993) with similar, 
although less dense E-18 primary cultures showed that the cellular density of rhodamine-a- 
Bgt binding was not uniform, with the highest density occurring at the somato-dendritic 
region and comparatively less labelling in the processes. A smaller proportion of 
hippocampal neurones have also revealed immunoreactivity to a4 specific antibodies, 
although [3H]nicotine/[3H]cytosine binding was not detected (Barrantes et al 1995a). In 
agreement with these results, electrophysiological studies also reported the predominance 
of Type IA currents in the hippocampus, which are associated with a7 containing nAChR 
(see Chapter 1).
Brain slices
Although not ustilised in the present work, brain slices from brain preparations have been 
widely used for both biochemical and electrophysiological studies, and results obtained with 
this preparation will be extensively discussed later in this chapter. Unlike tissue culture 
techniques, brain slices allow the maintenance of a significant amount of the original tissue 
architecture and connectivity. In particular, perhaps the single biggest advantage of brain 
slice studies is that it allows patch clamping to study synaptic transmission at synapses that 
are probably identical to those functioning in vivo. In the particular case of the nAChR, 
studies in slice preparations allowed the analysis of post-synaptic currents mediated by 
nAChR at hippocampal interneurones (see Chapter 1). Overall, data from brain slices 
demonstrated that the hippocampal formation can express functional a7 and a4p2 nAChR, 
similar to reports in hippocampal primary cultures (Albuquerque et al., 1998).
As illustrated above, the function of nAChR in the hippocampus can be studied using 
different experimental approaches. The use of the relatively homogeneous hippocampal 
primary cultures facilitated the biochemical studies developed in the present work. On the 
whole, hippocampal primary cultures are a suitable model for the study of nAChR and, in 
particular, they represent a unique culture assay for the functional study of a7 nAChR.
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2.2.3 Neurotoxicity and neuroprotection experiments 
Drug treatments
After 8-10 days in culture, hippocampal neurons were subjected to the 
neurotoxic/neuroprotective treatments. The culture medium was removed and kept while the 
cell cultures were incubated with various drugs at 37°, in an exposure buffer solution (EBS) 
of the following composition: 2.5 mM CaCI2, 5 mM KCI, 137 mM NaCI, 0.3 mM KH2P04, 4 
mM NaHC03, 0.3 mM Na2HP04, 5.6 mM glucose, 0.01 mM glycine, 10 mM HEPES (pH 
7.4). NMDA (200 pM and 1 mM) or glutamate (300 pM, 500 p.M and 1 mM) were applied for 
1 h as the excitotoxic insult. For the assessment of neuroprotection, nicotine was co-applied 
with NMDA (200 i^M), or applied for 1 h immediately after removal of NMDA. Controls 
consisted of no drug treatment, and were processed in parallel. Where antagonists were 
used, these were added to the cultures 15 min before the excitotoxic insult and maintained 
throughout the period of drug treatment. At the end of the incubation with drugs, the EBS 
was replaced with the medium that had previously been removed. When EGTA was 
included in the EBS buffer, the estimated concentration of remaining free Ca2+ was 130 nM 
(calculated using the programme WinMAXC v. 1.78; Bers et al., 1994).
Cell Viability assays 
MTT method
Cell viability was assayed 20-24 h after the drug treatments using an assay based on the 
incorporation of the tetrazolium salt 3-[4,5-Dimethylthiazol-2-y]-2,5-diphenyltetrazolium 
bromide, MTT (Carmichael et al., 1987). Dissolved MTT is converted to an insoluble 
formazan by cleavage of the tetrazolium ring by mitochondrial dehydrogenase enzymes. 
Active mitochondrial dehydrogenases of living cells will cause this conversion while dead 
cells will not. After three hours of incubation with the MTT, isopropanol was added and 
optical density was read at 570 nm.
Fluorescent method
Nicotine protection against NMDA-evoked neuronal loss was also assayed using a 
Live/Death fluorescent method for culture preparations (Molecular probes LIVE/DEAD 
viability/cytotoxicity kit, with calcein AM and ethidium homodimer). This assay is based on 
the ability of the fluorogenic esterase calcein AM to get incorporated into living cells, being 
then hydrolysed to a green fluorescent product. Therefore, green fluorescence is an 
indicator of cells that have esterase activity as well as an intact membrane to retain the 
esterase products. Ethidium homodimer-1 is a high affinity red fluorescent nucleic acid stain 
that is only able to pass through the compromised membranes of dead cells. The assay was 
performed according to manufacturer’s instructions. In brief, 24 h after drug treatments
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fluorescent dyes (320 nM calcein AM and 1.6 pM ethidium homodimer-1) were added to the 
hippocampal cultures and incubated for 1 h before examination under a fluorescent 
microscope. At least 15 different fields from two independent experiments were analysed. 
Data are expressed as a percentage of the total number of cells counted (~ 80 per analysed 
field) and represents the mean ± SD.
2.2.4 Cytopiasmic Ca2+ measurements: Fura-2
Ten-day-old cultures, grown on PEI coated borosilicate glass cover slips (BDH/Merck Ltd., 
Poole, Dorset, UK) were ester-loaded with 5 pM Fura-2 AM by incubation at 37° for 30 min. 
The unloaded dye was removed by washing twice with the exposure solution. Fluorescence 
was measured using a pre-heated (37°) fixed stage microscope (Nikon) equipped with 
epifluorescence and a photometric analysis system (CAIRN). Excitation of Fura-2 was 
performed at 340, 360 and 380 nm while emission was measured between 400 and 520 nm. 
An infrared video camera was used to select and visualize a field containing 8-10 neurons. 
For UV excitation the equipment used a spinning wheel at 20 rev/s, allowing only brief 
exposures of the loaded cells to the UV light. The stability of the traces and the 
reproducibility of responses (Fig 2.7) demonstrated that phototoxicity was not a problem. For 
more information about Ca2+ sensitive dyes and fluorescence measurements see Methods 
section of Chapter 3 and Appendix 1.
Calculation of “resting” Ca2+: calibration of the dual-wavelength fluorescence data (ratio 
340/380) was made using the calcium ionophore ionomycin (2mM), Ca2+ free EBS plus 5mM 
EGTA and MnCI2 (2mM), according to Thomas and Delaville (1991). A Kd of 225 nM for 
Fura-2 was used in calculations of cytoplasmic Ca2+, made using the background subtraction 
method described by Thomas and Delaville (1991). The following equation was used: 
[Ca2+]j=Kd*[(R-Rmin)/(Rmax-R)]*X, where Rmin is the fluorescence ratio under nominally “zero” 
free Ca2+ conditions, Rmax is the fluorescence ratio under saturating conditions, and X  = 
F'min38o/F'max38o where F' is the fluorescence value corrected with its respective value found 
after addition of manganese. Responses to NMDA were about 20 % of the R max ( R nmda  /  
Rmax ratio = 0.202 ± 0.014, n=6), thus they were not close to saturation of the dye.
Ca2+ imaging
Nicotine stimulation of hippocampal cultures was also studied at the single cell level using
Dynamic video imaging (Concord Hardware, Perkin Elmer, UK) and Merlin data adquisition
software (Perkin Elmer). The fluorescent signal was recorded with an intensified Ultrapix low
light level camera and a fast wavelengths changing SpectroMaster allowed the illumination
of the cells at 340 and 380. Emmited light was collected at 510 nm. Cells were loaded with
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Fura-2 as previously described (see above) and experiments were carried out at 37 in the 
dark.
2.2.5 Neuronal uptake of 45Ca2+
Hippocampal cells were cultured for 8-10 days before incubation for 1 h, in the presence or 
absence of stimulus (NMDA, nicotine, KCI), in EBS containing 45Ca2+ (1 pCi/ml). Cells were 
then washed three times with EBS, and perchloric acid (0.4 M) was added to lyse the cells. 
Samples were counted for radioactivity in a Tri-Carb 1600 liquid scintillation counter.
2.2.6 Data analysis and statistics
Statistical significance was determined using paired Student’s t test and/or ANOVA plus post 
hoc Tukey’s test as stated in the figure legends, with a statistical significance level of p < 
0.05. Error bars show the standard deviation of the mean (SD) or standard error of the mean 




2.3.1 Glutamate and NMDA excitotoxicity
To determine the most suitable condition producing an excitotoxic insult in hippocampal 
cultures, the effect of a series of concentrations of glutamate and NMDA were compared. 
Cell viability was measured using the MTT assay as described in the methods section. 
Exposure of 8-10 day old cultures to glutamate (300 pM, 500 pM and 1 mM) for 1 h caused 
a significant and dose dependant reduction in neuronal survival, when compared to cultures 
submitted to the exposure buffer solution (EBS) alone (Fig 2.2). Similarly, NMDA (200 pM 
and 1 mM, in Mg2+ free conditions) also resulted in decreased cell viability, with slightly 
higher potency than glutamate (Fig 2.2). As the effect of NMDA can be ascribed to one 
particular class of glutamate receptor, subsequent experiments used a 1 h incubation with 
200 pM NMDA as the excitotoxic stimulus, a condition that decreased cell viability by 25 ± 5 
%. The involvement of NMDA receptors in mediating the neurotoxic effects of NMDA was 
confirmed by the ability of the selective antagonists MK-801 (10 pM) and 7-chlorokynurenic 
acid (500 pM) to prevent the neuronal loss (Fig 2.2).
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Fig 2.2 Cell viability in hippocampal cultures after excitotoxic treatments.
Hippocampal neurons were cultured for 8-10 days and then incubated with glutamate (300, 500 and 
1000 pM) or NMDA (200 and 1000pM) for 1 h. To confirm the involvement of NMDA receptors, 
NMDA (200 pM) was co-incubated with two NMDA receptor antagonists, MK-801 (10 pM) and 7- 
chlorokynurenic acid (500 pM). Control cultures, with no added drugs, were processed in parallel. 
Cell viability was assessed 24 h after drug incubation, using the MTT method. Data are expressed as 
percentage of controls and bars represents the mean + SD from at least 4 independent experiments. 




Co-application of nicotine (10 pM) with NMDA (200 pM) for 1 h resulted in the complete 
protection of hippocampal cultures against the excitotoxic effect of NMDA (Fig 2.3), as 
estimated using the MTT cell viability assay. The nicotine-evoked protection was not 
observed when lower concentrations of nicotine were used (1 pM and 5 pM; Fig 2.3). 
Neuroprotection was also analysed using a different method for determining cell viability. 
Confirming the results obtained with the MTT assay, the live/dead fluorescent method 
showed that nicotine co-incubation significantly protected hippocampal cultures against 
NMDA-evoked neuronal loss (from 51 ± 12 % of dead cells after NMDA to 32.5 ± 9 % of 
dead cells after NMDA plus nicotine; Fig 2.4). Subsequent experiments on neuroprotection 
used the MTT method for evaluation of cell viability.
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Fig 2.3 Effects of nicotine and nAChR antagonists on NMDA neurotoxicity.
Stimulation with 10 pM nicotine (but not 1 or 5 pM) protected hippocampal cultures when co­
incubated with NMDA (2 0 0  pM) for 1 h. To assess the involvement of nAChR, two nAChR 
antagonists, methyllycaconitine (1 pM) and a-bungarotoxin (1pM), were present 15 min before and 
during the nicotine and NMDA co-incubation. Cell viability was assessed 24 h after drug incubation, 
using the MTT method. Data are expressed as percentage of controls and bars represents the mean 
+ SD from at least 4  independent experiments. Significantly different from control (*, p < 0.05 , 
Student’s t test) or from NMDA 2 0 0  pM (#, p < 0.05 , ANOVA and post hoc Tukey’s test).
To confirm the presumption that nicotine protection was mediated through nAChR, two 
antagonists were compared. Both methyllycaconitine (MLA, 1 pM) and a-Bgt (1 pM) 
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Fig 2.4 Nicotine protection assayed using a Live/Death fluorescent method.
Hippocampal cultures were assayed for neurotoxicity using calcein AM (green fluorescent marker: 
living cells) and ethidium homodimer (red fluorescent marker: dead cells). Cultures were treated with 
NMDA (a) or NMDA + nicotine (b) as previously described (see methods). Nicotine (10 pM) protected 
hippocampal cultures when co-incubated with NMDA (200 pM) for 1 h. The fluorescent assay was 
performed 24 h after drug treatments, and at least 15 different fields from two independent 
experiments were analysed. Data are expressed as a percentage of the total number of cells counted 
(~80 per analysed field) and represents the mean ± SD. The number of dead cells after treatment 




In order to examine the relationship between NMDA and nicotine-mediated effects we 
devised a post-incubation protocol for nicotine stimulation. In these experiments, nicotine 
was present for 1 h subsequent to the removal of NMDA from the culture wells, but not 
together with NMDA. Interestingly, nicotine still prevented the NMDA toxicity when applied 
after the NMDA stimulation (Fig 2.5). The nicotine protection observed with this post­
incubation protocol offered an opportunity to examine the Ca2+ dependence of nicotine’s 
effects. Following the NMDA treatment in normal buffer (2.5 mM Ca2+), nicotine was applied 
for 1 h in buffer containing 5 mM EGTA. Under this “Ca2+ free” condition, nicotine failed to 
prevent the NMDA-mediated decrease in cell viability (Fig 2.5). Paradoxically, the toxic effect 
of NMDA was also Ca2+ dependant, as shown by the lack of significant neurotoxicity when 
NMDA was administered in the presence of 5 mM EGTA (Fig 2.5). Incubation with EGTA 
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Fig 2.5 Effect of nicotine 1 h post-incubation on neurotoxicity and Ca2+ dependence.
Hippocampal cultures were incubated for 1 h with NMDA (200 pM) before a subsequent 1 h nicotine 
(10 pM) incubation was carried out (postincubation). To assess the Ca2+ dependence of nicotine 
protection, EGTA (5 mM) was added to the nicotine post-incubation protocol. In separate 
experiments, EGTA was also present during NMDA (200 pM) incubations (coincubation). Cell viability 
was assessed 24 h after drug incubation, using the MTT method. Data are expressed as percentage 
of controls and bars represents the mean + SD from at least 4 independent experiments. Significantly 
different from control (*, p < 0.05, Student’s t test) or from NMDA 200 pM (#, p < 0.05), ANOVA and 
post hoc Tukey’s test.
In addition to nAChR or NMDA receptors, Ca2+ influx into hippocampal neurones can also 
occur after activation of VOCC. To examine the effect that Ca2+ entry through VOCC might 
have on the NMDA evoked neurotoxicity of hippocampal neurones, we incubated NMDA 
treated cells with the general depolarising agent KCI (20 mM). A 1 h co-incubation with 20 
mM KCI did not protect hippocampal neurones against the NMDA-evoked excitotoxicity (Fig 
2.6). In contrast, preliminary studies with trophic factors showed that incubation with nerve
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growth factor (NGF; 50 ng/ml) for 24 hours after the 1 h NMDA insult significantly prevented 
the neuronal loss (Fig 2.6).
NMDA 200 nM
KCI NGF
20 mM 50 ng/ml
Fig 2.6 Effect of KCL and NGF on NMDA neurotoxicity.
Hippocampal cultures were incubated with NMDA for 1 h and KCI (20 mM, 1 h co-incubation) or NGF 
(50 ng/ml, 24 h post-incubation) was added to the EBS or culture medium, respectively. Cell viability 
was assessed 24 h after incubation with NMDA, using the MTT method. Data are expressed as 
percentage of controls and bars represent the mean + SD from at least 4 independent experiments. 
Significantly different from control (*, p < 0.05, Student’s t test).
2.3.3 Nicotine and NMDA mediated increase in 
cytoplasmic Ca2+
The resting free Ca2+ concentration measured in Fura-2 loaded hippocampal neurons was in 
the physiological range (70.8 ± 5.6 nM, n=9). Acute stimulation with nicotine (10 pM) evoked 
an increase in the fluorescence ratio (F340/F380) that persisted over the time of drug 
incubation (5 min, Fig 2.7a). NMDA (200 pM) induced a higher and sustained increase in the 
fluorescence ratio (5 min, Fig 2.7a), and this was not diminished when added in the 
presence of nicotine (Fig 2.7b). The nicotine-evoked increase in the fluorescence ratio was 
completely blocked by 1 pM a-bgt (Fig 2.7c), demonstrating that the a7 subtype of nAChR 
accounts for this response.
Calculation of the cytoplasmic Ca2+ concentration showed that NMDA stimulation (200 pM) 
increased cytoplasmic Ca2+ 4-fold, compared with a 1-fold increase in response to nicotine 
(Fig 2.7d). This difference in the magnitude of the responses to nicotine and NMDA was also 
observed when equivalent concentrations of nicotine and NMDA (200 pM) were compared 
(Fig 2.7d). The absence of interaction between nicotinic and NMDA receptor Ca2+ responses 
was also demonstrated using a lower concentration of NMDA (10 pM, Fig 2.7e). In this
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experiment, the increase in fluorescence ratio after NMDA was the same, regardless of 
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Fig 2.7 Nicotine and NMDA evoked changes in cytoplasmic Ca2*.
Hippocampal neurons were loaded with Fura-2 AM and the fluorescence ratio at 340/380 was 
measured. A: nicotine (10 pM) or NMDA (200 pM) was applied for 5 min, separated by an 
intermediate wash. B: NMDA (200 pM) stimulation was performed in the presence of nicotine (10 
liM). C: nicotine (10 pM) stimulation was carried out in the presence of a-bungarotoxin (1 pM). D: 
cytoplasmic Ca2+ concentrations were calculated according to Thomas and Delaville (1991) and bars 
represent the mean + SEM from at least 4 independent experiments. All the treatments were 
significantly different from resting Ca2+ levels (p < 0.05, Student’s t test). E: NMDA (10 pM) 
stimulation was performed before, during or after a nicotine (10 pM) stimulus.
2.3.4 Ca2+ Imaging
Stimulation of hippocampal cultures with nicotine (100 pM) produced a significant increase 
in single cell fluorescence as observed with the dynamic video imaging system (Fig 2.8). 
Interestingly, only a subpopulation of hippocampal neurones was sensitive to the nicotine 
stimulation. This was not a consequence of poor neuronal viability, as submitting the same 
cultures to a general depolarisation with KCI produced a significant increase in fluorescence 




Fig 2.8 Ca2+ imaging of hippocampal cultures.
Hippocampal neurones were loaded with fura-2 AM as described in the methods section and 
changes in cytoplasmic Ca2+ levels were analysed using an intensified UltraPix low light level 
camera, with a fast wavelength changing SpectroMaster. Images shown were acquired before (1-3) 
and 1s, 2s, 5s, 15s, 30s, 45s, 60s and 120s after nicotine stimulation (100 pM; images 4-11) or 1s, 2s 
and 15s after stimulation with KCI (20 mM; images 13-15).
2.3.5 Neuronal loading of ^Ca2*
As the cytotoxic and neuroprotective treatments involved a 1 h incubation, it was important 
to determine the total Ca2+ accumulation (cytoplasmic plus intracellular stores) at the end of 
this long incubation with the drugs. To measure the extent of Ca2+ load into the neurons, 
45Ca2+ was added to the EBS and its intracellular accumulation measured. Notably, the 1 h 
incubation with NMDA (200 pM) produced a dramatic increase in 45Ca2+ load, almost 6 fold 
higher than controls (Fig 2.9). In contrast, incubation with 10 pM nicotine produced no 
significant increase in 45Ca2+ accumulation (Fig 2.9). A higher concentration of nicotine (100 
pM) also failed to give any increase in 45Ca2+ loading. The nicotine stimulation did not 
prevent the NMDA-evoked effect, as co-incubation of NMDA (200 pM) and nicotine (10 pM) 
increased the 45Ca2+ load to a level similar to that of NMDA alone (Fig 2.9). For comparison, 
KCI depolarisation (20 mM; 1 h) was also examined, and found to produce no significant 
increase in 45Ca2+ accumulation at the end of the incubation (Fig. 2.9).
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Fig 2.9 Intracellular accumulation of 45Ca2+ in hippocampal primary cultures.
Hippocampal primary cultures were incubated with nicotine (10 or 100 pM), NMDA (200 pM) or KCI 
(20 mM) for 1 h, in the presence of 1pCi/ml of 45Ca2+. When the incubation was over, cells were 
washed and lysed and 4 Ca2+ accumulation was measured. Data are expressed as percentage of 
controls and bars represents the mean + SD from at least 4 independent experiments. Significantly 




2.4.1 Neurotoxicity and neuroprotection
The results presented in this chapter support the proposition that activation of the a7 
subtype of nAChR can protect hippocampal neurons against an excitotoxic insult through a 
Ca2+ dependant mechanism. Both nicotine and NMDA acutely increased intracellular Ca2+, 
but differed markedly in the magnitude of this response and in the Ca2+ load after long 
incubations.
In recent years, nicotine and other nicotinic agonists have been recognised as 
neuroprotective agents in several models of neuronal death, both in vivo and in vitro 
(reviewed by Donnelly-Roberts and Brioni, 1999). However, this is the first time that nicotine 
has been shown to protect hippocampal cultures against NMDA-induced neurotoxicity. As 
illustrated in the Introduction of this chapter, the hippocampal region is functionally involved 
in the progression of AD, while excitotoxic damage due to excess glutamate stimulation has 
been proposed as a common contributor to neurodegenerative diseases (Meldrum and 
Garthwaite, 1990; Leist and Nicotera, 1998). In our experimental model, a 1 h exposure of 
hippocampal primary cultures to glutamate or NMDA produced a significant and 
concentration-dependent decrease in neuronal viability. The sensitivity of NMDA 
excitotoxicity to MK-801 and 7-chlorokynurenic acid confirmed that NMDA receptors mediate 
this effect.
The neuronal loss provoked by over-stimulation of the NMDA receptor has been commonly 
associated with necrotic-type cell death. In fact, it has been suggested that injury by 
neurotoxins or glutamate lacked the regulated series of events involved in a death 
programme. However, more recent evidence suggests that excitotoxic injury can also 
involve key regulators of apoptosis, like p53, Bax and/or Bcl-2 (Nicotera et al., 1999 and 
references therein). In fact, the impression that entirely distinct types of cell death take place 
under a variety of conditions could be misleading. Instead, it is increasingly believed that cell 
death might be accomplished following a core programme, with a choice of different 
execution routines that often produce dissimilar morphologies (for review see Nicotera et al.,
1999). This concept is directly corroborated in in vitro experiments showing that 
excitotoxicity can cause both apoptosis and necrosis (Ankarcrona et al., 1995), and with 
reports demonstrating that caspase inhibitors significantly reduce the extent of excitotoxic 
damage (Leist et al., 1997). The insult intensity can also contribute to the nature of the 
neuronal loss. Accordingly, on exposure to mild excitotoxic insults, neurones die exhibiting 
the typical apoptotic features. With stronger insults, however, the degradative processes
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responsible for apoptotic morphology are often prevented and neurones die by necrosis 
(Bonfoco et al., 1995; Ankarcrona et al., 1995). It has been suggested that this “switch” 
mechanism could be due to untimely energy dissipation; in fact, recent evidence has 
revealed that, when energy levels are rapidly compromised, cells triggered to undergo 
apoptosis are instead forced to die by necrosis (see Nicotera et al., 1999; Roy and Sapolsky, 
1999). Taking into account all these variables, it is difficult to predict with certainty the 
precise mode of neuronal death occurring in our experiments with hippocampal neurones. 
Although it is probable that both apoptotic and necrotic mechanisms occur, some preliminary 
experiments using the TUNNEL method for the detection of apoptotic neurones have 
suggested that, in hippocampal cultures, the stimulation with 200 pM NMDA for 1 h 
produced a predominantly necrotic form of excitotoxic neuronal loss.
Regardless of the apoptotic or necrotic nature of excitotoxicity, 10 pM nicotine significantly 
prevented the NMDA-evoked neuronal loss analysed using two different methods, and thus 
demonstrated the capacity of nicotine to rescue hippocampal neurones from an excitotoxic 
insult. The a7 subtype of nAChR has been proposed to mediate nicotine neuroprotection in 
a number of experimental models, mainly because of its high Ca2+ permeability (Donnelly- 
Roberts and Brioni, 1999; Kihara et al., 2001). However, in many cases where protection by 
nicotinic agonists was shown, there has not been definitive pharmacological evidence to 
support a role for a7 nAChR. Here, we found that the protection given by nicotine was 
completely prevented by co-application of 1 pM MLA, a concentration which also blocked 
the protection by the novel nAChR agonist GTS-21 against NGF and serum deprivation in 
PC12 cells (Li et al., 1999). Although this MLA antagonism confirms that nicotine is acting 
via nAChR, the concentration of MLA used would be expected to non-selectively block most 
nAChR subtypes. Lower concentrations of MLA gave variable results, possibly due to its 
instability, and were therefore not shown. However, the complete inhibition of nicotine 
neuroprotection in the presence of the definitive a7 antagonist a-Bgt (Fig 2.3) provides firm 
evidence that a7 nAChR do mediate nicotine’s effect, a result consistent with previous 
reports showing that a-Bgt blocks nicotine protection against neurotoxicity in cortical cultures 
(Donnelly-Roberts et al., 1996; Carlson et al., 1997; Kaneko et al., 1997; Kihara etal., 2001). 
The blockade of nicotine protective effects by nAChR antagonists demonstrates that 
activation of nAChR is indeed required for the achievement of neuroprotection. At the same 
time, it argues against the proposition that nAChR desensitisation can act as a functional 
mechanism in nicotine-evoked neuroprotection (Donnelly-Roberts and Brioni, 1999). Finally, 
the preponderant role of the a7 subtype of nAChR in the present study is compatible with 
the high levels of a7 mRNA expression (Seguela et al., 1993) and [125l]a-Bgt and [3H]MLA 
binding in the hippocampus (Whiteaker et al., 1999), and with the high density of [125l]a-bgt
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binding sites (Barrantes et al., 1995a) and type IA currents (Alkondon and Albuquerque,
1993) present in hippocampal primary cultures.
The majority of the previous studies addressing nicotine neuroprotection, used a pre­
incubation with nicotine in order to prevent the neuronal loss after a toxic stimulus (e.g.: 
Donnelly-Roberts et al., 1996; Semba et al., 1996). In our experiments, we found that co­
application of nicotine with NMDA was sufficient to ameliorate the toxicity, a result consistent 
with observations by Marin et al. (1994) and Kihara et al. (1997), in striatal and cortical 
cultures respectively. An initial explanation for the nicotine protection observed after co­
application with NMDA could have been provided by the blockade and/or inhibition of NMDA 
activation by nicotine stimulation. In fact, it has been previously shown that nAChR agonists, 
including nicotine, can partially inhibit NMDA evoked responses in rat cortical neurones 
(Aizenman et al., 1991). In addition, NMDA receptors can be inactivated by Ca2+-dependent 
mechanisms, including the Ca27calmodulin-dependant protein phosphatase calcineurin 
(Legendre et al., 1993; Lieberman and Mody, 1994; Tong et al., 1995). Nicotine has been 
shown to elevate intracellular Ca2+ and activation of acetylcholine receptors can induce 
Ca27calmodulin-dependant intracellular cascades in PC12 cells (MacNicol and Schulman, 
1992). Therefore, a plausible explanation for the protection produced by co-incubation of 
nicotine with NMDA could have been the direct inactivation of NMDA receptors. However, 
this hypothesis is not tenable for the reason that nicotine was still neuroprotective when 
administered after the 1 h NMDA stimulation. In fact, this is the first report to show that 
nicotine can protect when applied subsequent to the toxic stimulus, an observation that has 
important consequences for the proposition of functional mechanisms mediating 
neuroprotection. In this regard, it has been demonstrated that the cellular processes that 
lead to neurodegeneration occur over relatively long periods, even after the toxic input is 
over (Choi et al., 1987). In our experimental conditions, the observed neuronal loss is 
probably a result of a relatively long process of neuronal degeneration occurring over a 24 h 
period. Therefore, the capacity of nicotine post-stimulation to be protective indicates that 
nAChR activation can trigger a series of intracellular protective mechanisms that, without 
blocking the NMDA receptor itself, can prevent the neuronal loss by acting down stream to 
the initial toxic stimulus. This may well confer a significant advantage in the development of 
nAChR agonists as therapeutic targets against neurodegeneration.
The ability of nicotine to protect when applied subsequent to the excitotoxic insult not only 
allowed us to abandon the hypothesis of a NMDA receptor inhibition, but also gave the 
opportunity to examine some of the mechanisms underlying the nicotine neuroprotection, 
without interfering with the NMDA receptor activation. Indeed, the removal of extracellular 
Ca2+ from the stimulation buffer during nicotine post-incubation demonstrated that the
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nicotine neuroprotection was Ca2+ mediated, while parallel experiments showed that the 
excitotoxic effect of NMDA was, as expected, also dependent on extracellular Ca2+ (Fig 2.5). 
Although this can be viewed as paradoxical, it could be explained by the particular properties 
of the nAChR and NMDA receptors, which differ not only in cellular localisation but also in 
Ca2+ permeability (Rogers and Dani, 1995; Role and Berg, 1996; more details in Chapter 1). 
Our studies have addressed some of these questions, by monitoring the changes in 
intracellular Ca2+ after nicotine and/or NMDA stimulation.
2.4.2 Receptor mediated changes in Ca2+ levels
The monitoring of intracellular Ca2+ levels in hippocampal neurones after nicotine and/or 
NMDA stimulation produced dissimilar results. Nicotine stimulation increased cytoplasmic 
concentrations of free Ca2+ from 70 to 200 nM, while NMDA generated substantially bigger 
increases (up to 500 nM). This difference in the magnitude of maximal increases was also 
observed when equivalent concentrations of nicotine and NMDA were compared (nicotine 
and NMDA 200 pM), and confirms previous assumptions of the relative Ca2+ permeability of 
nAChR and NMDA receptors. In addition, NMDA and nAChR receptors also produced 
different results when comparing the overall Ca2+ load after the 1 h incubation. In effect, 
NMDA produced a huge rise in accumulated 45Ca2+, which was not observed after nicotine 
stimulation. Although this disparity may be partly explained by the NMDA and nAChR 
relative permeability to Ca2+ (see Chapter 1), it is very likely that the results observed are 
due to their differences in desensitisation rates (see Dingledine et al., 1999, for NMDA 
receptors and Role and Berg, 1996, for a7 nAChR), which can dramatically affect the overall 
changes in intracellular Ca2+. In fact, the sustained increases in cytoplasmic Ca2+ 
concentrations after stimulation with NMDA are in agreement with the relatively slow 
desensitisation rates of NMDA receptors (Dingledine et al., 1999). When considering the fast 
desensitisation kinetics of nAChR, the observation that nicotine stimulation also produced 
sustained Ca2+ increases is somewhat more difficult to explain, and may suggests the 
involvement of various sources of Ca2+ influx (see Chapter 3 for related results and further 
discussion).
The a-Bgt sensitivity of the cytoplasmic Ca2+ increase after application of a neuroprotective 
concentration of nicotine (10 ^M, 5 min, Fig 2.7c) confirms that a7 nAChR not only mediates 
the neuroprotection, but also the observed increase in free Ca2+ concentration. In addition, 
the analysis of cytoplasmic Ca2+ levels allowed us to further confirm the notion that NMDA 
receptor blockade is not necessary to achieve nicotine protection. In effect, we
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demonstrated that NMDA-evoked Ca2+ signals were not affected when nicotine was applied 
before or together with the NMDA stimulus (Fig 2.7e).
2.4.3 Ca2+ as a life or death intracellular signal
Intracellular Ca2+ signals are a fundamental part of neuronal function, and in physiological 
conditions, they are rapidly buffered after fulfilling their role as mediators of intracellular 
signalling mechanisms. However, when Ca2+ homeostasis is altered and buffering systems 
are overwhelmed, neuronal Ca2+ excess can be linked to injurious processes, like 
proteolysis, mytochondrial dysfunction and production of toxic reactions (Leist and Nicotera, 
1998; Nicholls and Budd, 2000). For that reason, Ca2+ has been proposed as a key mediator 
of neurodegeneration (Tymianski et al., 1993; Berridge, 1998). In general, the cellular influx 
of Ca2+ has been associated with both early neuronal degeneration (Randall and Thayer, 
1992) and/or delayed neurotoxicity occurring up to many hours after the initial insult (Choi et 
al., 1987). Nevertheless, in spite of its clear role as mediator of neuronal degeneration, it has 
been difficult to demonstrate a relationship between the actual level of intracellular Ca2+ load 
and neuronal death: while early reports showed a correlation between the magnitude of the 
rise in free intracellular Ca2+ and the extent of the neuronal loss (Milani et al., 1991), others 
could not demonstrate such association (Michaels and Rothman, 1990; Dubinsky and 
Rothman, 1991). Supporting the link between the amount of intracellular Ca2+ load and the 
level of neuronal toxicity, a “Ca2+ set” hypothesis was proposed, in which the trespassing of 
a set level of intracellular Ca2+ concentration should lead to neuronal death (Franklin and 
Johnson, 1992). As a further development of this theory, it was suggested that moderate 
levels of Ca2+ concentrations should be able to buffer incoming Ca2+ insults and thereby 
promote survival (Franklin and Johnson, 1992). In fact, this latest hypothesis was proposed 
as a functional mechanism behind the protective effects observed after modest 
depolarisation (Franklin and Johnson, 1992) and nicotine stimulation (Donnelly-Roberts and 
Brioni, 1999).
In spite of the initial appeal of the "Ca2+ set” level hypothesis of toxicity and protection,
several reports have critically challenged this theory, establishing that simple linear
relationships were inadequate to demonstrate a significant association between intracellular
Ca2+ levels and neuronal death (Michaels and Rothman, 1990; Dubinsky and Rothman,
1991; Tymianski et al., 1993). In an elegant report by Tymianski et al. (1993) it was
quantitatively demonstrated that the toxicity evoked by NMDA stimulation was not due to the
ability to trigger comparatively greater Ca2+ increases, but rather to some attribute that,
although not defined, must have been specifically associated with the NMDA-mediated Ca2+
influx. In support of this proposition, a more recent report by Sattler et al. (1998)
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demonstrated that Ca2+ loading through VOCC was not toxic, even when maximal Ca2+ 
accumulations were identical to those obtained with a toxic NMDA stimulus. In summary, 
what these and other studies proposed was that spatially restricted changes in free Ca2+ 
concentration should be more relevant to both signalling and cytotoxicity, than changes in 
the total amount of cytoplasmic Ca2+ (for review see Leist and Nicotera, 1998). In the 
present study, we report several results that argue in favour of the “Ca2+ source” theory 
rather than the “Ca2+ set” hypothesis. In particular, we demonstrate that nicotine did not 
prevent the NMDA-evoked massive load of intracellular Ca2+. Consequently, this would 
suggest that a nicotine stimulation that is able to inhibit the NMDA-evoked neuronal loss, is 
doing so without preventing the overall increase in intracellular Ca2+ accumulation observed 
after NMDA stimulation. Added to this, a one-hour incubation with a general depolarising 
agent (KCI) did not prevent the NMDA-evoked toxicity, suggesting that only the specific Ca2+ 
influx through the a7 nAChR mediates the protection of hippocampal neurones. It is 
important to mention that the differences observed in the overall 45Ca2+ load are not simply a 
reflection of differences in drug concentration, as higher nicotine concentrations also failed 
to increase the accumulation of 45Ca2+ above control levels. When tested for toxicity, even a 
high nicotine concentration, which differed markedly from NMDA in their Ca2+-evoked 
effects, did not reduce neuronal viability (107.5 + 6 % of cell viability respect to controls after 
nicotine 200 pM).
In conclusion, and consistent with the theory that the influx pathway but not Ca2+ load 
determine neuronal vulnerability, we showed that total Ca2+ overload, such as that produced 
by NMDA in the present experiments (Fig 2.9), does not lead inexorably to cell death. In fact, 
the addition of nicotine was neuroprotective through an autonomous Ca2+-dependent 
mechanism (Fig 2.10). As well as differences in the magnitude of Ca2+ changes, the spatial 
segregation of nAChR and NMDA receptors, facilitating coupling to distinct Ca2+-dependent 
signalling pathways, is likely to be crucial in determining the opposing outcomes of nicotine 
and NMDA application. In this regard, NMDA receptors have been reported to be associated 
to particular neurotoxic pathways. In a report by Tymianski and collaborators (Sattler et al., 
1999), the suppression of PSD-95 protein expression, a member of the postsynaptic density 
that binds NMDA receptors, produced a specific blockade of NMDA-evoked excitotoxicity in 
cortical cultures. This deficiency in PSD-95 had no effects on NMDA receptor currents, or in 
the total Ca2+ load after NMDA stimulation. Moreover, suppressing PSD-95 expression 
affects neither the toxicity nor the Ca2+ influx triggered through pathways other than NMDA 
receptors. Overall, these results provide firm evidence for the existence of specific signalling 
pathways that link the NMDA receptor with potentially toxic signalling cascades.
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Fig 2.10 Schematic diagram of excitotoxic and protective pathways.
The over-stimulation of NMDA receptors generates several signalling mechanisms and toxic 
pathways that eventually lead to neuronal death. Activation of a7 nAChR evoked an increase in 
cytoplasmic Ca2+ levels that was neuroprotective through an autonomous Ca2+-dependent 
mechanism down stream of the NMDA receptor activation. The precise intracellular steps involved in 
mediating the neuroprotective effects of nAChR activation are still unknown. However, it is likely that 
a cascade of intracellular events (protein phosphorylation and/or alteration of neurotrophic factor 
levels) occur. Some of these nicotine evoked signalling processes will be investigated in Chapters 3 
and 4.
2.4.4 Possible mechanisms of Ca2+-dependent nicotine 
protection
The actual intracellular steps involved in mediating the neuroprotective effects of nAChR 
ligands are still unclear (Fig 2.10). However, it is assumed that a cascade of intracellular 
events such as protein phosphorylation and/or alteration of the levels of neurotrophic factors 
occur. In vivo, nicotine was shown to increase the tissue levels of NGF and BDNF (Belluardo 
et al., 1998; Maggio et al., 1998), and because increased intracellular Ca2+ can induce 
release of neurotransmitters and other substances, it could be suggested that high Ca2+ 
might promote survival by causing release of one or more autocrine factors (i.e. NGF). 
These factors would then bind to specific neuronal receptors and promote survival. In effect, 
our results show that incubation with NGF for 24 h after the NMDA insult significantly 
protected hippocampal preparations, indicating that trophic factors can be neuroprotective in 
this particular experimental model. Even though the possibility of nicotine protection being 
mediated by the release of trophic factors is theoretically possible, it seems unlikely, since
cell density does not significantly affect the survival-promoting action of depolarisation
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(Franklin and Johnson, 1992, unpublished observations) or nicotine stimulation (personal 
observation). If trophic factors were released by depolarisation, high-density cultures should 
be more sensitive to protection than low density ones, since a higher amount of trophic 
factors would be released. Added to this, the stimulation with a depolarising KCI stimulus 
failed to protect hippocampal neurones against NMDA evoked excitotoxicity. As a result, it 
seems more likely that increased Ca2+ promotes neuronal survival by affecting intracellular 
signalling mechanisms within the cell.
Although the mechanisms of nicotine protection are not fully resolved, a series of reports 
that appeared since the results presented in this chapter were obtained indicated some of 
the possible mechanisms underlying nicotine neuroprotection. According to Garrido et al. 
(2001) nicotine can protect spinal cord neurones through the inhibition of arachidonic acid 
induced cellular apoptosis cascades, in a mechanism that does not involve increased 
expression of Bcl-2. In cortical cultures, nicotine protected against Ap neurotoxicity through a 
mechanism that implicated phosphatidylinositol 3-kinase (PI3-kinase) and, unlike spinal cord 
neurones, upregulation of Bcl-2 (Kihara et al., 2001). Finally, a report by Prendergast et al. 
(2001) reported that NMDA-evoked toxicity in hippocampal slices could be prevented by 
chronic pre-exposure to nicotine. Consistent with our results, they show that nicotine does 
not inhibit NMDA Ca2+ signals, and suggest that nicotine protection could be associated with 
an increase in the expression of the cytosolic Ca2+ buffering protein calbindin-D28K.
In summary, the results presented here are consistent with the notion of regulation of cellular 
function by the specificity of signalling routes. The a7 nAChR has been shown to activate 
sustained Ca2+ signals, which are most probably capable of stimulating specific intracellular 
mechanisms. Both aspects of cellular function, the integration of various Ca2+ signals and 
the activation of intracellular signalling molecules, must act in conjunction to elaborate the 
cellular responses after nicotine stimulation. The elucidation of some of these aspects 
should contribute to the understanding of nAChR function in neuronal systems. Therefore, in 
the following chapters of this thesis, we analysed some of these particular features that 
follow the activation of nAChR, including:
- The study of the particular Ca2+ sources contributing to the sustained elevations in 
intracellular Ca2+ evoked by nicotine (Chapter 3).
- The analysis of some of the intracellular signalling mechanisms generated after 





< nAChR Mediated Ca2+ Signals >
3.1 Introduction
Intracellular Ca2+ has a pivotal role in regulating diverse aspects of neuronal function 
(Berridge, 1998; Rose and Konnerth, 2001), as local changes in Ca2+ levels underpin major 
neuronal processes, such as transmitter release, excitability, synaptic plasticity and gene 
expression (Ghosh and Greenberg, 1995; Berridge et al., 1998; see Chapter 1). The 
remarkable versatility and signal specificity of this ubiquitous ion arises from the independent 
regulation of distinct signalling pathways linked to specific routes of Ca2+ influx (Ghosh and 
Greenberg, 1995). The importance of specific receptor-mediated Ca2+ signals was indeed 
illustrated in Chapter 2, with the activation of Ca2+-dependent protective as well as 
excitotoxic mechanisms in hippocampal neurones, thus demonstrating the role of Ca2+ as a 
life or death signalling messenger. Overall, the study of neuronal function must be closely 
associated with the understanding of Ca2+ signals and the corresponding Ca2+ evoked 
signalling routes.
In the process of examining intracellular Ca2+ signals, there are two aspects of cytoplasmic
Ca2+ dynamics that are important to consider. First, the cytosol is extensively buffered by
Ca2+ binding proteins, including mediators of Ca2+ action (e.g. calmodulin), and proteins that
have no known function other than the binding of the cation itself (e.g. calbindin). Secondly,
diffusion of Ca2+ throughout the cytosol is very slow, at only one hundredth of the diffusion
rate in pure water. As a direct consequence of these properties of cytosolic Ca2+ dynamics,
any cellular Ca2+ influx event would result in the generation of transient high Ca2+
microdomains, which would be localised in the proximity of the activated channels (Llinas
and Moreno, 1998). However, it is a well established observation that the intracellular
consequences of cytoplasmic Ca2+ signals are not only limited to changes in Ca2+ levels
beneath the plasmalemma. In fact, as already discussed in Chapters 1 and 2, neuronal
function involves a complex series of intracellular signalling phenomena that are known to
depend on Ca2+ as a trigger. In the last decade, it has become increasingly clear that most
of these processes can be partly sustained by the existence of intracellular Ca2+ stores,
which are able to rapidly accumulate considerable amounts of Ca2+ and to release them at
rates in the same order as those of surface influx (for review see Meldolesi, 2001). In effect,
the spatial and temporal characteristics of a particular cytoplasmic Ca2+ signal are
determined by the combination of extracellular and/or intracellular Ca2+ sources. Although
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voltage- or receptor-operated Ca2+ channels are the most common initiators of increases in 
cytoplasmic Ca2+, it is increasingly accepted that intracellular stores contribute to the 
generation and regulation of discrete Ca2+ signals, while in some cases they can also trigger 
the initial Ca2+ response (Simpson et al., 1995). In the previous chapter, we demonstrated 
the existence of sustained elevations of cytoplasmic Ca2+ after activation of nAChR. It was 
therefore proposed that Ca2+ signals triggered by the stimulation of nAChR most probably 
involve the integration of various sources of cytoplasmic Ca2+ increase.
The combination of extracellular influx and intracellular release of Ca2+ has been established 
as a key premise in the neuronal signalling process. In fact, it has been indicated that Ca2+ 
release from diverse sources is a critical factor in the generation of Ca2+ signals with 
sufficient complexity to regulate the vast number of Ca2+ dependent cellular functions 
(Johnson and Chang, 2000). The spatial and functional heterogeneity of intracellular stores 
is a crucial element in the generation of such complex Ca2+ signals. The identification and 
characterisation of the cytoplasmic Ca2+ signals generated at specific sites by Ca2+ release 
from stores has lead to the proposal of the endoplasmic reticulum (ER) as an intracellular 
excitable membrane system working co-ordinately with the surface plasmalemma (Berridge,
1998). As illustrated in Chapter 1, intracellular stores not only contribute to segregated 
intracellular Ca2+ elevations, but they also take part in the propagation of intracellular Ca2+ 
signals through the sequential activation of IP3 and ryanodine receptors. The generation of 
these intracellular Ca2+ waves is particularly relevant within the complex cellular geometry of 
neurones. In effect, waves generated following the evoked Ca2+ influx at the post-synaptic 
membrane can undergo various developments: they can remain localised in the generating 
compartment, move to adjacent dendrites, or even invade the whole neuron (Petrozzino et 
al., 1995; Korkotian and Segal., 1998; Svoboda and Mainen, 1999; Berridge, 1998). These 
Ca2+ waves may not necessarily be confined to single neurones, but can be expanded to 
their neighbours after store-operated Ca2+ influx and stimulation of transmitter release 
(Taylor and Peers, 2000), or via activation of store operated Ca2+ signals in astrocytes 
(Sharma and Vijayaraghavan, 2001)
3.1.1 Molecular components of the ER membrane system
At variance with other membrane systems, such as the mitochondrial inner membrane, no 
potential exists across the ER membrane. Instead, the steep Ca2+ gradient that provides the 
driving force for Ca2+ release from stores is maintained by a family of ATPase pumps, called 
the sarcoplamic-endoplasmic reticulum Ca2+ ATPases (SERCA), which are molecularly 
different from the pumps of the plasma membrane. The regulation of the SERCA pump is 
highly complex, depending on the Ca2+ existing at both the cytosolic and luminal surface of
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the ER, and at the latter in particular, it has been demonstrated that Ca2+ binding proteins 
can have an inhibitory effect by establishing a direct interaction with the pumps (John et al.,
1998). Another particularly important aspect of store function is the low affinity of the major 
luminal Ca2+ binding proteins, about two orders of magnitude lower than corresponding 
proteins in the cytosol (see Meldolesi, 2001). As a result, diffusion of Ca2+ within the lumen is 
fast, with stores Ca2+ concentration expected to be largely the same throughout discrete 
endomembrane compartments, and to decrease homogeneously after discharge (Park et al.,
1999). When considering that ER channels are also sensitive to internal levels of Ca2+ in the 
lumen, the above mentioned properties could play a crucial part in the functional integration 
of highly localised Ca2+ signals.
From the experimental point of view, specific drugs are available to rapidly block the SERCA 
ATPases either irreversibly (by thapsigargin; Treiman et al., 1998) or reversibly (with 
cyclopiazonic acid; Plenge-Tellechea et al., 1997). However, in addition to SERCAs, other 
Ca2+ pumps insensitive to thapsigargin and associated to Ca2+ pools that are also released 
after cell stimulation have been described in the stores of a variety of eukaryotic cells 
(Meldolesi, 2001).
The two major types of store channels, the IP3R and RyR, are expressed by most, if not all, 
neurones (Meldolesi, 2001). For both channels, further complexity is provided by the 
occurrence of different isoforms, which differ in tissue distribution and functional properties 
(e.g. Ca2+ sensitivity and activation mechanisms; Hagaret al., 1998; Sutko and Airey, 1996). 
This heterogeneous distribution in different brain areas may underlie the occurrence of 
functionally distinct stores, with independent functions and recruitment mechanisms 
(Rizzuto, 2001 and references therein). In fact, the intracellular localisation of RyR and IP3R 
plays a fundamental role in the appearance and development of the Ca2+ release event. In 
an area with a low density of channel distribution, activation of a single receptor most often 
results in a local and minor event, whereas in a dense area can trigger activation of adjacent 
receptors, giving rise to non-decremental processes that may invade the whole cell 
(Meldolesi and Pozzan, 1998; Berridge, 1998).
The functional regulation of RyR and IP3 receptors is highly complex (see Chapter 1, section
1.4). In experimental terms, several pharmacological tools have been developed in order to 
study the internal stores channel function. In the case of IP3 receptors, generation of the 
second messenger can be inhibited by phopholipase C blockers such as U-73122, which 
unfortunately also has some unwanted effects on various other steps of Ca2+ homeostasis 
(Grierson and Meldolesi, 1995). As far as the drugs that act directly at the receptor level, 
adenophostins, which are Penicillum derivatives, are potent agonists (Takahashi et al.,
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1994), while xestospongins are known as blockers (Gafni et al., 1997). However, it has to be 
mentioned that xestospongin-c has also been reported to inhibit the SERCA pumps (De 
Smet et al., 1999). Another permeant agent, 2-aminoethoxy-diphenyl borate (2APB), can be 
better defined as a modulator, since it blocks IP3R at concentrations of 50 and stimulates 
release at higher concentrations (Maruyama et al., 1997). Blocking of the IP3R can be also 
obtained by the application of heparin (Ehrlich et al., 1994), although its inability to cross 
membranes, resulting in the requirement for microinjection, has limited its use.
The RyR operates primarily as a positive modulator of intracellular Ca2+ signals, sustaining 
their propagation via its regenerative activation along defined pathways. RyR are therefore 
responsible, more than any other membrane component, for the excitable properties 
attributed to the endomembrane ER system (Berridge, 1998). RyR receptor regulation 
depends not only on cytoplasmic Ca2+ rises, but also on internal stores Ca2+ concentrations. 
In fact, release responses induced via CIRC, and also by drug agonists, are much larger 
when the store is full (Meldolesi, 2001). Caffeine, together with a few analogues, is the RyR 
activator most commonly used (Ehrlich et al., 1994). However, the concentrations needed to 
induce adequate responses are quite high (up to 25 mM!) and the effect of the drug is far 
from being specific (Zacchetti et al., 1991). Ryanodine, from which the receptor takes its 
name, is considered a blocker, although in most cell types it can also be a stimulator at low 
concentrations (Ehrlich et al., 1994). In recent years, the use of these pharmacological tools 
has allowed the identification of the role of intracellular Ca2+ stores in the modulation of 
different aspects of neuronal function, and has provided much information in understanding 
the complexity of cytoplasmic Ca2+ signals.
3.1.2 The human neuroblastoma SH-SY5Y cell line as a 
model system
In the process of studying the function of the nervous system, several experimental models
have been developed. Primary cultures from CNS neurones, like the ones described in the
previous chapter, constitute a widely used approach, which provides neuronal tissue in an
environment that can be easily manipulated. A different approach in the study of neuronal
function is given by the use of clonal cell lines derived from tumorigenic tissue. In contrast
with primary cultures, clonal cell lines have become immortalised and therefore can be
maintained through many passages, giving almost limitless quantities of material. This
property has several advantages, but in particular, it allows the increase in the amount of
experimental material whenever sensitivity is a problem. An additional benefit of working
with neuronal cell lines is the fact that every cell in a clonal line culture is initially isolated
from a single cell, thus providing highly homogeneous tissue cultures. In general, this may
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also translate into a simplification in the range of macromolecules being expressed and in 
the interactions occurring between them.
Regardless of the above-mentioned advantages, perhaps the main concern in the use of 
clonal neuronal cultures is whether the molecules under scrutiny would be regulated in the 
same way as they are in the analogous, non-neoplastic cells. Although studies on this 
aspect are scarce, when effects were effectively compared they seem to indicate close 
similarities in the mechanisms of regulation (for review see Lukas, 1998). In fact, it is 
increasingly recognised that, in practical terms, it would be very difficult to elucidate 
supramolecular mechanisms involved in the control of receptors or signalling molecules 
using brain preparations, intact animals, or many heterologous expression systems. Cell 
lines are perhaps more useful for such studies, at least in helping to narrow the realm of 
mechanistic possibilities for regulation of neuronal functional mechanisms, so that other 
studies can be designed more incisively in particularly relevant models. In this regard, cell 
lines have been extensively used in the determination of an enormous amount of cellular 
mechanisms governing neuronal function. These functional studies include ion flux assays, 
immunologically based assays, intracellular signalling sytems and gene expression studies 
(Lukas, 1998 and references therein).
In spite of their valuable use, the actual origin of clonal cell lines constitutes one of its major 
disadvantages in the study of neuronal preparations. This is because dividing CNS neurones 
are predominantly restricted to periventricular zones in embryonic development and, as a 
result, the existence of CNS neuron-like tumours, and consequently clonal cell lines, is 
extremely rare. Various attempts have been made in order to immortalise CNS derived 
neuronal cultures. These included the fusion of primary CNS neuronal cells with peripheral 
neuroblastomas or the use of virally transformed or otherwise immortalised neuronal cells 
(Banker and Goslin, 1991). Although the development of such cell lines holds promise, the 
task of finding a CNS immortalised cell line expressing functional nAChR has been largely 
unsuccessful (personal observation).
Clonal cell lines derived from autonomic peripheral ganglia provide the closest alternative for 
the studies of functional mechanisms in neuronal preparations. The human neuroblastoma 
clonal cell line was derived through sequential sub-cloning from the SH-SY line and the 
parental SK-N-SH line, which has been established from a biopsied, metastatic tumour 
diagnosed as a peripheral neuroblastoma (Biedler et al.t 1973; Ross et al., 1983). Cells of 
the SH-SY5Y clone have neuroblastic morphological character and resemble human foetal 
sympathetic neurones grown in primary cultures (Ross et al., 1983). The neuronal character 
of SH-SY5Y cells has been confirmed by a variety of markers, including expression of
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neurofilament proteins, glutamic acid decarbolxylase, neuron specific enolase, GABA and 
noradrenaline uptake and muscarinic acetylcholine receptors (Lukas et al., 1993 and 
references therein).
3.1.2.1 nAChR in SH-SY5Y cells
A substantial limitation in the use of clonal cell lines is that those established and 
characterised may not express all of the important nAChR subtypes that mediate nicotine's 
effect in vivo. In the case of the SH-SY5Y cell line however, several nAChR subunits have 
been shown to be expressed, including the a3, a5, a7, 02 and 04, which form a7 and a3* 
subtypes of nAChR (Lukas, 1993; Peng et al., 1994; Wang et al., 1996; Ridley et al., 2001b). 
This composition of nAChR subunits accurately reflects the expression of corresponding 
analogues in the autonomic nervous system and supports the view that the SH-SY5Y cell 
line is a valuable neuronal model for the study of nAChR function.
In SH-SY5Y cells, it has been previously shown that nicotinic receptor activation can 
mediate the generation of inward currents and the subsequent release of noradrenaline 
(Gould et al., 1992; Wade et al., 1998), a cellular mechanism most probably mediated by 
Ca2+ influx through the nAChR itself and VOCC. Although a functional implication for the 
nicotine-evoked Ca2+ signals has been suggested, the demonstration of a nicotine-mediated 
Ca2+ elevation is still lacking. In fact, most of the Ca2+ studies after cholinergic stimulation 
have focused on the effect of muscarinic receptors, which have been shown to modulate 
intracellular Ca2+ levels through activation of IP3-dependent internal stores (Murphy et al., 
1991; Forsythe et al., 1992). In more recent studies carried out in our laboratory, we were 
able to demonstrate that the activation of nAChR could indeed increase the intracellular Ca2+ 
concentrations in SH-SY5Y cells (Ridley et al., 2002).
3.1.2.2 Ca2+ studies in SH-SY5Y cells
SH-SY5Y cells have been extensively used in the study of intracellular Ca2+ signals and their 
modulation after diverse stimuli. They have been shown to express both L- and N-type Ca2+ 
channels (Morton et al., 1992), while the existence of whole cell Ca2+ channel currents was 
verified as well (Reeve et al., 1994). The induced depolarisation of SH-SY5Y cells promoted 
the cytoplasmic influx of Ca2+ through the activation of VOCC, indicating the functional 
coupling of Ca2+ channels (Lambert et al., 1990). In addition, the existence of internal stores 
channel proteins was also suggested, when the expression of IP3 and ryanodine receptors 
was demonstrated using isoform specific antibodies (Mackrill et al., 1997).
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The activation of intracellular Ca2+ signals in SH-SY5Y cells has been shown after 
stimulation with platelet-derived growth factor (Wheldon et al., 2001), neuropeptide Y and 
somatostatin (Connor et al., 1997), acetylcholine and muscarinic receptor selective agonists 
(Lambert et al., 1990; Murphy et al., 1991; Forsythe et al., 1992) and potassium chloride 
(Lambert et al., 1990; Morton et al., 1992). Added to this, studies with muscarinic agonists 
suggested the involvement of an acetylcholine-induced production of IP3, with the 
subsequent modulation of internal stores Ca2+ release (Lambert et al., 1990; Murphy et al., 
1991). The Ca2+ mobilisation from IP3-dependent stores was suggested to contribute to the 
bradykinin-evoked noradrenaline release (Purkiss et al., 1995), and is consistent with a 
functional role of internal stores in SH-SY5Y physiology.
3.1.3 General Aims of this chapter
All nAChR, and particularly the a7 subtype, exhibit high relative permeability to Ca2* (see 
Chapter 1 and 2). The opening of the nAChR channel can lead to a direct increase in 
cytoplasmic Ca2+ concentrations, whilst Na+ influx can cause neuronal depolarisation, 
activation of VOCC and subsequent amplification of Ca2+ transients (Vijaraghavan et al., 
1992; Rathouz and Berg, 1994). The Ca2+ entry after activation of nAChR has been reported 
to regulate a diverse array of cellular processes, including neurotransmitter release 
(Soliakov and Wonnacott, 1996; Gray et al., 1997; Kulak et al., 2001), neuroprotection 
(Donnelly-Roberts et al., 1996; Dajas-Bailador et al., 2000) and synaptic plasticity 
(Matsuyama et al., 2000; Mansvelder and McGehee, 2000). nAChR-evoked Ca2+ entry can 
also result in the activation of key signalling molecules, such as PKC (Messing et al., 1989), 
CaMK II (Tsutsui et al., 1994), ERK1/2 (Dineley et al., 2001; see Chapter 4) and CREB 
(Dineley et al., 2001).
The evident versatility of nAChR-mediated cellular functions suggests the involvement of 
elaborated Ca2+ signals, which probably result from the integration of different sources of 
intracellular and/or extracellular Ca2+. In fact, the contribution of internal Ca2+ stores to the 
sustained Ca2+ signals activated by nAChR stimulation has been reported in chick cilliary 
ganglion cells (Shoop et al., 2001) and substantia nigra brain slices (Tsuneki et al., 2000), 
while nicotinic activation of store-operated Ca2+-induced Ca2+ release has been recently 
demonstrated in hippocampal synaptic neuronal boutons and astrocytes, and at single 
terminal varicosities of postganglionic sympathetic nerve terminals (Emptage et al., 2001; 
Sharma and Vijayaraghavan, 2001; Brain et al., 2001). However, the relationship between 
different Ca2+ sources in the elaboration of nicotine-evoked Ca2+ signals should be further 
complicated by the contribution of different nAChR subtypes. The understanding of how
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diverse nAChR subtypes may differentially integrate a variety of extracellular and 
intracellular Ca2+ signals is required.
The aim of the present study was to explore the relative contributions of particular nAChR 
subtypes and different Ca2+ sources to the nicotine-evoked modulation of intracellular Ca2+ 
signals. In particular, we wanted to use the human neuroblastoma SH-SY5Y cell line in order 
to characterise the generation of sustained elevations in cytoplasmic Ca2+ observed after 
nicotine stimulation, modelling similar responses observed in hippocampal cultures (Fig 2.7). 
The particular objectives addressed in the present chapter were:
- The replication in SH-SY5Y cells of the sustained Ca2+ signals shown to occur in 
hippocampal primary cultures.
- The characterisation of the nAChR subtypes involved in the generation of Ca2+ 
responses.
- The analysis of the different Ca2+ sources contributing to the nicotine-evoked Ca2+ 
signals, including VOCC and internal stores.
- The study of possible differences in the Ca2+ signals evoked by diverse subtypes of 
nAChR, with particular emphasis on the a7 subtype.





Tissue culture media, serum and plasticware were obtained from Gibco BRL (Paisley, 
Renfrewshire, Scotland). Media supplements, a-Bgt, cadmium chloride, (-)-nicotine 
hydrogen tartrate, nifedipine, ryanodine and mecamylamine were purchased from The 
Sigma Chemical Co. (Poole, Dorset, U.K.). Xestospongin-c and a-conotoxin Iml (a-Ctx-lml) 
were from Calbiochem (Nottingham, UK). a-Conotoxin Mil (a-Ctx-MII) was synthesised as 
previously described (Cartier et a!., 1996; Kaiser et al., 1998). Fluo-3 AM and pluronic F127 
were purchased from Molecular Probes, (Oregon, USA). The concentrations of nAChR 
antagonists, VOCC blockers and ryanodine and IP3 receptor inhibitors were selected in 
order to give maximum blockade of their targets, based on previous studies (Kaiser et al., 
1998, for a-Ctx-MII; Johnson et al., 1995, for a-Ctx-lml; Pereira et al., 1999, for a-Bgt; 
Sharma and Vijayaraghavan, 2001, for CdCI2; Taylor and Peers, 1999, for nifedipine; Gafni 
et al., 1997, and Gueorguiev et al., 2000, for xestospongin-c; Shoop et al., 2000, for 
ryanodine).
3.2.2 Cell culture
Human neuroblastoma SH-SY5Y cells (ECACC, Salisbury, UK; passages 14-20) were 
cultured as previously described (Sharpies et al., 2000; Ridley et al., 2001). In brief, cultures 
were maintained in 175 cm2 tissue culture flasks in DMEM:F12, supplemented with 15 % 
foetal bovine serum, 2 mM L-glutamine, 1 % non-essential amino acids and 190 U/ml of 
penicillin and 0.2 mg/ml of streptomycin, until confluent (see Fig 3.1). Cells were plated (1:5 
dilution from flask) into 96 well Primaria plates (Falcon, New Jersey, USA) and experiments 
were performed 72 h later with confluent cultures.
Fig 3.1 SH-SY5Y cells in culture.
Human neuroblastoma SH-SY5Y cells (passages 14-20) were cultured in 75 cm2 tissue culture 
flasks. A 75 % confluent 3-day old culture is shown in the figure. For experiments, cells were cultured 
until they reach 100 % confluency.
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3.2.3 Cytoplasmic Ca2+ measurements: Fluo-3
After removal of the medium from the confluent cultures, SH-SY5Y cells were washed twice 
with Tyrode’s Salt Solution (TSS: 137 mM NaCI, 2.7 mM KCI, 1.0 mM MgCI2, 1.8 mMCaCI2) 
0.2 mM NaH2P04, 12 mM NaHC03l 5.5 mM glucose; pH 7.4) and incubated with the 
membrane permeable Ca2+-sensitive dye fluo-3-AM (10 pM) and 0.02 % pluronic for 1h at 
room temperature in the dark. Cells were then washed twice with TSS, before adding 80 pi 
buffer, with or without added drugs, per well. After 15 min pre-incubation (or 30 min in the 
case of a-Bgt or thapsigargin) at room temperature in the dark, changes in fluorescence 
(excitation 485 nm, emission 538 nm) were measured using a Fluoroskan Ascent 
fluorescent plate reader (Labsystems, Helsinki, Finland).
Fluorescence was monitored in short-term or long-term protocols as follows. Basal levels of 
fluorescence were monitored for 5 s (short term protocol) or 20 s (long term protocol) before 
addition of nicotine (20 pi) using an automatic dispenser. After stimulation, changes in 
fluorescence were monitored for 20 s (initial increase; short term protocol) or 10 min 
(sustained response; long term protocol). For normalising fluo-3 signals, responses from 
each well were calibrated by determination of the maximum and minimum fluorescence 
values. At the end of each experiment, addition of 0.2% Triton (F max) was followed by 40 
mM MnCI2 (F min). The mean F min / F max ratio was 0.24 ± 0.03 (mean ± SEM, n = 32) 
and 0.26 ± 0.04 (mean ± SEM, n = 30) for short- and long-term measurements respectively; 
these values were consistent with those reported for this dye in other systems (Minta et al., 
1989; Sharma and Vijayaraghavan 2001). According to previous studies, the manganese- 
saturated fluorescence corresponds to an intracellular Ca2+ concentration of 100 nM (Minta 
et al., 1989). The average baseline fluorescence normalised to F min was 1.15 ± 0.02 (n = 
25). Data were calculated as a percentage of F max - F min. Values were expressed as a 
percentage of the response to 30 pM nicotine (included in all experiments), unless otherwise 
stated. Maximal responses to nicotine were approximately 20 % of the F max -  F min, thus 
not close to saturation of the dye. No significant effects on basal levels of fluorescence were 
observed after incubation with any of the antagonists or blockers used, with the exception of 
CdCI2. Incubation with CdCI2 produced a rather slow but sustained increase in basal 
fluorescence, which precluded its use in long-term experiments.
3.2.4 Statistical analysis
Data represent the mean ± SEM of 3 or more independent experiments (each with 4 
replicates). Statistical significance was determined using Student’s t test or one-way ANOVA
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3.3.1 Nicotine-evoked Ca2+ signals
In SH-SY5Y cells loaded with the Ca2+-sensitive dye fluo-3, nicotine (30 pM or 100 pM) 
produced rapid and significant increases in fluorescence. The time course of the response to 
30 pM nicotine indicated that maximal fluorescence levels were reached within 100 s, and 
were sustained for the duration of the recording in the continued presence of nicotine (10 
min; Fig 3.2a). In comparison, stimulation with 100 pM nicotine evoked a more rapid 
increase in fluorescence values (Fig 3.2) with a moderately higher maximum level (Fig 3.2b), 
which was, however, not significantly different from the maximum increase in response to 
nicotine 30 pM (Fig 3.2). ). In contrast to the sustained response to 30 pM nicotine, elevated 
fluorescence evoked by 100 pM nicotine slowly decreased towards a lower plateau after 
approximately 30 s (Fig 3.2a, b). Subsequent experiments concentrated on the analysis of 
the factors contributing to the initial and sustained responses to 30 pM nicotine.
nicotine
20 s max 10 min
time (s) nicotine 30 pM nicotine 100 pM
Fig 3.2 Elevation of intracellular Ca2* levels after nicotine stimulation.
Representative traces from SH-SY5Y cells loaded with fluo-3 AM and stimulated with 30 pM or 100 
pM nicotine are shown in (a). Changes in fluorescence were monitored for 10 min. In (b), the 
increase in fluorescence in response to 30 pM and 100 pM nicotine stimulation was determined at 20 
s and 10 min, as well as the respective maximum values (max). Data are expressed as the 
percentage of Fmax - Fmin (mean ± SEM), as described in the methods, from at least four 
indeoendent exoeriments
Pre-incubation with the general nAChR antagonist mecamylamine (10 pM) completely 
prevented the nicotine evoked increase in fluorescence (see Fig 3.4), confirming that 
nicotine exerted its effect through nAChR. The contribution of nAChR activation to the
106
CHAPTER 3
sustained elevation in fluorescence after incubation with 30 pM nicotine was examined by 
applying mecamylamine (10 pM) during the nicotine stimulus (Fig 3.3). The addition of 
mecamylamine 150 s after nicotine stimulation (when the maximum response has been 
reached) produced an almost immediate and complete inhibition of the nicotine-evoked 
increase in fluorescence (Fig 3.3a, c). When the same application protocol was performed 
with buffer alone, only a small decrease (15 %) in fluorescence was observed, which can be 
attributed to dilution and/or mechanical perturbation of the sample (Fig 3.3b, c). The rapid 
decrease in the Ca2+ signal observed in response to the application of mecamylamine 
indicates that the dye was not rate limiting in determining the duration of the response In 
fact, the relatively low affinity of fluo-3 for Ca2+, which will give comparatively faster 
dissociation rates (Minta et al., 1989), should allow a good temporal resolution of Ca2+ 
signals, as the bound dye would not artificially extend the time course of intracellular Ca2+ 
elevations. Therefore, the inhibition seen with mecamylamine indicates that nAChR 










Fig 3.3 Effect of mecamylamine on the sustained elevation of intracellular Ca2+ after nicotine.
SH-SY5Y cells were stimulated with 30 pM nicotine and fluorescence was monitored for 5 min. Then 
(a) mecamylamine or (b) buffer was added and fluorescence was monitored for further 10 min. 
Representative traces are shown, (c) Percentage inhibition of the nicotine-evoked fluorescence 
signal after mecamylamine (mec) or buffer application, measured at the end of the 15 min recording 
period. Data represent the mean ± SEM of three independent experiments, each carried out in 
quadruplicate.
3.3.2 nAChR subtypes involved
The relative contribution of nAChR subtypes and different Ca2+ sources to the initial (20 s) 
rise in fluorescence evoked by 30 pM nicotine stimulation was examined. In order to define 
the nAChR subtypes involved, maximally effective concentrations (see methods) of the a7 
nAChR selective antagonists a-Bgt (40 nM) and a-Ctx-lml (1 pM), and the a3|32*-selective
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antagonist a-Ctx-MII (200 nM) were used. In the presence of each of these antagonists 
nicotine-evoked responses were significantly inhibited by about 20 % (Fig 3.4). Co­
application of a-Ctx-MII plus a-Bgt or a-Ctx-lml produced an additive effect, inhibiting about 
40 % of the response to 30 pM nicotine (Fig 3.4). The a3p4 selective antagonist a-Ctx-AulB 
was also used in some experiments, inhibiting only 11 % of the nicotine evoked response 
(Fig 3.4). Although attempts were also made to determine the nAChR subtypes involved in 
the long term Ca2+ response, these were largely unsuccessful. Application of a-Bgt (40 nM) 
and a-Ctx-MII (1pM) after nicotine-evoked Ca2+ levels have reached maximal values, 
produced only a small decrease of fluorescence, not distinguishable from the reduction after 
buffer addition (data not shown). Interestingly, when stimulating with 100 pM nicotine (Fig
3.5) a-Bgt did not block any significant component of the initial nicotine-evoked response, a 
result that probably indicates the rapid desensitisation of a7 nAChR receptors when using 
higher nicotine concentrations. This is also indicating that the progressive decrease of the 
long-term fluorescence elevation after 100 pM nicotine might be due to desensitisation of a7 
nAChR. When lower concentrations of nicotine were used (10 and 30 pM), a-Bgt 
significantly blocked nicotine-evoked responses (Fig 3.5).
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30 uM 200 nM 10 1 40 nM 1 40 nM 10 uM free
______________________________________g-MII 200 nM__________________
nicotine 30 uM
Fig 3.4 Contribution of nAChR subtypes to the nicotine-evoked increase in intracellular Ca2+. 
SH-SY5Y cells loaded with fluo-3 AM were stimulated with 30 pM nicotine in the presence or 
absence of mecamylamine (mec; 10 pM), a-Ctx-MII (a-MII; 200 nM), a-Ctx-AulB (a-AulB; 10 pM), a- 
Ctx-lml (a-lml; 1 pM) or a-Bgt (40 nM). Nicotine stimulation was also carried out after co-incubation 
with a-Ctx-MII plus a-Ctx-lml or a-Bgt. Antagonists were incubated with the cells for 15 min, or 30 
min in the case of a-Bgt, before addition of nicotine. Fluorescence was monitored for 20 s after 
nicotine stimulation. Values at the 20 s timepoint are expressed as a percentage of the nicotine 
control response, measured in parallel. Data represent the mean ± SEM of at least 4 independent 
experiments, each carried out in quadruplicate. Significantly different from nicotine stimulation, * p < 
0.05, Student’s t test; or from nicotine stimulation in the presence of a-Ctx-MII, # p < 0.05, ANOVA 













Fig 3.5 Contribution of a7 nAChR to the nicotine-evoked increase in intracellular Ca2+. 
SH-SY5Y cells loaded with fluo-3 AM were stimulated with 10, 30 and 100 pM nicotine in the 
presence or absence of a-Bgt (40 nM, 30 min pre-incubation). Fluorescence was monitored for 20 s 
after nicotine stimulation. Values at the 20 s timepoint are expressed as a percentage of their 
respective nicotine control responses, measured in parallel and represented with a dotted line. Data 
represent the mean ± SEM of at least 4 independent experiments, each carried out in quadruplicate. 
Significantly different from nicotine stimulation, * p<  0.05, Student’s t test.
The nicotine-evoked increase in fluo-3 fluorescence was totally dependent on extracellular 
Ca2+, as no response was observed when nicotine stimulation was carried out in the 
absence of extracellular Ca2+ (Ca2+ free buffer plus 2 mM EGTA; Fig 3.4). In standard 
conditions (1.8 mM extracellular Ca2+) CdCI2 (100 pM) blocked more than 80 % of the 
nicotine-evoked increase in fluorescence (Fig 3.6), indicating that VOCC mediate most of 
the response. The residual nicotine-evoked increase in fluorescence in the presence of 
CdCI2 was significantly decreased, by a further 9 %, by a-Bgt (Fig 3.6), whereas a-Ctx Mil 
had no additive effect (Fig 3.6). This suggests that a7 nAChR contribute to the VOCC- 
independent increase in intracellular Ca2+. The L-type VOCC blocker nifedipine (5 pM) 
inhibited 67 % of the nicotine-evoked increase in fluorescence. In the presence of nifedipine, 
both a-Bgt and a-Ctx-MII produced an additional, statistically significant, inhibition of 9 % 
and 5 % respectively (Fig 3.6).
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Fig 3.6 VOCC-dependent and -independent Ca2+ influx activation of nAChR.
The contribution of VOCC-dependent and -independent Ca2+ influx to the nicotine-evoked elevation 
of intracellular Ca2+ was examined. SH-SY5Y cells loaded with fluo-3 AM were stimulated with 30 pM 
nicotine after incubation with CdCI2 (100 pM) or nifedipine (nif; 5pM), and after co-incubation with 
CdCI2 plus a-Bgt (40 nM) or a-Ctx-MII (a-MII; 200 nM), and nifedipine plus a-Bgt or a-Ctx-MII. 
Fluorescence was monitored for 20 s after nicotine stimulation. Values at the 20 s timepoint are 
expressed as a percentage of the nicotine control response, measured in parallel. Data represent the 
mean ± SEM of at least 5 independent experiments, each carried out in quadruplicate. All drug 
treatments were significantly different from nicotine stimulation, p < 0.05, Student’s t test. Significantly 
different from CdCI2 or nifedipine are indicated, # p < 0.05, ANOVA and post hoc Tukey’s test.
3.3.4 Intracellular Ca2+ stores and the nicotine-evoked Ca2+ 
signals
To establish if intracellular Ca2+ stores also contributed to the overall increase in cytoplasmic 
Ca2+, we used selective inhibitors of IP3- and ryanodine-sensitive stores. Pre-incubation with 
ryanodine (30 pM), a selective blocker of Ca2+-induced Ca2+ release from ryanodine 
receptors, produced a significant decrease (39 %) in the nicotine-evoked rise in fluorescence 
measured at 20 s (Fig 3.7). Consistent with this observation, stimulation of SH-SY5Y cells 
with caffeine (30 mM), an agonist of ryanodyne sensitive Ca2+ stores, produced an increase 
in fluorescence equivalent to -  30 % of the nicotine-evoked response (Fig 3.7). No further 
inhibition was observed when a-Bgt or a-Ctx-MII was co-applied with ryanodine (Fig 3.7). 
Xestospongin-c (10 pM), a membrane permeant, non-competitive inhibitor of IP3R (Gafni et 
al., 1997), produced greater inhibition than ryanodine (60 %, Fig 3.7), and when applied 
together, the two agents showed a partially additive effect, reducing the nicotine-evoked 
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Fig 3.7 Contribution of intracellular stores to the nicotine-evoked increase in intracellular Ca2+. 
SH-SY5Y cells loaded with fluo-3 AM were stimulated with 30 pM nicotine after incubation with 
ryanodine (rya; 30 pM), xestospongin-c (Xe-c; 10 pM), or after co-incubation with ryanodine plus a- 
Bgt (40 nM) or a-Ctx-MII (a-MII; 200 pM) and ryanodine plus xestospongin-c. In a separate group of 
experiments, SH-SY5Y cells were also stimulated with 30 mM caffeine. Fluorescence was measured 
for 20 s after nicotine stimulation. Values at the 20 s timepoint are expressed as a percentage of the 
nicotine control response measured in parallel. Data represent the mean ± SEM of at least 4 
independent experiments, each carried out in quadruplicate. All drug treatments were significantly 
different from nicotine stimulation, p < 0.05, Student’s t test. Significantly different from ryanodine or 
xestsopongin-c is indicated, # p < 0.05, ANOVA and post hoc Tukey’s test.
The contribution of intracellular Ca2+ stores has been thus far described for the initial phase 
of the Ca2+ response to nicotine (20 s time point; Fig 3.2b). We also analysed the 
involvement of internal stores in the long-term responses, by examining the role of Ca2+ 
release through ryanodine and/or IP3 receptors in the sustained increase in fluorescence 
evoked by 30 pM nicotine. Consistent with the involvement of Ca2+ stores, inhibition of the 
SERCA ATPase pump after a 30 min preincubation with thapsigargin, produced a 69 ± 5 % 
reduction of the nicotine-evoked increase (data not shown in figure). Pre-incubation with 
ryanodine (30 pM) produced a significant depression of the nicotine response throughout the 
time course monitored (Fig 3.8a, b). However, comparison of the effect of ryanodine at the 
initial (20 s) versus the later phase of the fluorescence response (10 min) showed 
significantly greater inhibition at the early stage, than at the end of the 10 min incubation (Fig 
3.8b). In contrast to ryanodine, the response to nicotine in the presence of xestospongin-c 
showed a quite different profile (Fig 3.8a). The initial inhibition produced by xestospongin-c 
at 20 s (60 %) was followed by a progressive decrease in the nicotine-evoked fluorescence, 
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Fig 3.8 Involvement of Ca2+ stores in the sustained elevation of intracellular Ca2+.
In (a), representative traces of long-term fluorescence measurements (10 min) of SH-SY5Y cells 
loaded with fluo-3 AM are shown. Cells were stimulated with 30 pM nicotine in the presence or 
absence of ryanodine (30 pM) or xestospongin-c (10 pM). (b) Percentage inhibition of nicotine’s 
response in the presence of ryanodine or xestospongin-c, measured at 20 s or 10 min after 
stimulation. Data are expressed as a percentage of the corresponding nicotine control at that time 
point (dotted line) and bars represent the mean ± SEM of at least 3 independent experiments, each 
carried out in quadruplicate. All drug treatments were significantly different from nicotine stimulation, 
p < 0.05, Student’s t test. Significantly different from ryanodine (20 s) or xestsopongin-c (20 s) is 




In this chapter, experiments designed to investigate the intracellular Ca2+ signals generated 
by the activation of nAChR in SH-SY5Y cells loaded with the Ca2+-sensitive dye fluo-3 are 
described. The results demonstrate that stimulation of nAChR produces rapid and sustained 
elevations in cytoplasmic Ca2+ levels, which are dependent on the activation of different Ca2+ 
sources, including extracellular Ca2+ influx through nAChR and VOCC channels and 
intracellular Ca2+ from internal stores.
3.4.1 nAChR subtypes, VOCC and the nicotine-evoked 
Ca2+ signals
The rapid and sustained elevations of intracellular Ca2+ levels in response to nicotine 
stimulation were prevented by the general nAChR antagonist mecamylamine (Fig 3.3; 3.4) 
or when carried out in the absence of extracellular Ca2+, demonstrating that activation of 
nAChR and extracellular Ca2+ influx mediate nicotine-evoked Ca2+ signals in SH-SY5Y cells. 
The use of selective nAChR antagonists disclosed the contribution of both a7 and a3p2* 
nAChR in the initial phase (20 s) of the Ca2+ increase after stimulation with 30 pM nicotine. 
The a-Ctx-MII is a relatively novel antagonist of nAChR, which blocks the response to 
acetylcholine in oocytes expressing a3p2 nAChR, being 2-4 orders of magnitude less potent 
on other nAChR subunit combinations (Cartier et al., 1996). Although the co-application of 
a-Ctx-MII with a7 selective antagonists was additive, it only inhibited nicotine’s response by 
40 %, indicating that other nAChR subtypes must be also involved. SH-SY5Y cells express 
a3, a5, a7, p2 and p4 nAChR subunits (Lukas et al., 1993, Peng et al 1994), which can form 
a variety of nAChR subtypes (Wang et al., 1996). Immunoprecipitation studies suggest that 
in SH-SY5Y cells, 50 % of the a3* nAChR, also contain the p2 subunit (Wang et al., 1996); 
the presence of an a3p2 interface should make such nAChR susceptible to a-Ctx-MII 
(Cartier et al., 1996), and previous experiments carried out in this lab show that 200 nM is 
enough to maximally inhibit a3p2* responses (Kaiser et al. 1998; Ridley et al., 2002). This 
study suggests that 40 % of the Ca2+ response is attributable to a3p2* and a7 nAChR, 
whereas 60 % is mediated by a non-a7, non-a3p2* nAChR subtype, with the a3p4* nAChR 
being the most likely candidate. In fact, the relatively high Ca2+ permeability (Ragozzino et 
al., 1998) and slow rate of desensitisation (Cachelin and Jaggi, 1991; Vibat et al., 1995;) of 
heterologously expressed a3p4 nAChR may be relevant to the sustained Ca2+ changes 
observed in the present study. Although there is no commercially available antagonist of the 
a3p4* subtype of nAChR, preliminary experiments with the newly described a-Ctx-AulB
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(donated by M. McIntosh) indeed demonstrated that a significant, although relatively modest, 
component of the nicotine evoked Ca2+ increase is mediated through a3p4 nAChR. The 
small amount of toxin available precluded its use in co-incubation experiments with other 
toxins.
The sustained increase in Ca2+ levels throughout the duration of the nicotine stimulation is 
consistent with the results obtained in hippocampal cultures (see Chapter 2; Dajas-Bailador 
et al., 2000), where long-term Ca2+ responses were also detected. At first, this characteristic 
of the nicotine-evoked response seems to be in conflict with the reported rapid 
desensitisation of nAChR (McGehee and Role, 1995). However, consistent with the results 
shown in hippocampal neurones and SH-SY5Y cells, sustained elevations of intracellular 
Ca2+ after nicotine stimulation have been also observed in chick cilliary ganglia neurones 
(Shoop et al., 2001) and PC12 cells (Gueorguiev et al., 2000). As a first approach towards 
the study of these long-term Ca2+ responses, it was important to analyse if the activation of 
nAChR was a constant requirement for sustaining the prolonged Ca2+ signals. The ability of 
mecamylamine, applied after Ca2+ levels had reached a plateau, to provoke the rapid return 
of intracellular Ca2+ to basal values, suggests that activation of nAChR is required 
throughout the nicotine-response in order to maintain the sustained elevation in the Ca2+ 
signal (Fig 3.3a). This is likely to reflect the inability of 30 fiM nicotine to fully desensitise the 
entire nAChR population concurrently. As a result, there is the probability that at any given 
time during the nicotine stimulation, a proportion of the nAChR population would be 
responsive to activation by the agonist. This interpretation is consistent with the failure to 
sustain maximum Ca2+ increases at higher nicotine concentrations (100 fxM; Fig 3.2), which 
would desensitise a greater proportion of nAChR.
Attempts to define the relative contribution of nAChR subtypes to the nicotine-evoked long­
term increase (5-10 min) in Ca2+ signals were largely unsuccessful. Unlike mecamylamine, 
addition of a-Bgt or a-Ctx-MII after the nicotine-evoked Ca2+ increase had reached maximal 
values, failed to give any significant blockade. In the case of a-Bgt this may be partly 
explained by the slow kinetics of interaction with the receptor, which would prevent the rapid 
blockade of the nicotine response (Lukasiewicz and Bennett, 1978). However, it is also 
possible that the rapidly desensitising a7 nAChR do not contribute significantly to the long- 
lasting elevation in cytoplasmic Ca2+. In fact, long-term responses after stimulation with a 
higher nicotine concentration (100 (iM) produced a progressive decrease after reaching 
maximal values, an indication that a particular population of nAChR is more susceptible to 
functional desensitisation. In addition, pre-incubation with a-Bgt failed to produce any 
significant block of the initial Ca2+ rise after stimulation with 100 fiM nicotine. Most likely, this
would indicate that the a7 nAChR are primarily active in the initial phases of the 10-30 jiM
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nicotine-evoked Ca2+ signal, while long-term agonist exposure or high agonist concentration 
might induce a shift of the population of a7 nAChR towards desensitised states. The failure 
of a-Ctx-MII to produce a significant block when applied halfway during nicotine stimulation 
is more difficult to explain, although it may be possible that the a7 and a3p2 nAChR (both 
with relatively fast desensitisation rates; see Role and Berg, 1996) are not mediating the 
sustained elevations of Ca2+. Instead, this could be a functional role for the a304, a nAChR 
subtype with a comparatively slow rate of desensitisation (Cachelin and Jaggi, 1991; Vibat et 
al., 1995; Role and Berg, 1996), and therefore a more likely mediator of sustained Ca2+ 
responses. However, it is important to note that the rapid decrease observed after addition 
of mecamylamine might be a direct consequence of its channel blocker properties, which 
allows the rapid prevention of nicotine responses, even in the presence of the agonist. 
Unlike mecamylamine, a-Bgt and a-Ctx-MII do not prevent nicotine response by blocking the 
ion channel, a difference that may also explain the results obtained.
Despite the high relative Ca2+ permeability of neuronal nAChR, the vast majority of the 
nicotine-evoked increase in intracellular Ca2+ in SH-SY5Y cells is dependent on the 
activation of VOCC, as incubation with CdCI2 blocked more than 80 % of the response (Fig
3.6). This is consistent with previous studies in other preparations, including hippocampal 
neurones (Barrantes et al., 1995b) and chick cilliary ganglia (Rathouz and Berg, 1994; 
Shoop et al., 2001), where it was also demonstrated that CdCI2 does not block nAChR 
directly (Rathouz and Berg, 1994). The CdCI2 resistant increase in intracellular Ca2+ was not 
further blocked by a-Ctx-MII (Fig 3.6), suggesting that a3p2* nAChR do not account directly 
for any measurable part of the Ca2+ increase. This is compatible with the elegant study by 
Shoop et al (2001), which concluded that the role of a3* nAChR in generating Ca2+ 
responses in chick cilliary ganglion somatic spines could be primarily that of a catalyst for 
the mediation of membrane depolarisation and VOCC activation. In contrast to these 
observations, co-application of a-Bgt and CdCI2 produced an additive effect, which suggests 
that, unlike a3p2* nAChR, the a7 nAChR subtype may be responsible for a component of 
the Ca2+ increase that is independent of VOCC activation. This is consistent with previous 
results found in chick ciliary ganglia (Rathouz and Berg, 1994) and hippocampal slices (Gray 
et al., 1996).
SH-SY5Y cells have been shown to express both L- and N-type VOCC (Morton et al., 1992).
In effect, L-type VOCC appears to be responsible for part of the CdCI2-sensitive response,
as incubation with nifedipine significantly decreased the nicotine-evoked increase in Ca2+
levels (Fig 3.6). However, the ability of dihydropyridines to block the neuronal nAChR,
especially a3* subtypes (Lopez et al., 1993; Herrero et al., 1999 and references therein;
Shoop et al., 2001), compromises the estimation of the extent of the L-type VOCC
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contribution. Nevertheless, co-application of nifedipine and a-Ctx-MII resulted in significantly 
greater inhibition (Fig 3.6) possibly implying that a subpopulation of a3p2* nAChR are 
preferentially associated with non-L-type VOCC. The suggestion of a specific coupling is in 
agreement with the previous finding of Kulak et al. (2001), interpreted in favour of a 
functional association between a3p2* nAChR and N-type VOCC in rat brain synaptosomes. 
Although indicating the specific segregation of nAChR associated Ca2+ signalling pathways, 
the functional consequences of these forms of association are still unknown.
3.4.2 nAChR and intracellular Ca2+ stores
It is widely recognised that neuronal Ca2+ signals initiated by voltage- or receptor-operated 
Ca2+ permeable channels can induce Ca2+ mobilisation from intracellular Ca2+ stores, which 
can play a crucial role in defining complex Ca2+ responses (for review, Simpson et al., 1995; 
Berridge, 1998; Rose and Konerth, 2001). SH-SY5Y cells have both IP3 and ryanodine 
receptors (Mackrill et al., 1997), and we have shown that both contribute to the nicotine- 
evoked Ca2+ signals. Indeed, pre-incubation with ryanodine prevented a significant part of 
the nicotine-evoked elevation in cytoplasmic Ca2+, suggesting that Ca2+ influx through the 
nAChR receptor itself, or through VOCC, provokes Ca2+ induced Ca2+ release from 
ryanodine dependent storage sites (Fig 3.7). The increase in Ca2+ observed after incubation 
with caffeine, an agonist of the ryanodine receptor, further confirms the functional presence 
of ryanodine-dependent Ca2+ stores in SH-SY5Y cells (Fig 3.7). Although Ca2+ release from 
ryanodine receptors contributes to both the initial and sustained Ca2+ elevation in response 
to nicotine (Fig 3.7; 3.8), the contribution of Ca2+ mobilisation from this source seems to 
decrease with time, as ryanodine has a larger effect during the initial phase of the response 
(Fig 3.8a, b). In contrast, Ca2+ released via IP3 receptors, disclosed by inhibition with 
xestospongin-c, plays a fundamental role in the maintenance of sustained Ca2+ responses 
evoked by nicotine (Fig 3.8). IP3 receptors are sensitive to both Ca2+ and the intracellular 
messenger IP3. In PC12 cells, it has been shown that nicotine stimulation can lead to the 
production of IP3 (Gueorguiev et al., 1999), while consistent with our findings, IP3 dependent 
storage sites are involved in the long-term elevations in intracellular Ca2+ concentrations 
after activation of nAChR (Gueorguiev et al., 2000). It is important to mention that taking into 
account the reported ability of xestospongin-c to partially block the ER pump, the precise 
extent of the IP3 dependent Ca2+ elevation is difficult to estimate. In fact, we have shown that 
a 30 min pre-incubation with thapsigargin, a SERCA ATPase inhibitor, produced a drastic 
inhibition of the nicotine’s responses (69 %). However, the IP3 involvement should not be 
invalidated, when considering that in experiments with xestospongin-c, the inhibitor was only 
preincubated for 10 min before nicotine stimulation. In thapsigargin experiments, a more
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prolonged incubation (30 min) in Ca2+ free buffer was required in order to obtain the 
significant reduction of the nicotine response. When thapsigargin was applied in similar 
conditions to xestospongin-c, the inhibition observed after thapsigargin was relatively 
modest (22 ± 4 % inhibition with respect to controls, data not shown in figure).
The functional interaction of ryanodine- and IP3-dependent Ca2+ stores has been described 
as a key signalling mechanism in neurones (Berridge, 1998), where they are considered to 
be separate but interacting processes (for review see Simpson et al., 1995). Interestingly, 
the inhibition of the response to nicotine after the simultaneous addition of ryanodine and 
xestospongin-c was only partially additive (Fig 3.7), suggesting that part of the store 
dependent Ca2+ release is occurring through sequential activation of ryanodine and IP3 
receptor dependent Ca2+ stores.
It is increasingly assumed that the versatility of specific Ca2+ signals is accomplished by the 
selective segregation of precise Ca2+ sources with particular signalling mechanisms. As 
discussed above, we found that after stimulation with nicotine, a fraction of the Ca2+ influx 
seemed to be directly mediated by the a7 nAChR (Fig 3.6). As a-Bgt produced no further 
inhibition in the presence of ryanodine, the increase in Ca2+ levels mediated by a7 nAChR 
could be specifically associated with ryanodine-sensitive Ca2+ stores. This would indicate 
that Ca2+ influx via a7 nAChR might activate ryanodine receptors directly, without the 
contribution of VOCC. The existence of this functional coupling between Ca2+ influx through 
a7 nAChR and Ca2+ induced Ca2+ release from ryanodine receptors may be pertinent to the 
particular activation of specific Ca2+-dependent signalling mechanisms by a7 nAChR.
Overall, the functional coupling between nAChR and intracellular store channels provides a 
further spatial and temporal dimension to the Ca2+ signals evoked by nicotine stimulation. 
Indeed, recent evidence has highlighted the importance of the intimate cross-talk between 
the Ca2+ entry and Ca2+ release mechanisms, which should play a fundamental role in 
defining the specificity of nicotine-evoked Ca2+ signals. At present, several mechanisms are 
known to cooperate in the definition of the spatio-temporal patterns of cytoplasmic Ca2+ 
signals. These include the molecular repertoire of internal stores Ca2+ channels expressed 
and their intracellular distribution. In effect, the Ca2+ release channels show a complex and 
finely regulated distribution in the various neuronal subtypes, and throughout development 
(Rizzuto, 2001). The expression patterns of Ca2+ release channels are also modified by 
neural activity (Zhao et al 2000) and in pathological conditions (Lin et al., 2000). Interactions 
between organelles and/or the cell membrane can provide local signalling domains that 
control the diffusion of the cytoplasmic Ca2+ rise and the activation of effector systems. The 
wide extension of the ER network allows the propagation of Ca2+ induced Ca2+ signals
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throughout the neuron (Berridge, 1998). This already intricate scenario should be further 
extended when considering the huge variety of cell membrane Ca2+ channels, including the 
nAChR, which could interact with these Ca2+ sources. The mechanisms underlying this 
seemingly complex system of channels, receptors and membranes, bring to light an 
incredible variety of specific Ca2+ signals that are able to transduce a specific stimuli into 
particular patterns of cellular activity.
3.4.3 nAChR and Ca2+ stores: functional implications
The complex repertoire of intracellular Ca2+ sources and sinks, as well as the molecular 
diversity of the machinery for Ca2+ accumulation, release and storage, translates functionally 
in the regulation of neuronal development, activity and eventually death (for review see 
Rizzuto, 2000). These signals follow a well-defined spatio-temporal pattern, occurring as 
waves that usually diffuse from specific pacemaker regions (Rizzuto, 2000; Meldolesi, 2001). 
The diffusion of the Ca2+ signal to the cell nucleus, by acting on transcription factors (Bito et 
al., 1997; Hu and Chrivia et al., 1999) or repressor proteins (Carrion et al., 1999), changes 
the gene expression patterns and is thus responsible for long term changes in neuronal 
morphology and activity.
The results presented here indicate that different nAChR and various Ca2+ sources, namely 
VOCC and ryanodine and IP3 dependent Ca2+ stores, mediate the elevation of intracellular 
Ca2+ after nicotine stimulation of neuroblastoma cells (see Fig 3.9). Using combinations of 
antagonists, we deduce that whereas a3p2* nAChR couple exclusively to VOCC, a portion 
of a7 nAChR-mediated Ca2+ influx may directly activate Ca2+ induced Ca2+ release from 
ryanodine receptors. Furthermore, analysis of the sustained elevations of Ca2+ indicate that 
continuous activation of nAChR is required and that IP3-sensitive stores play a crucial role in 
maintaining the sustained Ca2+ responses after nicotine stimulation. These data provides 
insights into the complexity of Ca2+ signals emanating from the activation of nAChR, a 
functional characteristic that probably underlies the remarkable versatility of nAChR- 
dependent neuronal functions.
Ultimately, changes in cytoplasmic Ca2+ constitute the conventional key that opens the 
Pandora’s box of downstream signalling. The intricate regulation of the spatial and temporal 
patterns of Ca2+ signalling leads to the alteration in the activity of specific signalling 
molecules, and most probably, the modification of gene expression. The demonstration of 
precise Ca2+ signals mediated by the a7 subtype of nAChR, both in the stimulation of Ca2+ 
induced Ca2+ release and in the activation of neuroprotective mechanisms, certainly suggest
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that specific signalling mechanisms might be involved in the aftermath of a7 nAChR 
activation. In this regard, results presented in the next Chapter will explore the specific 






Fig 3.9 Generation of complex Ca2+ signals after stimulation of nAChR in SH-SY5Y cells.
The results presented indicate that different nAChR and various Ca2+ sources, namely VOCC and
ryanodine and IP3 dependent Ca2+ stores, mediate the elevation of intracellular Ca*+ after nicotine 
stimulation. Using combinations of antagonists we deduce that a portion of the a7 nAChR-mediated 
Ca2+ influx may directly activate Ca2+ induced Ca2+ release from ryanodine receptors. In adition, we 
demonstrated that continuous activation of nAChR is required, and that IP3 sensitive stores play a 
fundamental role in maintaining the sustained Ca2+ responses after nAChR stimulation. Although 
capacitative Ca2+ entry (CCE) might be anticipated to participate in the observed process, its role in 
nicotinic evoked signalling remains unanswered. The data depicted in the schematic diagram 






< nAChR Mediated ERK Signalling >
4.1 Introduction
4.1.1 Intracellular Ca2+ signalling
Neuronal systems must be able to integrate activity-dependent changes in synaptic inputs 
into concerted responses and long-term cellular processes, which are normally dependent 
on intracellular messengers and protein synthesis (Bailey et al., 1996, and see Chapter 1). 
The integration of voltage signals and generation of action potentials is one of the key 
mechanisms for information processing in neurones. The other main integrator of synaptic 
inputs is the nucleus, which elaborates the long-term responses of cellular activity. In fact, 
both the axon initiation zone and the nucleus can be considered as functional integrators of 
synaptic activity. However, while the axon hillock takes one type of input (membrane 
voltage) and generates one type of output (the action potential), the nucleus has many 
different types of inputs (multiple signalling cascades) and generates many different types of 
outputs (gene expression at different levels). Although the generation of slow and persistent 
signal inputs (i.e. hormones) is an important mechanism in neuronal processing, it is also 
fundamental to consider the fast changes in synaptic input, which relay important and crucial 
information as well.
As a widespread strategy for rapidly transducing fast synaptic information to the nucleus, 
excitable cells developed the fast conversion of electrical to biochemical signals through an 
intense and local influx of Ca2+ (Bito et al., 1997). LGIC and VOCC are able to respond 
quickly to millisecond-scale electrical events and generate quite complex cytoplasmic Ca2+ 
signals (see Chapters 1 and 3). The decoding of this Ca2+ signals by the appropriate Ca2+- 
sensitive proteins provides the functional basis for the Ca2+ mediation of synapse-to-nucleus 
signalling. In effect, the use of Ca2+-dependent molecules with different Ca2+ sensitivity 
and/or Ca2+ targets that are activated and inactivated over time provides discrimination 
between synaptic signals of varying amplitude and duration. Added to this, the source of the 
highly regulated Ca2+ signal offers a localised and precise source of specificity for the 
signalling-to-nucleus process (see Chapters 2 and 5).
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The intracellular processes activated by Ca2+ influx are part of an extremely intricate and 
complex scenario, involving an enormous amount of signalling molecules that are dependent 
on Ca2+ for activation. As a result, the study of the nAChR activated Ca2+ signals can be an 
extremely complicated task. In the next sections of the Introduction to this chapter I will try to 
summarise the rationale behind our investigation of nicotine dependent signalling processes.
4.1.2 nAChR and Ca2+ signalling
The capacity of nAChR to increase cytoplasmic Ca2+ levels has been extensively illustrated 
and discussed in the preceding chapters of this thesis. In fact, the capacity of nicotine to 
increase cytoplasmic Ca2+ concentrations through permeation of the nAChR channel per se 
and by recruiting VOCC might grant the activation of nAChR with the ability to relay 
information from activity dependent inputs to the nucleus. The a7 nAChR, in particular, has 
been implicated in several cellular processes, including long-term potentiation (Matsuyama 
et al., 2000; Mansvelder and McGehee, 2000), neuroprotection (Donnelly-Roberts et al., 
1996; Dajas-Bailador et al., 2000; Kihara et al., 2001) and learning and memory (Levin et al., 
1999). However, although the potential of nAChR signalling has been apparent, the great 
majority of studies on the general mechanisms of Ca2+ signalling have relied, by far, on the 
investigation of Ca2+ signals following glutamate receptors and/or VOCC activation. In part, 
this is probably a result of the comparatively lower Ca2+ responses obtained after nAChR 
stimulation, which have made the NMDA receptor or VOCC a much more attractive model 
for the study of Ca2+ mediated signalling processes. As a result, the role of nAChR in the 
activation of Ca2+ dependent signalling cascades has remained, in comparison, largely 
unexplored. However, in spite of the relative lack of information, nicotine has been shown to 
activate various kinases, including PKC (TerBush and Holz, 1986; Messing et al., 1989; 
Tuominen et al., 1992; Cox and Parsons, 1997) and CaMK II; Tsutsui et al., 1994). In PC12 
cells, human lung cancer cells and hippocampal neurones, nicotine has been reported to 
activate MAPK/ERK (Cattaneo etal., 1997; Heusch and Maneckjee, 1998; Tang et al., 1998; 
Dineley et al., 2001) through PKC dependent (Tang et al., 1998) or PKC independent 
pathways (Heusch and Maneckjee, 1998). Overall, these results clearly indicate that nAChR 
are relevant targets for the activation of specific signalling pathways in neuronal systems.
Given the various signalling molecules that are dependent on Ca2+ for activation, it was 
important to narrow the realm of possible targets for the nicotine-evoked Ca2+ activated 
signalling mechanisms. The reasons for studying the MAPK/ERK are illustrated in the 
following sections of the introduction. On the whole, the role of MAPK/ERK in diverse 
neuronal processes in the hippocampus (summarised below) and its “location” down-stream
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of many signalling molecules, made it a suitable and relevant target for the study of nAChR 
dependent signalling processes in neuronal models.
4.1.3 Mitogen activated protein kinase (MAPK)
The MAPK cascade is one of the various pathways used to convey extracellular signals into 
intracellular biochemical responses. Being a member of the serine/threonine protein kinase 
family, it has been classically associated with the regulation of a diverse array of cellular 
processes, such as cell growth and proliferation, differentiation and apoptosis (Fukunaga 
and Miyamoto, 1998; Grewal et al., 1999).
The MAPK cascades are found in all eukariotic organisms and basically consist of a three- 
kinase module that includes a MAPK activated by a MAPK kinase (MEK), which is in turn 
activated by a MEK kinase (MEKK). To date, 12 member proteins of the MAPK family, 5 of 
the MEK and 14 of the MEKKs have been identified in mammalian cells, and it is 
increasingly believed that the specificity of MAPK responses is achieved by the activation of 
different modules in response to different stimuli (Garrington and Johnson, 1999). Although 
the combination of different members of the module may seem extraordinarily complex, 
certain themes start to emerge on a more detailed inspection. First, the MEKs have the 
fewest number of members in the MAPK module, which considering their high specificity for 
their MAPK substrates, allows minimal variation of the MEK-MAPK section. In contrast, the 
fourteen defined MEKKs are more diverse in structure, with particular regulatory motifs that 
are not found in the other members of the module. As a result, MEKKs can be differentially 
activated by a variety of upstream inputs, thus producing the selective regulation of the 
MEK/MAPK pathway (Garrington and Johnson, 1999).
MAPKs are grouped into subfamilies on the basis of sequence similarity, mechanisms of
upstream regulation, and sensitivity to activation by different MEKs (Widmann et al., 1999).
Most family members require phosphorylation on one tyrosine and one threonine residue for
activation (Cobb and Goldsmith, 1995). At present, three subfamilies have been described,
including the ERK (sometimes also referred as MAPK), c-Jun amino-terminal kinase/stress-
activated protein kinase (JNK/SAPK) and p38 (Robinson and Cobb, 1997). In addition,
several different subtypes have been described for each of the three subfamilies, including
five MEK family members (MEKs 1-5; Robinson and Cobb 1997). With respect to subtype
specificity, the MEK1/2 act on ERK1/2, MEK3 acts on p38, MEK4 acts on JNK/SAPK and
perhaps also p38, while MEK5 has no proven substrates (Robinson and Cobb, 1997).
Among the MEKKs, the first described members were the Raf proteins, which were originally
studied as oncogene products (Robinson and Cobb, 1997). Unlike the MEK family, MEKKs
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are difficult to categorise by primary sequence similarity. The diversity of regulatory domains 
in different MEKKs gives the family of MAPK the flexibility to respond to a wide range of 
cellular stimuli. The variety of motifs include proline rich sequences for binding SH (Src 
homology) 3 domains, binding sites for GTP-binding proteins, leucine-zipper dimerisation 
sequences, and phosphorylation sites for tyrosine and serine/threonine kinases (Garrington 
and Johnson, 1999).
4.1.4 Extracellular signal-regulated kinase (ERK)
The genes of ERK are highly expressed in the CNS (Thomas and Hunt, 1993), and proteins 
of both ERK1 and ERK2 are widely but differentially distributed in various regions of the rat 
brain (Ortiz et al., 1995). In situ hybridisation studies revealed that the signal for ERK2 
mRNA was highly intense in many regions, including the cerebral cortex, olfactory bulb, 
hippocampus, amygdala, basal ganglia (except the globus pallidus), brain stem nuclei and 
cerebellum, among others. In contrast, hybridisation signals for ERK1 were relatively weak 
and were observed in restricted regions in comparison to ERK2 (Thomas and Hunt, 1995). 
These included the olfactory bulb, cortex, cerebellum and some hypothalamic and brain 
stem nuclei. In the hippocampus, ERK1 was highly expressed in the dentate gyrus and was 
practically absent in the CA1 region, which contrasts to expression of ERK2 in all regions of 
the hippocampus (Thomas and Hunt, 1995). Expression of the upstream kinases of ERK1/2 
has been also noted in the brain. The direct upstream kinases MEK1 and 2 are both 
expressed in the brain, as indicated by northern blot analysis (Brott et al., 1993). In addition, 
a number of MEK activating kinases, MEKKs, have been reported in the CNS, most notably 
c-Raf-1 and B-Raf, with the latter being the most abundant (Storm et al., 1990; Bamier et al., 
1995).
4.1.5 Activation of ERK by neurotrophic factors
In the last decade, the role of ERKs in the regulation of neuronal function has received 
increasing attention, and although various routes to ERK activation have been recently 
described (see later), much of the characterisation of ERK signalling cascades was initially 
focused on the actions of neurotrophic factors (Segal and Greenberg, 1996). It is well 
established that multiple neurotrophins regulate the development of the nervous system. 
Accordingly, extensive studies have been centred on intracellular signal transduction of 
neurotrophins and in the elucidation of the role of ERK activation in neurones. In effect, the 
examination of the actions of NGF has provided important information about neurotrophin- 
mediated signalling pathways. It has been established that at least three proteins, namely,
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the adaptor protein She and its neural specific isoform N-Shc, the phospholipase PLC-y1, 
and the phosphotyrosine phosphatase SHP directly associate with NGF-activated tyrosine 
kinase receptor, Trk (for review see Kaplan and Miller, 1997), thus coupling Trk to several 
intracellular signalling pathways. For example, She association with Trk, and its tyrosine 
phosphorylation by it, results in the rapid activation of phosphatidylinisitol 3-kinase, Ras, and 
the serine-threonine kinases B-Raf and ERK (Kaplan and Miller, 1997; Grewal et al., 1999, 
and references therein).
Recent studies have also identified a novel mechanism for NGF-induced stimulation of 
ERKs (Yao et al., 1998). This pathway involves the PKA-dependent activation of the Ras- 
related small G-protein Rap1 and the subsequent activation of B-Raf, a Raf isoform. In fact, 
given the high localisation of B-Raf in neurones, it has been suggested that the ability of 
PKA and Rap1 to couple to ERKs activation may have significant implications for neuronal 
signalling, including the regulation of neuronal survival and synaptic plasticity (Grewal et al.,
1999).
4.1.6 Ca2+ dependent activation of ERK
As discussed in chapters 1 and 2, Ca2+ influx can modulate various cellular events, including 
neuronal survival, excitotoxicity and also synaptic remodelling and adaptive responses. 
Many of the Ca2+ functions in neuronal activity are associated with changes in gene 
expression, which may then lead to structural and functional changes, underlying long-term 
adaptive responses. For many years, the majority of studies examining Ca2+ dependent 
signal transduction in neuronal models have focused on the PKC and the CaMK family. 
Many PKC isoforms as well as the CaMK require Ca2+ for activity in vitro, and contain 
conserved domains responsible for direct binding of Ca2+ or Ca2+/calmodulin complexes 
(Hanson and Schulman, 1992). More recent studies have demonstrated that Ca2+ influx in 
neurones might also lead, by indirect mechanisms, to the stimulation of other intracellular 
signals, including ERK (Rosen et al., 1994). In effect, ERK does not require Ca2+ for activity 
in vitro, but is instead regulated by phosphorylation on conserved threonine and tyrosine 
residues (Seger and Krebs, 1995). As a result, activation of ERK in response to Ca2+ influx 
implicates the mediation of one ore more additional second messengers.
Rosen et al., (1994) first demonstrated that Ca2+ influx through VOCC activates the ERK
cascade, via activation of the small GTP-binding protein Ras, which is also associated with
the NGF dependent ERK activation. In recent years it has become evident that Ras, and
other Ras related G-proteins like Rap-1, are able to function as molecular switches that
transmit receptor signals to downstream MEK/ERK cascades (Finkbeiner and Greenberg,
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1998; Grewal et al., 1999). Prior to stimulation, Ras resides at the inner face of the plasma 
membrane in an inactive state, bound to GDP. The activity of Ras and Rap1 is tightly 
regulated by specific guanine nucleotide exchange factors (GEFs) and GTPase-activating 
proteins (GAPs) (Grewal et al., 1999). In effect, Ras has been implicated as a major target 
for Ca2+ signalling to ERKs, particularly through the stimulation of a specific GEF, RasGRF, 
which is activated by binding to calmodulin (Farnsworth et al., 1995), or via tyrosine kinases 
such as Src or Pyk2 after recruitment into multiprotein complexes (see Finkbeiner and 
Greenberg, 1996 for review). More recent studies have also identified other GEFs that can 
be regulated by a variety of intracellular second messengers. For example, CalDAG-GEFI 
and CalDAG-GEFII can bind directly to and be activated by both Ca2+ and DAG (Ebinu et al., 
1998; Kawasaki et al., 1998). Likewise, cAMP-GEFI and cAMP-GEFII are activated directly 
by cAMP, independently of PKA, while C3G is regulated by cAMP in a PKA dependent 
manner (Grewal et al., 1999 and references therein). Furthermore, nitric oxide has been 
reported to be an intermediate between NMDA receptor activation and Ras stimulation (Yun 
et al., 1998). The use of multiple signalling pathways probably allows neurones to regulate 
the kinetics of ERK activation, and such mechanisms may be important for translating 
specific patterns of neuronal activity into qualitatively different intracellular signals (see Fig
4.1 for a schematic diagram of some of the ERK pathways).
4.1.7 Functional role of the Ras-ERK cascade in neurones
Taking into account the many signalling paths to ERK, it is important to establish the 
biological consequence of ERK activation in the nervous system, and the significance of the 
various possible pathways of Ca2+ dependent ERK signalling. ERK phosphorylate a wide 
range of substrates, which include various downstream Ser/Thr effector kinases. For 
example, the transcription factor CREB can be phosphorylated and activated in an ERK 
dependent manner via stimulation of the CREB kinase RSK2 (Xing et al., 1996). This action 
is a major target of both neurotrophin and neuronal Ca2+, while PKA has been shown to use 
an ERK-dependent pathway to CREB (Roberson et al., 1999). More recent studies have 
also suggested that ERKs have multiple roles in the stimulation of transcription, and more 
importantly, that these include the translocation of ERKs from the cytoplasm to the nucleus, 
where they can directly phosphorylate and thereby stimulate transcription factors (Thomson 
et al., 1999). The mechanisms leading to ERK nuclear localisation are still unclear, but they 
appear to require both ERK phosphorylation and dimerisation (Khokhlatchev et al., 1998).
The present understanding of the functional effects of ERK activation are still far from 
complete, however, several lines of evidence suggest that ERKs, and in particular the Ras-
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ERK pathway, may contribute to the regulation of differentiation, survival and synaptic 
plasticity (Finkbeiner and Greenberg, 1996):
4.1.7.1 ERK and neuronal survival
It has been demonstrated that Ras is an important factor for neurotrophin induced neuronal 
survival, and the introduction of Ras into embryonic neurones mimics growth factor 
treatment (Borasio et al., 1993). In addition, an anti-apoptotic role for ERKs has been 
reported in PC 12 cells after growth factor withdrawal (Xia et al., 1995), and it has been also 
demonstrated that ERKs can protect certain populations of neurones against specific toxic 
stimuli (Maher et al., 2001; Punn et al., 2000; Anderson and Tolkovsky, 1999). In spite of 
these reports, other studies indicate that ERK might not be required in NGF-mediated 
survival (Creedon et al., 1996; Virdee and Tolkovsky, 1996). Overall, although under certain 
circumstances ERK activity may not be sufficient to mediate survival, it appears as an 
important factor for survival under some physiological or pathological conditions (Anderson 
and Tolkovsky, 1999).
4.1.7.2 ERK and synaptic plasticity
A relatively recent set of studies suggests that the ERK cascade plays a fundamental role in 
vertebrate and invertebrate memory consolidation, in particular, through the regulation of 
synaptic activity after increases in intracellular Ca2+ (for review see Grewal et al., 1999). In 
fact, ERK signalling components are highly enriched in the adult CNS, while expression of 
many ERK regulators, including many GEFs and Rafs, is largely restricted to the CNS. In 
addition, expression of ERK signalling components is especially high in association areas 
implicated in learning and memory, such as the hippocampus, neocortex and cerebellum (for 
review see Impey et al., 1999).
Several aspects of the ERK signalling cascade make it an attractive candidate for the 
mediation of some of the Ca2+-dependent intracellular mechanisms observed in synaptic 
plasticity. First, the sequential nature of the ERK cascade provides multiple points at which 
the response can be regulated by phosphorylation and desphosphorylation, allowing for 
tremendous amplification of extracellular signals. Secondly, because Ca2+ signals are highly 
regulated in the contexts of space and time, the Ca2+ dependent activation of ERK can be 
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Fig 4.1 Schematic model for the activation of ERK1/2 in neurones
Activation of the ERK1/2 signalling pathway can occur through a variety of intracellular routes. In the 
context of growth factor signalling, various adaptor molecules (She, Grb2) are capable of recruiting 
specific guanine nucleotide exchange factors (GEFs), such as Sos, into multiprotein complexes that 
signal to the downstream Ras pathway. Ca2+ influx can also activate the ERK1/2 cascade through 
various mechanisms, of which only some are depicted in the present model. The essential link is 
provided by the GEF proteins, which connect various Ca2+ dependent processes into an increase of 
Ras activity. Recent studies have identified specific GEFs that can be regulated directly by 
intracellular second messengers, such as cAMP, PKA, Ca2+/calmodulin (CaM) and PYK2, among 
others. The complexity and, at the same time, specificity of these signalling pathways may explain 
the ample role of ERKs in the regulation of activity dependent neuronal events, such as synaptic 
plasticity and cell survival.
As illustrated in Chapter 1, LTP is an activity-dependent strengthening of synaptic efficacy, 
proposed as a cellular model for vertebrate memory formation. Relatively recent reports 
indicate that ERK signalling plays an important role in the induction of LTP. For example, 
stimuli that induce LTP in area CA1 of the hippocampus also potently activate ERK (English 
and Sweatt 1996, Sweatt, 2001), while pharmacological inhibition of MEK partially inhibits 
LTP formation in area CA1 of hippocampal slices (English and Sweatt, 1997). In addition, 
the inhibition of MEK prevents the gene expression-dependent long-lasting LTP (Impey et 
al., 1999). Therefore, ERK signalling not only regulates short-term synaptic function, but may 
also promote the transcription and translation of new proteins required for long-lasting LTP.
Several transgenic mouse mutants have also implicated the ERK pathway in vertebrate 
long-term memory formation. Mice deficient for RasGRF, an activator of Ras (see above), 
show a marked deficiency in LTP in the basolateral amygdala (Brambilla et al., 1997), a
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structure believed to help encode certain forms of associative fear conditioning. 
Consequently, Brambilla et al. (1997) examined the cued fear conditioning, in which mice 
learn to fear a normally innocuous auditory tone by paired aversive stimuli, in Ras-GRF 
deficient mice. In fact, the long-term memory formation for cued fear conditioning was 
markedly compromised in Ras-GRF mutant mice. Considering that Ras-GRF is a potent 
activator of the ERK cascade, these results suggest a role for Ras-ERK in long-term 
memory formation.
Complementary studies in animal models of long-term memory have been also carried out 
utilising pharmacological inhibitors of MEK. This approach avoids the problems associated 
with gene disruption studies, in which compensatory changes can affect the outcome 
synaptic functioning. Atkins et al. (1998) demonstrated that systemic injection of the MEK 
inhibitor SL327 blocks cued fear conditioning in rats, suggesting that ERK activity is required 
for memory formation. In addition, the behavioural model of contextual fear conditioning 
utilised also induces a marked activation of ERK in the rat hippocampus, as demonstrated 
by western blotting experiments. Interestingly, SL327 also blocks hippocampal LTP (Atkins 
et al., 1998), a results that when added to the evidence showing the necessity of ERK 
activity for LTP, suggests that ERK signalling is essential for hippocampus dependent long 
term memory, and supports the notion that LTP and memory consolidation share similar 
mechanisms.
In summary, these findings indicate that the ERK cascade should join the CREB/CRE and 
PKA pathways as evolutionary conserved regulators of memory formation. Of particular 
interest is the fact that the activity dependent Ca2+ influx in CNS neurones can lead to the 
increase in cAMP, and through particular GEFs couple to activation of ERK (Vossler et al., 
1997; Grewal et al., 1999). Consistent with this, activation of adenylyl cyclase markedly 
increases ERK activity in hippocampal neurones (Impey et al., 1998). Thus, in addition to 
being activated by Ca2+, ERK may also be a major cAMP-stimulated kinase in the CNS. In 
fact, these studies raise the possibility that some of the effects of cAMP, which have been 
attributed to PKA, may be the result of ERK activation (Impey et al., 1999).
4.1.8 General Aims of this chapter
The stimulation of the ERK1/2 constitutes one of the possible candidates for the mediation of 
some of the neuronal actions of nAChR activation. In fact, nAChR modulate many cellular 
processes in which ERKs are implicated, including cell growth, differentiation and synaptic 
plasticity (Role and Berg, 1996; Fukunaga and Miyamoto, 1998; Sweatt, 2001).
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As illustrated earlier in this chapter, the cellular signalling pathways that can lead to 
activation of ERK1/2 are complex and may proceed through a variety of intracellular routes 
(Grewal et al., 1999). In general, the common downstream pathway is comprised by the 
activation of the Raf MEKKs, which leads to the activation of the ERK1/2, through 
phosphorylation by activated MEK (Sweatt, 2001). Several second messenger systems 
converge on the MEK-ERK1/2 cascade, including signalling routes that involve the 
integration of Ca2+ signals. In addition, the generation of cAMP can also result in the 
activation of the ERK1/2 cascade (Vossler et al., 1997), while PKA has been more recently 
described as a novel link between Ca2+ entry through VOCC and subsequent activation of 
the ERK1/2 signalling pathway (Grewal et al., 2000a,b).
In view of the above-mentioned role of the ERK signalling cascade in neuronal processes of 
survival and synaptic plasticity, nicotine-evoked ERK activation constituted an attractive 
candidate for the mediation of nAChR intracellular actions in primary hippocampal cultures. 
In order to analyse the involvement of ERK in nicotine-evoked signalling processes, and to 
define the precise mechanisms involved, the first part of the study was carried out using the 
SH-SY5Y cell line as a model system, which allowed a more detailed definition of the 
particular signalling steps occurring. Subsequent studies defined the involvement of ERK 
signalling after nicotine stimulation in the hippocampus. In particular, the aims of this chapter 
were:
- To determine if nicotine could increase ERK1/2 activity in SH-SY5Y cells and 
hippocampal primary cultures.
- To establish the nAChR subtype involved and the intervening signalling steps leading 
to activation of ERK1/2.
- To determine if the ERK1/2 cascade has a role in the previously observed nicotine- 
evoked protection in hippocampal cultures.






The following antibodies were used in this study: mouse E10 monoclonal anti-phospho- 
p44/42 ERK1/2 (Thr 202/Tyr 204) and rabbit polyclonal anti-p44/42 ERK1/2, anti-phospho- 
MEK1/2 (Ser 217/221) and anti-MEK1/2 antibodies were purchased from New England 
Biolabs Ltd. (Hertfordshire, UK). Rabbit polyclonal anti-Raf-B (C-19) and E10 mouse 
monoclonal anti-Raf-1 antibodies were obtained from Santa Cruz Biotechnology Inc. 
(Autogen Bioclear UK Ltd, Mile Elm Caine, Wiltshire). Recombinant inactive mouse p42 
MAP kinase 2/ERK 2 (62 kDa fusion protein) and recombinant inactive mouse MEK 1 (71 
kDa fusion protein) were provided by Upstate Biotechnology (TCS Biologicals, 
Buckingamshire, UK). Anti-mouse IgG-horse radish peroxidase (HRP), myelin basic protein 
(MBP), (-)-nicotine, insulin-like growth factor 1 (IGF-1), L-glutamine, gentamicin, non- 
essential aminoacids, penicillin and streptomycin were from Sigma-Aldrich (Dorset, UK). 
Anti-rabbit IgG-HRP conjugates were from Vector Laboratories (Burlingame, USA), [y- 
32P]ATP (3000 Ci/mmol) was purchased from Amersham International (Little Chalfont, UK). 
Mecamylamine and a-bungarotoxin were provided by Tocris Cookson (Bristol, UK). 
PD98059, KT5720, H-89, forskolin, Ro 31-8220, KN-62, LY294002 were from Calbiochem 
(Nottingham, UK). COMPLETE™, a protease inhibitor cocktail, was purchased from 
Boehringer (Lewes, UK). DMEM, Neurobasal medium and B-27 supplement were from 
Gibco BRL (Paisley, UK). All other chemicals and reagents were obtained from the usual 
commercial sources.
4.2.2 Cell culture
Human neuroblastoma SH-SY5Y cells, (ECACC, Salisbury, UK; passages 14-20) were 
cultured in 75 cm2 tissue culture flasks and maintained in DMEM, supplemented with 15 % 
foetal bovine serum, 2 mM L-glutamine, 1 % non-essential amino acids and 190 U/ml of 
penicillin and 0.2 mg/ml of streptomycin, until confluent. In experiments on SH-SY5Y cells, 
culture medium was replaced by serum-free medium (0.1 % albumin instead of foetal bovine 
serum) 24 h prior to drug treatments.
High-density hippocampal cultures were prepared from the hippocampi of E18 Wistar rat
foetuses and maintained in serum free conditions as described in the methods section of
Chapter 2. Kinase inhibitors or nAChR antagonists were incubated with cells for 30 min prior
to nicotine treatment. In “Ca2+-free” experiments, EGTA (3mM) was co-applied with nicotine.
Forskolin treatment was carried out for 10 min before nicotine. In each case stimulation was
terminated by aspiration of the medium, followed by two washes with 15 ml of ice-cold PBS
(120 mM NaCI, 19 mM Na2HP04, 6 mM KH2P04). Cells were then lysed by adding 1 ml of
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lysis buffer (137 mM NaCI, 1 mM EDTA, 1 mM MgCI2> 10% glycerol, 1% NP-40, 20 mM Tris, 
pH 8.0, supplemented with protease inhibitor cocktail, 1 mM PMSF, 1 mM orthovanadate 
and 1 mM dithiothreitol), followed by shaking on ice for 10 min. The lysed cells were passed 
through 25 G needles and centrifuged at 13,000 rpm for 10 min, the supernatant fraction 
was collected and pre-cleared by rotation with protein-A-agarose beads at 4°C. The protein 
concentration was estimated by the Bradford assay and equal amounts of protein were used 
for immunoprecipitation or Western blot analysis.
4.2.3 Western blotting
Samples (cell lysates or immune complexes) were heated for 7-10 min at 95° C, resolved 
using 7.5% SDS-PAGE and blotted onto PVDF (Millipore) membranes. Western blotting was 
performed with phospho-specific (anti-phospho-p44/42 ERK1/2; diluted 1:1000) or 
phosphorylation state independent (anti-p44/42 ERK1/2, anti-Raf-B and anti-Raf-1; diluted 
1:1000) primary antibodies. HRP-conjugated secondary antibodies, anti-mouse IgG (diluted 
1:3000) or anti-rabbit IgG (diluted 1:4000) were used accordingly. Electro Chemi- 
Luminescence (ECL) western blotting reagents (Amersham International) were utilised for 
the detection of bands. For data analysis see corresponding section below.
4.2.4 Immunoprecipitation
Immune complexes were prepared by incubating SH-SY5Y cell lysates (250 pg of protein) 
with either phospho-specific p44/42 ERK1/2, Raf-1 or Raf-B antibodies for 1.5-2.0 h at 4°C, 
followed by mixing the suspensions with protein-A-agarose beads at 4°C overnight. Immune 
complexes were then washed twice with each of the following solutions: lysis buffer (see 
above), PBS and kinase buffer (20mM p-glycerolphosphate, 0.1 mM pyrophosphate, 0.1 mM 
orthovanadate, 2 mM dithiothreitol, 20 mM Tris, pH 7.5); kinase activity associated with 
immune complexes was measured as described below.
4.2.5 ERK1/2 kinase activity assay
ERK1/2 activity was assayed by incubating the immune complexes in kinase buffer (as 
above) with 20 pM ATP, 5pCi [y-32P] ATP and 3-6 pg of myelin basic protein (MBP) 
substrate in a final volume of 30 pi. Following incubation for 20 min at 30° C, phosphorylation 
was stopped by addition of 15pl of 3x concentrated Laemmli sample buffer, followed by 
heating at 95° C for 10 min. Samples were resolved using 12% SDS-PAGE and gels were 
subsequently dried and exposed to BioMax film (Kodak) for 18 hours at -70° C.
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4.2.6 Raf-1/B-Raf kinase assays
This assay was performed in accordance with the manufacturer’s instructions (Upstate 
Biotechnology), with minor modifications. Immune complexes containing Raf-1 or B-Raf 
were incubated with inactive GST-MEK-1 (0.4|jg) and inactive GST-ERK2 (1.4 pg) in kinase 
assay medium (125pM ATP, 20mM p-glycerolphosphate, 0.1 mM pyrophosphate, 0.1 mM 
orthovanadate, 2 mM dithiothreitol, 20 mM Tris, pH 7.5, in a total volume of 40pl). After 30 
min at 30° C, an aliquot (10 pi) of the medium was taken and kept on ice for subsequent 
kinase assay (see below), and the residual amount was mixed with 3x Laemmli sample 
buffer, heated for 10 min at 95° C and resolved using 7.5% SDS-PAGE. Gels were blotted 
onto PVDF (Millipore) membranes and bands corresponding to phosphorylated GST-MEK1 
were identified using phospho-MEK1/2 specific primary antibodies (dilution 1:1000) and 
secondary anti-rabbit IgG-HRP conjugates (1:3000-1:4000 dilution). ECL western blotting 
reagents were used for detection.
An additional method for determining Raf-1/B-Raf activity was used, in which the reserved 
aliquots were mixed with 150pM ATP, 10pM [y-32P] ATP and 20pg MBP in 30pl of kinase 
assay buffer. After 10 min at 30° C, the reaction was stopped by spotting 25 pi aliquots of 
the samples on to P81 filter paper (Whatman, 2x2 cm each). Filters were washed three 
times in 0.75% phosphoric acid (5 min per wash) and once with acetone, before being 
placed in scintillation vials and counted for radioactivity in a liquid scintillation counter 
(Packard 6000).
4.2.7 Cell Viability
Neuronal survival of hippocampal primary cultures after different treatments was estimated 
using the MTT method for cell viability, according to the procedures described in the 
Methods section of Chapter 2.
4.2.8 Data analysis and statistics
Autoradiographs were quantified by densitometry using OneDscan v 1.0 (Scanalytics Inc., 
Fairfax, USA). Results are expressed as a percentage of control responses (stimulated with 
buffer alone) and data represent the mean ± SEM of 3 or more independent experiments. 
Statistical significance was determined using Student’s t test and one-way ANOVA plus post 





4.3.1 nAChR-mediated activation of ERK1/2 in SH-SY5Y 
cells
In initial experiments, SH-SY5Y cells were stimulated with a range of nicotine concentrations 
(100 nM - 100 pM) for 40 s, and ERK1/2 phosphorylation and activity were analysed by 
western blotting and kinase assay respectively. The highest concentration of nicotine tested 
(100 pM) consistently induced a significant enhancement of ERK1/2 phosphorylation (Fig 
4.2a) and activity (Fig 4.2b), approximately 50% above basal levels. This response was 
relatively modest compared with ERK1/2 phosphorylation after IGF-1 (Fig 4.2a).
The time course of activation of ERK1/2 by 100 pM nicotine in SH-SY5Y cells showed that 
ERK1/2 phosphorylation was increased at 10 s and persisted over 40 s of nicotine 
stimulation (Fig 4.2a). Activity of ERK1/2, estimated using MBP as substrate, was also 
increased at 40 s and 10 min (Fig 4.2b) but then declined with prolonged stimulation (up to 
20 min, Fig 4.2b). A 40 s treatment with 100 pM nicotine was used for further experiments 
on SH-SY5Y cell cultures.
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Fig 4.2 Time-course of nicotine-evoked activation of ERK1/2.
SH-SY5Y cells were stimulated with nicotine or IGF-1 for the indicated times and then lysed for 
further analysis. Activation of ERK1/2 was determined directly by Western blotting of cell lysates or 
by in vitro kinase assay using immune complexes, (a) Time-dependent phosphorylation of ERK1/2 
after nicotine, identified in cell lysates by Western blotting using anti-phospho-p44/42 ERK 
monoclonal antibodies (top panel). The total amount of ERK1/2 in each sample was estimated with 
an anti-p44/42 ERK polyclonal antibody (bottom panel), (b) Timedependent increase in ERK1/2 
activity after nicotine stimulation. Immune complexes containing activated ERK1/2 (phospho-ERK1/2) 
were incubated with MBP as a substrate in the presence of [y- P] ATP and subjectd to SDS-PAGE. 
Incorporation of 32Pj into MBP was identified by autoradiography as described in the Methods section.
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In the presence of a selective inhibitor of the ERK1/2 kinase, MEK (PD98059; 50pM, 30 
min), the activation of ERK1/2 by nicotine was totally prevented (nicotine: 146.0 ± 17.9 %; 
nicotine + PD98059: 103.3 ± 14.8 % of control values; n=3, p<0.05, Fig 4.3a), thus 
demonstrating that the nicotine-induced activation of ERK1/2 required MEK activity.
To ascertain if nicotine was acting through a nAChR to increase ERK1/2 activity, SH-SY5Y 
cells were pre-incubated with either the general nAChR antagonist mecamylamine (10pM, 
30 min) or the a7-specific nAChR antagonist a-Bgt (10nM, 30 min), before stimulation with 
100 pM nicotine (40 s). Incubation with either antagonist completely abolished the nicotine- 
dependent activation of ERK1/2, from 160.7 ± 19.0 % to 105.7 ±11.8 % of controls for 
mecamylamine (n=6, p<0.05, Fig 4.3b) and from 151.7 ± 15.9 % to 100.7 ±11.5 % of 



















Fig 4.3 Nicotine-induced activation of ERK1/2 via a7 nAChR and the upstream kinase MEK.
SH-SY5Y cells were treated with (a) the MEK inhibitor PD98059 (50pM), (b) mecamylamine (Mec, 
10pM) or (c) a-bungarotoxin (a-Bgt, 10nM) for 30 min, followed by nicotine stimulation (100pM, 40 s). 
Controls were treated with buffer. Cell lysates were immunoprecipitated with phospho-p44/42 ERK 
monoclonal antibodies and the in vitro kinase assay was carried out using MBP as a substrate, as 
described in the Methods section. Autoradiographs were analysed by densitometry and values are 
expressed as a percentage of the buffer control run in parallel; representative autoradiographs are 
shown in the upper panels. Data are expressed as the mean ± SEM of 3 to 7 experiments. 
Significantly different from control, * p<0.05, Student’s Mest. Significantly different from ERK1/2 
activity in the presence of nicotine, # p<0.05, ANOVA and post hoc Tukey’s test.
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The high Ca2+ permeability of a7 nAChR suggests that this receptor may activate second 
messenger cascades by increasing cytoplasmic Ca2+ concentrations. To examine the Ca2+- 
dependence of the nicotine-evoked increase in ERK1/2 activity, SH-SY5Y cells were 
stimulated with nicotine in nominally Ca2+-free medium, by co-incubation with EGTA (3 mM). 
This “Ca2+-free” condition significantly reduced the nicotine-evoked activation of ERK1/2, 
from 149 ± 15.5 % to 107.6 ± 8.5 % of controls (n=5, p<0.05, Fig 4.4). EGTA itself did not 







Fig 4.4 Nicotine-induced activation of ERK1/2 is dependent on extracellular Ca2+. 
SH-SY5Y cells were treated with nicotine (100pM, 40 s) in normal medium or in the presence of 
EGTA (3 mM), followed by lysis and immunoprecipitation with phospho-p44/42 ERK monoclonal 
antibodies. The in vitro kinase assay with MBP as a substrate was performed as described in the 
Methods section. Autoradiographs were analysed by densitometry and values are expressed as a 
percentage of the buffer control run in parallel; representative autoradiographs are shown in the 
upper panel. Values are the mean ± SEM of 5 experiments. Significantly different from controls, * 
p<0.05, Student’s f-test. Significantly different from ERK1/2 activity in the presence of nicotine, # 
p<0.05, ANOVA and post hoc Tukey’s test.
4.3.2 Kinase pathways and the nAChR-induced activation 
of ERK1/2
A variety of intracellular kinases can be activated by increases in cytoplasmic Ca2+. To 
elucidate the signalling pathway that mediates the Ca2+-dependent nicotine stimulation of 
ERK1/2, SH-SY5Y cells were incubated for 30 min with inhibitors of several Ca2+-dependent 
kinases reported to operate upstream of ERK1/2, prior to the addition of nicotine (100pM, 40 
s). Ro 31-8220 (1 juM), KN-62 (5pM) or LY294002 (50pM) did not significantly modify the
135
CHAPTER 4
nicotine-evoked activation of ERK1/2 (Fig 4.5a), indicating the lack of a major involvement of 
PKC, CaMK II or PI3 kinase, respectively. In contrast, two selective and structurally different 
inhibitors of PKA, KT5720 (0.5pM, 30 min) and H-89 (5pM, 30 min) reduced the nicotine- 
evoked increase in ERK1/2 activity from 151 ± 15.4 % to 98.6 ± 8.7 % (n=10, p<0.05) and
106.7 ±11.8 % (n=8, p<0.05) of controls respectively (Fig. 4.5b).
The capacity of PKA to lead to the activation of ERK1/2 in SH-SY5Y cells was supported by 
the ability of forskolin (10pM, 10 min) to elevate the activity of ERK1/2 (136.0 ± 15.9% of 
controls, n=4, p<0.05) to an extent comparable with the effect of 100 pM nicotine (Fig 4.5c). 
Application of nicotine (100 pM, 40 s) in the presence of forskolin (10 pM, 10 min) showed 
no additive effect (146 ± 26.6% of controls, n=3, Fig 4.5c) compared with either drug alone. 
The effect of forskolin plus nicotine was completely abolished by pretreatment with KT5720 
(0.5pM, 30 min, 97.7 ± 6.1% of controls, n=3; Fig. 4.5c). Forskolin stimulation produced no 
significant increase in cytoplasmic Ca2+ concentrations (forskolin: 12 ± 8 % compared to 
control nicotine stimulation) and neither forskolin nor the PKA inhibitor H-89 significantly 
affected the increase in cytoplasmic Ca2+ evoked by nicotine (nicotine + H-89: 95 + 3 % of 
control nicotine stimulation), as determined by fluorescence measurements using the Ca2+ 
sensitive dye Fluo-3.
The intermediate steps connecting the nAChR-mediated activation of PKA to the activation 
of MEK and ERK1/2 in SH-SY5Y cells were investigated by examining the activation of the 
MEK kinases Raf-1 and B-Raf. The activities of Raf-1 and B-Raf were estimated in 
immunoprecipitates, either by direct measurement of MEK1 phosphorylation by Western 
blotting, or by indirect measurement of 32Pj incorporation into MBP. Both methods showed 
that nicotine differentially affected Raf-1 and B-Raf kinase activities in SH-SY5Y cells. The 
ability of Raf-1 to phosphorylate MEK-1 was slightly but significantly increased by nicotine 
treatment, compared to controls (116.8 ± 5.4 %, n=7, p<0.05, Fig 4.6a), whereas B-Raf 
phosphorylation of MEK-1 was significantly reduced (85.5 ± 4.8%, n=7, p<0.05, Fig 4.6b). 
Changes in Raf-1 and B-Raf activity after nicotine stimulation were completely prevented by 
the PKA inhibitor H-89 (5pM, 30 min; 103.2 ± 2.8 %, n=10 and 100.8 ± 5.5 %, n=10 
respectively, Fig 4.6a, b). The indirect determination of Raf-1 activity by analysis of the MBP 
phosphorylation in an in vitro kinase assay indicated a tendency for Raf-1 activity to increase 
after nicotine stimulation, but this did not reach statistical significance (Fig 4.7). On the other 
hand, the in vitro kinase assay for B-Raf showed a significant decrease in B-Raf activity after 
nicotine (79.7 ± 6.0% of control, p<0.05, n=5; Fig 4.7), consistent with the Western blot 
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Fig 4.5 Nicotine-induced activation of ERK1/2 occurs via a PKA-dependent pathway.
SH-SY5Y cells were treated for 30 min with various kinase inhibitors, (a) PKC inhibitor Ro 31-8220 
(Ro, 1fiM), CaM kinase II inhibitor KN-62 (KN, 5pM) or PI3 kinase inhibitor LY294002 (LY, 50pM); (b) 
PKA inhibitors KT5720 (KT, 0.5pM) or H-89 (5pM). In (c) cells were treated with forskolin (Fsk, 10pM) 
for 10 min prior to incubation with nicotine (IOOjiM, 40 s) or buffer. Cell lysates were 
immunoprecipitated with anti-phospho-p44/42 ERK monoclonal antibodies and assayed for kinase 
activity as described in the Methods section. Representative autoradiographs are shown (top panels). 
Data are expressed as the mean ± SEM of 3 to 8 experiments. Significantly different from control, * 
p<0.05, Student’s f-test. Significantly different from ERK1/2 activity evoked by nicotine stimulation, # 


































Fig 4.6 Effects of nicotine treatment on phosphorylation of MEK by Raf-1 and B-Raf.
Raf-1 (panel a) and B-Raf (panel b) activities in SH-SY5Y cells were estimated from MEK-1 
phosphorylation as determined by Western blots with phospho-MEK-1 specific antibodies, see 
Methods section for details. SH-SY5Y cells were pretreated with H-89 (5pM, 30 min) or buffer prior to 
stimulation with nicotine (100pM, 40 s). Cell lysates were immunoprecipitated with antibodies against 
Raf-1 or B-Raf and immune complexes were incubated with equal amounts of GST-MEK1. The 
upper panel of blots demonstrates the presence of the respective Raf isoforms in the corresponding 
immunoprecipitates. The levels of total MEK present were assayed in parallel with MEK specific 
antibodies and shown in the middle panel. Phosphorylation of MEK1 was identified using phospho- 
MEK1/2 specific antibodies and the lower panel shows representative blots for phospho-MEK1. The 
summary of data for phospho-MEK1 obtained from 5 independent experiments is represented in the 
histograms (values are the mean ± SEM). Significantly different from control, *p<0.05, Student’s t- 
test.
4.3.3 nAChR-mediated activation of ERK1/2 in 
hippocampal neurones
The activation of ERK1/2 after nicotine stimulation was also analysed in hippocampal 
neurones by Western blotting with phospho-specific ERK1/2 antibodies. ERK 2 showed 
higher levels of phosphorylation and the results for this isoform only were quantitated by 
densitometry. Incubation of hippocampal primary cultures with nicotine (100 pM, 5 min) 
produced a significant increase in ERK 2 phosphorylation (134.6 ± 3 % of controls, p<0.05, 
n=6, Fig 4.8a). Similar to SH-SY5Y cells, the increase in ERK activation after stimulation 
with nicotine was substantially reduced by 30 min incubation with 10 nM a-Bgt (from 135.0 ±
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6 to 112.0 ± 5 % of controls, p<0.05, n=3, Fig 4.8b) and was dependent on extracellular 
Ca2+, as shown by the decrease in phosphorylation in the presence of EGTA (from 136.9 ± 9 
after nicotine to 63.5 ± 3.5 % of controls with nicotine + EGTA, p<0.05, n=3, Fig 4.8c). 
Interestingly, the “Ca2+-free” condition obtained with EGTA, significantly reduced the basal 
phosphorylation of ERK 2 to 74 ± 10.5 % of controls (p<0.05, n=3). A significant decrease in 
the basal phosphorylation of ERK 2 was also observed after inhibition of MEK by PD98059 
(50 pM, 30 min; 68.0 ± 10 % of controls, p<0.05, n=4). When incubated before nicotine, 
PD98059 prevented the stimulation of ERK 2 activity, and reduced levels of phospho- 
ERK1/2 to those observed in the presence of PD98059 alone (nicotine + PD98059: 66.6 ±
8.6 % of controls, n=3). The total amount of ERK2 was analysed in parallel and no 















Fig 4.7 Effects of nicotine on 32P j incorporation into MBP using Raf-1 and B-Raf
immunoprecipitates.
Raf-1 and B-Raf activities in SH-SY5Y cells were estimated after sequential phosphorylation of 
downstream kinases MEK1, ERK2 and its substrate MBP, see Methods section for details. SH-SY5Y 
cells were pretreated with H-89 (5jiM, 30 min) or buffer prior to stimulation with nicotine (100pM, 40 
s). Cell lysates were immunoprecipitated with antibodies against Raf-1 or Raf-B and immune 
complexes were incubated with equal amounts of GST-MEK1, GST-ERK2 and MBP. 32P( 
incorporation into MBP was measured by scintillation counting. Values are the mean ± SEM of at 
least 5 experiments. Significantly different from control, *p<0.05, Student’s f-test.
As we demonstrated in SH-SY5Y cells (Fig 4.5b), the PKA inhibitor H-89 completely 
prevented the nicotine-evoked activation of ERK 2 in hippocampal neurones, reducing 
values from 137.3 ± 4 % to 75.5 ± 12 % of controls, (p<0.05, n=4, Fig 4.8d). Basal levels of 
ERK 2 phosphorylation were slightly reduced after H-89 alone (76 ± 21 % of controls), but 
this was not significantly different from control values. Although ERK 1 showed generally low 
levels of basal phosphorylation in hippocampal neurons compared with ERK 2, nicotine
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stimulation increased amounts of phospho-ERK 1, and this was also dependent on a7 
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Fig 4.8 Nicotine-induced activation of ERK 2 in hippocampal neurones.
Hippocampal primary cultures were stimulated with (a) nicotine alone (100 pM, 5 min), or nicotine in 
the presence of (b) a-Bgt (10 nM, 30 min), (c) EGTA (3mM) and (d) H-89 (5 pM, 30 min). ERK1/2 
phosphorylation was determined by Western blotting using hippocampal culture cell lysates. 
Representative autoradiographs are shown in the upper panels. Autoradiographs were analysed by 
densitometry and values of ERK 2 are expressed as a percentage of the buffer control run in parallel. 




4.3.4 ERK1/2 and the nAChR mediated neuroprotection in 
hippocampal neurones
Taking into account the observed activation of ERK1/2 activity after nicotine stimulation, it 
was relevant to establish if the ERK1/2 signalling cascade was mediating the previously 
observed nicotine protection in hippocampal primary cultures. In order to do so, we 
submitted hippocampal cultures to the previously characterised NMDA (200 pM) insult (see 
Chapter 2), while nicotine’s ability to prevent NMDA excitotoxicity was tested in the presence 
(30 min pre-incubation and 1 h co-incubation) of the MEK inhibitor PD98059 (50 pM). 
Nicotine was still able to protect hippocampal cultures after inhibition of MEK by PD98059 
(Fig 4.9), thus not supporting the involvement of the ERK1/2 cascade in nicotine protection. 
It is important to mention that PD98059 was not able to protect hippocampal neurones per 


















Fig 4.9 Nicotine neuroprotection in hippocampal cultures is not mediated by ERK1/2.
Hippocampal primary cultures were submitted to the previously described excitotoxic insult (NMDA 
200 pM, see Chapter 2), and nicotine’s ability to protect hippocampal neurones was assayed in the 
presence of the MEK inhibitor PD98059 (PD, 50 pM, 30 min pre-incubation and 1 h co-incubation). 
Control cultures, with no added drugs, were processed in parallel. Cell viability was assessed 24 h 
after drug incubation, using the MTT method. Data are expressed as percentage of controls and bars 
represents the mean + SD from 3 independent experiments. Significantly different from control (*, p < 




The results presented in this chapter indicate that nicotine can activate the MEK-ERK1/2 
signalling cascade in the human neuroblastoma SH-SY5Y cell line and hippocampal 
neurones, via stimulation of the a7 subtype of nAChR, through a mechanism that is 
dependent on extracellular Ca2+ and requires PKA as an upstream mediator (Fig 4.10). 
Although the nicotine-evoked increase in ERK1/2 activity is relatively modest when 
compared with more robust stimulators of the ERK1/2 cascade, such as IGF-1 (Fig 4.2), 
these observations define a precise and novel cell signalling route through which a7 nAChR 
may exert a modulatory influence on cellular function.
4.4.1 a7 nAChR and the Ca2+-dependence of nicotine- 
evoked ERK1/2 activation
In SH-SY5Y cells, the sensitivity of the nicotine-induced increase in ERK1/2 activity to 
mecamylamine and a-Bgt indicates that this effect is mediated by a nAChR of the a7 
subtype. Although SH-SY5Y cells express a7 subunits (Lukas et al., 1993) and surface [125l]- 
a-Bgt binding sites have been detected (Ridley et al., 2001), studies have failed to 
demonstrate a7-mediated currents (Gould et al., 1992; Puchacz et al., 1994) or an a7- 
mediated component of nicotine stimulated Rb+ efflux (Lukas et al., 1993). However, results 
presented in Chapter 3 demonstrated the existence of a significant a-Bgt-sensitive 
component in the nicotine-evoked elevation of intracellular Ca2+ in SH-SY5Y cells. This 
situation is reminiscent of chick ciliary ganglion cells, in which a3* nAChR dominate the 
agonist-induced currents but a7 nAChR mediate a detectable increase in cytoplasmic Ca2+ 
(Vijayaraghavan et al., 1992). The results presented here provide further evidence for 
functional a7 nAChR on SH-SY5Y cells, which are capable of activating the ERK1/2 
signalling cascade. Interestingly, although other nAChR subtypes also contribute to Ca2+ 
responses in SH-SY5Y cells (see Chapter 3), the complete blockade of ERK activation after 
a-Bgt, suggests that only the a7 nAChR is associated with this particular signalling pathway. 
In addition, it should also be mentioned that stimulation of the a7 nAChR mediated the 
activation of ERK at a concentration (100 ^M) that failed to produce a detectable a7 
component of the Ca2+ increase in SH-SY5Y cells. As demonstrated in Chapter 3, 
stimulation with 100 pM nicotine produced a rapid and significant increase of cytoplasmic 
Ca2+, which was, however, not significantly blocked by a-Bgt, probably indicating the rapid 
desensitisation of a7 nAChR. Nevertheless, the ability of a7 nAChR receptors to still 
mediate the activation of ERK when stimulated with 100 jxM nicotine would suggest that a
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brief and localised Ca2+ signal is sufficient to activate the ERK signalling cascade. 
Accordingly, these results might indicate the existence of a specific and efficient association 
between a7 nAChR and the ERK signalling pathway in SH-SY5Y cells.
Hippocampal neurones also express a7 nAChR subunits (Seguela et al., 1993) and surface 
[125l]-a-Bgt binding sites (Barrantes et al., 1995a; Ridley et al., 2001a), but in contrast to SH- 
SY5Y cells, activation of a7 nAChR in hippocampal neurones gives rise to robust, rapidly 
desensitising currents (Alkondon et al., 1992). We have also shown that in hippocampal 
primary cultures the nicotine-evoked elevation in cytoplasmic Ca2+ levels was primarily 
mediated by the a7 nAChR (see Chapter 2). In the present study, we demonstrate that 100 
pM nicotine, acting through the a7 subtype of nAChR, can also increase the activity of ERK 
2 in hippocampal primary cultures (Fig 4.8). This concentration of nicotine gives almost 
maximal activation of a7 currents in hippocampal neurones (EC50 27 pM; Alkondon and 
Albuquerque, 1993), and our findings are in agreement with the recent report of Dineley et 
al. (2001) that used somewhat higher nicotine concentrations (500 pM).
In both SH-SY5Y cells and hippocampal neurones, the nicotine-induced ERK1/2 activation 
was dependent on extracellular Ca2+ (Fig 4.4, Fig 4.8c), consistent with the ability of 
neuronal nAChR to elevate intracellular Ca2+ concentrations, and with the reported Ca2+ 
dependence of ERK1/2 activation in PC12 cells (Rosen et al., 1994; Rusanescu et al., 1995; 
Grewal et al., 2000a) and CNS neurones in vitro (Kurino et al., 1995, Dineley et al., 2001). 
As illustrated in Chapter 3, results from various systems have shown that neuronal nAChR, 
including the a7 subtype, can increase intracellular Ca2+ by different routes, including the 
direct permeation of the nicotinic channel and the activation of VOCC (Rathouz et al., 1994; 
Barrantes et al., 1995b; Soliakov and Wonnacott, 1996). However, we have not 
distinguished between a direct and/or indirect route of Ca2+ entry with respect to nicotine- 
induced activation of ERK1/2: attempts to block VOCC with 200 i^M Cd2+ resulted in a 
further substantial enhancement of ERK1/2 activity. This observation is in agreement with 
the reported Cd2+-evoked ERK1/2 activation in rat mesangial cells (Ding and Templeton,
2000), and precluded the use of Cd2+ to dissect the contribution of VOCC in the present 
study. Interestingly, in hippocampal primary cultures (but not in SH-SY5Y cells) EGTA, and 
also the inhibition of MEK by PD98059, significantly reduced ERK1/2 activity below basal 
levels. This most probably reflects the occurrence of endogenous signals in hippocampal 
cultures that can activate ERK1/2 through Ca2+ and MEK dependent pathways.
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4.4.2 Signalling pathway linking a7 nAChR stimulation to 
ERK1/2 activation
As ERK1/2 activity is exclusively regulated by the upstream, dual specificity kinase MEK 
(Sweatt, 2001), the inhibition by the MEK inhibitor PD 98059 of nicotine’s effect on ERK1/2 
in SH-SY5Y cells and hippocampal neurones is persuasive evidence that nicotine elicits the 
phosphorylation (and hence activation) of ERK1/2 in both cell types. The intermediate steps 
coupling a7 nAChR activation and Ca2+ entry to the activation of MEK are likely to depend 
on stimulus-specific factors. The Ca2+-dependent activation of the ERK1/2 cascade could 
indeed proceed through a variety of upstream Ca2+-dependent kinases, including PI3-kinase, 
CaMK II, PKC and PKA (Sweatt, 2001). In PC12 cells in particular, nicotine-evoked 
activation of ERK1/2 was shown to occur through PKC dependent pathways (Tang et al., 
1998). Although classical or Ca2+- and diacylglycerol-dependent PKC isoforms are 
expressed in SH-SY5Y cells (Kramer and Simon, 1999), the failure of Ro 31-8220 to 
significantly reduce nicotine-stimulated activation of ERK1/2 (Fig. 4.5a) indicates the lack of 
involvement of PKC. In the investigation of PC12 cells (Tang et al., 1998), a higher 
concentration of nicotine (1 mM) and much longer exposure time to nicotine (30 min -1 2  h) 
was employed, which may have favoured activation of another nAChR subtype and / or a 
different route to MEK-ERK1/2. In cultured striatal neurones the Ca2+-dependent stimulation 
of ERK1/2 by AMPA (50 pM; 5 min) was not affected by Ro 31-8220, but proceeded through 
a PI3-kinase dependent cascade (Perkinton et al., 1999). Moreover, Kihara et al. (2001) 
have recently demonstrated the nicotine-dependent activation of PI3-kinase in cortical 
primary cultures. However, the failure of a maximally effective concentration of the PI3- 
kinase inhibitor LY294002 to prevent the nicotine-evoked increase in the ERK1/2 activity in 
SH-SY5Y cells demonstrates that PI3-kinase is not an essential intermediate between 
nAChR stimulation and ERK1/2 activation in these cells. Similarly, although nAChR 
activation can lead to the stimulation of CaMK II in adrenal medullary cells (Tsutsui et al., 
1994), the lack of effect of the CaMK II inhibitor, KN 62, on the nicotine-induced activation of 
ERK1/2 suggests that CaMK II does not mediate this response.
In contrast, the complete abolition of nicotine-evoked ERK1/2 activation in SH-SY5Y cells 
and hippocampal neurones by PKA inhibitors implicates PKA as the predominant mediator 
of this response. This is compatible with recent evidence for the Ca2+- and PKA-dependent 
activation of ERK1/2 in PC12 cells (Grewal et al., 2000a) and with the observation that 
forskolin can increase ERK1/2 activity, independently of nicotine stimulation (Ambrosini et 
al., 2000). Previous reports have suggested that nAChR may control some of its cellular 
functions through cAMP and PKA activation. In particular, nicotine has been shown to 
increase cAMP levels in PC12 cells (Gueorguiev et al., 1999), possibly through
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Ca27calmodulin-sensitive adenylyl cyclases (Xia and Storm, 1997). In addition, the nAChR- 
mediated expression of tyrosine hydroxylase was prevented in PKA deficient cells or after 
inhibition of adenylyl cyclase (Hiremagalur et al., 1993; Gueorguiev et al., 1999). The 
regulation by PKA of the MEK-ERK1/2 pathway after stimulation of the a7 nAChR 
constitutes a novel signalling cascade in both SH-SY5Y cells and hippocampal neurones.
Potential targets for PKA in the ERK1/2 pathway are the serine/threonine kinases Raf-1 and 
B-Raf, which have typical PKA phosphorylation consensus sites and whose cAMP- 
dependent modulation is well documented (Cook and McCormick, 1993; Peraldi et al., 1995; 
Vossler et al., 1997). It was recently demonstrated in both PC12 cells and hippocampal 
neurones that depolarisation-mediated Ca2+ influx induces the stimulation of the Ras-related 
small G-protein Rap1 and its association with B-Raf, thus leading to the formation of a 
Rap1/B-Raf signalling complex; this was dependent on PKA activity (Grewal et al., 2000b). 
However, the present study found that, at least in SH-SY5Y cells, the activity of B-Raf, 
estimated by two approaches, was significantly reduced by nicotine stimulation, and this was 
dependent on PKA as it was prevented by the PKA inhibitor H-89 (Fig 4.6b; 4.7). Peraldi et 
al. (1995) reported the cAMP-dependent inhibition of B-Raf kinase activity in PC12 cells, and 
although no alternative for MEK activation was proposed, it was demonstrated that in cAMP 
treated cells the association between Ras and B-Raf was virtually abolished. Interestingly, 
dissociation of the Ras/B-Raf complex could favour the association of GTP Ras with the 
other Raf isoform, Raf-1. In accordance with this hypothesis, our data show that the 
phosphorylation state of MEK-1 following incubation with Raf-1 immunocomplexes was 
significantly increased by about 15% after nicotine treatment, suggestive of an increase in 
Raf-1 activity, which was dependent upon the activity of PKA (Fig 4.6a). Raf-1 activity, 
measured by in vitro kinase assay with Raf-1 immunocomplexes and MBP as a substrate, 
showed a tendency to increase, but this did not reach statistical significance (Fig 4.7). In 
neuronal models, the modulation of Raf-1 activity by PKA has been generally found to be 
inhibitory (Grewal et al., 1999; Sweatt, 2001). Nevertheless, a Ca2+- and PKA-dependent 
increase in Raf-1 and ERK1/2 activity has been reported in neonatal rat cardiomyocytes 
(Yamazaki et al., 1997), and a positive link between PKA and Raf-1 may also exist in 
neurones.
4.4.3 ERK1/2 and the nicotine protection against NMDA 
excitotoxicity
ERK1/2 is a plausible mediator of the nicotine stimulation in neuronal survival (Chapter 2),
and this hypothesis was tested in our hippocampal primary cultures. The results obtained
indicate that ERK1/2 are not the key mediators of nicotine-induced neuroprotection in
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hippocampal cultures, as inhibition of MEK did not prevent the nicotine-evoked protection. In 
fact, although the prominent role of the Ras-ERK pathway in many NGF-mediated 
differentiation events is widely accepted (Kaplan and Miller, 1997), more recent evidence 
has not substantiated the hypothesis of the sufficiency of sustained Ras, MEK or ERK 
activity for many aspects of neuronal differentiation and survival (see below). Neither 
sustained ERK activity nor expression of activated MEK was sufficient to induce 
neuritogenesis in immortalised rat hippocampal cells (Kuo et al., 1996). Moreover, sustained 
activation of Ras and ERK was insufficient for survival responses of hippocampal pyramidal 
neurones (Marsh and Palfrey, 1996), while inhibition of MEK failed to block NGF-dependent 
survival of rat sympathetic neurones (Virdee and Tolkovsky, 1996). Overall, it is becoming 
apparent that other signalling pathways must act in concert with the Ras-ERK signalling 
cascade to induce survival and differentiation responses in neurones (Kaplan and Miller, 
1997). The PI3-kinase constitutes one of these possible candidates, as a number of studies 
have implicated PI3-kinase and its downstream substrate, the serine/threonine kinase Akt, in 
neuronal differentiation and survival (Kimura et al., 1994; Yao and Cooper, 1995). During the 
final stages of the present work, a report from Kihara et al. (2001) further substantiated the 
role of PI3-kinase in nicotine-evoked neuronal survival. In effect, it was demonstrated that 
nicotine activation protected cortical primary cultures against Ap neurotoxicity through the 
activation of PI3-kinase. Although this may suggest a role for PI3-kinase in the nicotine 
protection of hippocampal cultures, the experimental evidence is still lacking, and it is 
possible that various signalling pathways act in conjunction to achieve the observed effect.
4.4.4 a7 nAChR activation of ERK1/2: functional 
implications
The preservation of nicotine protection after inhibition of MEK most probably indicates that 
nicotine-evoked activation of ERK activity is not related to the protective properties of 
nicotine stimulation (see Chapter 2). In fact, several results suggest that the ERK stimulation 
in response to Ca2+ influx is distinct from the pathways activated by NGF. It was 
demonstrated by Rosen et al., (1994) that concentrations of KCI and NGF that were 
individually saturating for ERK activation, together produced an additive response at each 
time-point. In addition, the same authors reported that Ca2+ activation of ERK presented a 
relatively transient kinetic of activation, which peaked 3 min after stimulation and decreased 
to only 20 % of peak within 1 h. This was significantly different when compared with the 
more prolonged activation after NGF, which reached a maximum at 20 min and remained 
elevated for at least 1 h. In summary, the activation of ERK by stimulation of a l  nAChR is 
probably mediating an intracellular effect other than neuroprotection.
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The increased recognition that both the a7 nAChR and ERK1/2 are important players in the 
cellular mechanisms of learning and memory makes the signalling pathways elaborated in 
this study (Fig 4.10) of particular relevance for the hippocampus. In the case of the a7 
nAChR, its role in memory processes is supported not only by behavioural studies (Levin 
and Simon, 1998), but also by the demonstration at the cellular level that a7 nAChR may 
contribute to the induction of LTP in the intact mouse dentate gyrus (Matsuyama et al., 2000, 
and see Chapter 1 for more details). As illustrated in the Introduction of the present chapter, 
activation of ERK1/2 is considered critical for LTP and various forms of hippocampus- 
dependent memory formation (Sweatt et al., 2001). It is therefore possible that activation of 
the ERK pathway constitutes one of the key cellular mechanisms that mediate the functional 
role of nAChR in the modulation of memory processes in the CNS.
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Fig 4.10 Model for the nAChR-evoked activation of ERK1/2
Stimulation of the a7 nAChR by nicotine will increase intracellular Ca2+, either directly or via VOCC. 
This promotes the activation of PKA in an apparently indispensable step for the nicotine-induced 
activation of the MEK-ERK1/2 cascade in SH-SY5Y cells and hippocampal cultures. PKA modulates 
the phosphorylated state and kinase activity of other targets: in SH-SY5Y cells at least, this leads to 
the inhibition of B-Raf. A positive effect of PKA on Raf-1 kinase activity and its preferential 
association with Ras could then lead to the activation of MEK and ERK1/2 signalling cascades.
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One of the major roles for ERK is the regulation of gene expression. As an example, the 
transcription factor CREB can be phosphorylated and activated in an ERK dependent 
manner (Xing et al 1996). This constitutes a major target of both neurotrophin and neuronal 
Ca2+. Interestingly, PKA has also been shown to use an ERK-dependent pathway to CREB 
in the hippocampus (Roberson et al., 1999), while the transcription factor CREB has a well- 
defined role in memory mechanisms (Sweatt, 2001) and has been implicated in nicotine- 
ERK1/2 signalling in the hippocampus (Dineley et al., 2001). In fact, the regulation of the 
ERK cascade using PKC and PKA as upstream transducers has been suggested as a 
prominent mediator in the short- and long-term regulation of synaptic strength in the 
hippocampus (Roberson et al., 1999). In addition, the nAChR-PKA-ERK relationship may 
have wider significance beyond the neuronal memory processes and the hippocampus, as 
both a7 nAChR and CREB can also regulate the transcription of tyrosine hydroxylase 
(Gueorguiev et al., 2000; Lim et al., 2000), and this enzyme can be regulated by nicotine in a 
manner dependent on adenylyl cyclase activity (and most probably PKA) in PC12 cells 
(Gueorguiev et al., 1999). Thus, ERKs have probably multiple roles in the stimulation of 
transcription and, in many instances, the translocation of ERKs from the cytoplasm to the 
nucleus, where they can directly phosphorylate and stimulate specific transcription factors, is 
a pre-requisite step (Grewal et al., 1999; Patterson et al., 2001). In summary, the results 
presented would indicate that brief stimulation of the a7 nAChR and the subsequent 
activation of PKA and ERK1/2 signalling pathways could provide a functional cellular 





5.1 Specificity of neuronal signalling
It is now widely accepted that nAChR have a vital role in many of the diverse functional 
mechanisms that regulate CNS function, a concept that was illustrated in the course of the 
previous chapters. The experimental evidence presented here focused primarily on the 
specific and selective role of the a7 subtype of nAChR, demonstrating its mediation in 
neuroprotection, generation of intracellular Ca2+ signals and activation of signalling 
cascades.
In hippocampal primary cultures, the prevention of the Ca2+-dependent and NMDA-evoked 
neuronal loss by the activation of a7 nAChR provided direct evidence for the existence of 
specific Ca2+ signals able to activate neuroprotective cellular mechanisms (Chapter 2). In 
effect, the existence of Ca2+ as a signalling messenger represents one of the key 
mechanisms in the transduction of synaptic currents into biochemical events, while the 
specificity of Ca2+-activated cascades relies on the capacity to segregate diverse Ca2+ 
signals in the different contexts of space and time. In Chapter 2, the results presented 
demonstrated the versatility of Ca2+-dependent neuronal processes, which mediated 
neuronal responses as apart as life or death. In accordance with the proposal that the 
spatio-temporal complexity of intracellular Ca2+ signals allows the simultaneous control of 
multiple Ca2+ dependent cellular functions (Johnson and Chang, 2000), the results obtained 
are consistent with the notion that Ca2+ signal-specificity is highly dependent on the source 
of Ca2+ influx (Ghosh and Greenberg, 1995).
The overall profile of a particular increase in cytoplasmic Ca2+ concentration is determined
by the combination of extracellular and/or intracellular Ca2+ sources (Simpson et al., 1995).
In turn, the generation of these Ca2+ signals is a highly regulated process, which would be
selectively buffered and/or amplified in specific neuronal compartments. Taking into
consideration the ability of nAChR to regulate diverse cellular functions through elevation of
intracellular Ca2+ levels, it was thus suggested that stimulation of nAChR could generate
complex intracellular Ca2+ signals through activation of different Ca2+ influx and/or release
processes. By using the SH-SY5Y cell line as a model system, we were able to demonstrate
the contribution of various Ca2+ sources to the nicotine-evoked elevation of cytoplasmic Ca2+
(Chapter 3). Besides the direct influx through the a7 nAChR channel and the activation of
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VOCC, we demonstrated that the nicotine-evoked Ca2+ responses were highly reliant on the 
activation of Ca2+ induced- and IP3-evoked Ca2+ release from internal stores. Interestingly, 
our results might also indicate that the generation of a7 nAChR mediated Ca2+ increase is 
specifically associated with ryanodine-dependent Ca2+ release. On the whole, the 
recruitment of intracellular Ca2+ stores provides further complexity to the Ca2+ signals 
activated by stimulation of nAChR, a phenomenon that probably underlies the ability of 
nAChR to regulate multiple neuronal functions.
The generation of specific and complex Ca2+ signals following activation of nAChR is only 
the initial step towards the modulation of neuronal function. Eventually, much of the capacity 
to regulate intracellular mechanisms depends on the activation of specific signalling 
molecules. In Chapter 4, we showed how the activation of a7 nAChR regulates the activity 
of ERK, through a novel signalling cascade that involves the activation of PKA. Considering 
that SH-SY5Y cells express various functional nAChR, the complete inhibition of ERK 
activation following application of a7 selective antagonists indicates that the nicotine evoked 
ERK signalling activity is specifically associated to the a7 nAChR. In hippocampal neurones, 
where nicotine-evoked Ca2+ responses were exclusively mediated by a7 nAChR, nicotine 
also stimulated ERK activity via activation of PKA. Overall, results presented demonstrate 
the specific association of a7 nAChR with PKA and ERK signalling cascades in both SH- 
SY5Y cells and hippocampal cultures. The existence of this cascade in both of the neuronal 
models studied might indicate that the specific association of the a7 with PKA and ERK 
signalling provides a general cellular mechanism for the regulation of diverse neuronal 
processes in various neuronal systems.
The ability to segregate specific intracellular signalling mechanisms is one of the crucial 
aspects of signal transduction. However, the understanding of the process that allows 
intracellular signals to be relayed from the cell membrane to specific cellular targets remains 
a daunting challenge. It is presently known that the relatively broad substrate specificity of 
many protein kinases and also protein phosphatases may be used in varying combinations 
to achieve distinct biological responses. As a result, mechanisms must exist to organize the 
correct repertoire of enzymes into individual signalling pathways. The post-synaptic density 
is the functionally specialised region of the neuron involved in the transduction of synaptic 
inputs into intracellular events (for a review on the organisation of proteins at synapses see 
Kim and Huganir, 1999). Emerging evidence indicates that specificity is achieved, in part, by 
the use of scaffolding or anchoring proteins that coordinate the specific binding of upstream 
and downstream effectors, and can thus control signal transduction pathways (Burack and 
Shaw, 2000). In fact, scaffolding can bring together proteins for their interaction and 
regulation, or may conversely sequester proteins so they do not interact with other proteins
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(Garrington and Johnson, 1999). In practical terms, scaffolds are said to preserve the 
specificity of the signalling pathway, a function commonly described as “isolating” or 
“stabilising” the otherwise weak interactions between the kinases of a single cascade. Not 
surprisingly, the regulation of these scaffolding complexes provides a further level of control 
in the already complex system of intracellular signalling. Considering that the function of a 
scaffold is to bring together a variety of different proteins, the concentration of a scaffold 
needs to be titred closely to the concentration of the component to which it binds. Too much 
scaffold protein will dilute the pathway components, working to defeat the purpose of the 
scaffold by sequestering an activating kinase from its substrate. Interestingly, it is possible 
that signalling inhibitor proteins, which have been previously described in overexpression 
studies, are in fact scaffolding proteins (Burack and Shaw 2000). Overall, the relatively 
recent emergence of scaffolding complexes provided physical evidence for the ability of 
neurones to segregate specific signalling pathways. The presence of these localised protein 
complexes is also consistent with the existence of multidimensional Ca2+ microdomains able 
to activate specifically targeted molecules.
In recent years, studies mainly carried out with glutamate receptors, started to unravel the 
extreme complexity of receptor associated protein complexes. One of the key features 
required for the clustering of ion channels and receptors in the plasma membrane and for 
spatially directing kinases and phosphatases toward their substrates appears to be the 
presence of PDZ domains in specific interacting proteins (Sheng and Pak, 2000 and 
references therein). The PDZ domain is a protein-protein interaction motif of approximately 
90 aminoacids shown to be present in over 100 otherwise unrelated proteins (Ponting et al., 
1997). In the particular case of LGIC, Grant and co-workers have shown that the 2000 kD 
complexes of the NMDA receptor and the PDZ containing PSD-95 molecule with associated 
proteins comprised at least 78 proteins divided into receptors, adaptors, signalling and 
cytoskeletal proteins (Husi et al., 2000; Husi and Grant, 2001, and references therein). 
Complementing these studies, Valtschanoff and Weinberg (2001), demonstrated the laminar 
organisation of the NMDA receptor complex within the postsynaptic density, and by using 
quantitative immunogold electron microscopy, they provided valuable information into the 
architecture of the NMDA receptor complex. Their data revealed that some proteins (like 
PSD-95) lay close to the plasma membrane, others (such as the guanylate kinase 
associated protein, GKAP, and Shank) lay markedly farther away, while some lay in a 
position intermediate between the other two (nitric oxide synthase, nNOS; Fig 5.1). 
Functional studies have also shown that some of the proteins in these complexes are 
associated with the specific coupling of receptor function. In effect, NMDA toxicity in cortical 
neurones was significantly reduced in PSD-95 deficient neurones (Sattler et al., 1999). 
Interestingly, the PSD-95 deficiency did not affect the NMDA-evoked Ca2+ loading or the
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kainate-evoked neuronal toxicity, thus suggesting a selective coupling of NMDA and PSD-95 
with a specific toxic pathway. Taking into consideration that the lack of PSD-95 blocked the 
Ca2+-activated nitric oxide production by NMDA receptors selectively, without affecting 
neuronal nitric oxide synthase expression or function, Sattler et al. (1999) proposed that 
PSD-95 is required for efficient coupling of NMDA receptor activity to nitric oxide toxicity, 
imparting specificity to excitotoxic Ca2+ signalling. This report has particular relevance for the 
results described in Chapter 2, when Ca2+ signals evoked by NMDA or nicotine stimulation 
mediated totally opposed physiological outcomes.
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Fig 5.2 NMDA receptor and scaffolding proteins
The diagram shows the laminar organisation of the NMDA receptor complex. Based on data from 
immunogold labelling (Valtschnoff and Weinberg, 2001; Hering and Sheng, 2001) it was possible to 
establish that some proteins lay close to the plasma membrane (PSD-95), others lay markedly farther 
away (GKAP and Shank), whereas other lay in an intermediate position (Nos). In addition to the 
signalling processes, scaffolding proteins are fundamental in determining the structure of the 
dendritic spine by association with cytoskeletal proteins (i.e. interaction between SPAR, spine 
associated RapGAP, and F-actin.
In addition to the NMDA receptor complex, the AMPA subtype of glutamate receptors have 
been also analysed for their interactions with postsynaptic protein complexes. Similar to their 
NMDA counterparts, the C-terminal of AMPA receptor subunits has been identified as the 
main region to interact with cytoplasmic proteins. Studies using the yeast two-hybrid system 
demonstrated the interaction of AMPA receptors with glutamate receptor interacting proteins 
(GRIP), AMPA receptor binding protein (ABP) and protein interacting with C-kinase (PICK1), 
all containing the PDZ-domain (Braithwaite et al., 2000 and references therein). In addition, 
several non-PDZ domain-containing proteins have been also reported to associate with 
AMPA receptors. Most notably, the N-ethylmaleimide sensitive fusion protein (NSF) has 
been reported to bind to a seemingly unique recognition site within the C-terminus of AMPA 
receptors (Nishimune et al., 1998). This NSF protein is a well-characterised ATPase which 
plays a role in the membrane fusion processes of protein trafficking through the Golgi
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apparatus and in the vesicular release of neurotransmitters. Interestingly, the interaction 
between NSF and AMPA has been demonstrated to regulate the surface expression of 
AMPA receptors in hippocampal neurones (Nishimune et al., 1998), while inhibition of NSF 
can lead to LTP induction blockade (Lledo et al., 1998). The AMPA receptors have been 
also reported to interact directly with, and signal via, a protein tyrosine kinase called Lyn 
(Hayashi et al., 1999). A member of the src-family non receptor protein kinase, the rapid 
activation of Lyn by the AMPA receptor does not requires Ca2+ or Na+ influx, and can lead to 
the stimulation of the MAPK signalling cascade.
Unlike the glutamate receptors, the data regarding neuronal nAChR scaffolding proteins is 
still scarce. It is very likely, however, that the large cytoplasmic domain of nAChR provides 
the molecular structure to interact directly with cytosolic proteins of different function. In 
effect, Anand and co-workers have used the cytoplasmic domain of the a4 nAChR as a bait 
to screen mouse brain cDNA yeast two-hybrid library (Jeanclos et al., 2001). Hitherto, they 
have described the isolation of a previously known protein (14-3-3r|) that functions as 
intracellular regulator or scaffolding/adaptor protein in diverse cellular functions. In addition, 
a similar experimental approach using the cytoplasmic loop of the a7 nAChR, identified the 
PDZ containing PICK1 as one of the interacting molecules (Huh and Fuhrer, 2001). 
Interestingly, the interface seems to be specific for a7, as PICK1 did not interact with the 
cytoplasmic loops of a4, a3 and p2 nAChR subunits (Huh and Fuhrer, 2001). Although the 
physiological significance of PICK1-a7 interaction is presently unknown, it provides 
structural evidence for the existence of specific a7-mediated neuronal functions.
In recent years, the report and characterisation of diverse scaffolding proteins has provided 
a functional basis for efficient and specific intracellular signalling. However, some important 
questions remains still unanswered. In effect, if the role of scaffolding proteins is to reduce 
complexity, why has evolution conserved a complex system of interacting kinases? One of 
the possible explanations is given by the fact that multileveled signalling systems offer the 
opportunity for fine modulation, while signal amplification has also been postulated (Burack 
and Shaw, 2000). In fact, some of the results reported here suggest that the nAChR- 
mediated signalling cascade proceeds through a downstream amplification route, 
considering that a relatively modest activation of Raf-1 kinase (~15 %) gives rise to a more 
robust increase in ERK activity (-50 %). Nevertheless, there is still no strong evidence 
showing that the major reason for conserving the multiple steps levels of organisation is 
indeed amplification (Burack and Shaw, 2000).
In summary, the transduction of synaptic currents into biochemical changes of neuronal 
function involves the integration of a multilayered system, highly, although not exclusively
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dependent on Ca2+ as the main trigger. The existence of various membrane receptors (i.e. 
LGIC, VOCC) provides an initial set of diversity, allowing the activation of selective Ca2+ 
sources. Ultimately, the final level of integration is provided by the activation of Ca2+ 
dependent signalling cascades. It has been demonstrated that individual pathways transmit 
signals along linear tracts that result in the regulation of discrete cell functions. However, as 
increasingly larger numbers of cell signalling components and pathways are being identified 
and studied, it has become apparent that these linear pathways are not free-standing 
entities but parts of larger networks. The ability of a cell to regulate spatially resolved 
multiple functions in a coordinate manner seems to arise from the organisation of signalling 
pathways into networks, which result from the interconnections between signalling pathways 
that occur when the same signalling component is capable of receiving signals from multiple 
inputs. An early example of signal integrators was adenylyl cyclase, which was shown to 
produce cAMP in response to signals from G-coupled receptors, as well as Ca2+ (Poser et 
al., 2001; Hanoune et al., 2001). As a result, cAMP levels in the cell could serve as an 
indicator of the balance of signals between many pathways (Pieroni et al., 1993), while the 
subsequent activation of PKA can be routed to regulate numerous physiological events. 
Consistent with this mechanism, the signalling pathway that follows the stimulation of a7 
nAChR appears to depend on PKA as the intermediate connector to the ERK cascade. 
However, many other signalling pathways are probably simultaneously activated. In this 
regard, although results presented here do not support the notion of a nicotine-dependent 
PKC, CaMK II or PI3-kinase link to ERK, it remains possible that these kinases are activated 
after nicotine stimulation in SH-SY5Y cells or hippocampal neurones, their activation leading 
to other, non-ERK, signalling systems. To add more complexity into an already intricate 
process, any cellular response generated by systems of kinases will be subjected to the 
balance determined by stimulation of phosphatase systems, which in many cases can be 
also activated subsequent to Ca2+ dependent processes (Stull, 2001). In the end, models of 
signalling networks and their interface with cellular mechanisms are likely to be extremely 
complex, and although linear representations are useful for the process of understanding the 
basic principles, they are probably far from reality.
5.2 a7 nAChR and neuronal signaling
Consolidated synaptic inputs can produce changes in cellular function, and is the 
combination of these altered functions that gives rise to a final physiological response. For 
example, stimulation of the CA1 glutamatergic neuron can result in an immediate increase in 
synaptic efficiency, altered patterns of gene expression (Malenka and Siegelbaum 2000),
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stimulation of local protein synthesis (Frey et al., 1993) and dendritic outgrowth (Maletic- 
Savaticetal., 1999).
In the case of a7 nAChR, we have demonstrated its involvement in the various levels of 
signalling integration in neurones (see Fig 5.2). They can generate the activation of complex 
Ca2+ signals, stimulate key signalling molecules and promote neuroprotective Ca2+ 
processes. With the a7 nAChR, the cholinergic system has a precise and selective tool for 
the activation of specific Ca2+ signals, and as a direct result, the regulation of neuronal 
function. In the hippocampus in particular, the recent report by Fabian-Fine et al., (2001) has 
highlighted the putative relevance of nAChR in hippocampal function, after reporting a near- 
ubiquitous presence of a7 nAChR in hippocampal synapses, where 96 % of synaptic 
contacts were positive for a7 labelling. Double labelling for both a7 nAChR/GABA and a7 
nAChR/glutamate also revealed that most of the postsynaptic neurones with a7 nAChR 
were glutamatergic, presumably pyramidal neurones (Fabian-Fine et al., 2001). Remarkably, 
the mean immunogold particle density at these a7 nAChR labelled synapses was extremely 
close to the reported particle density for NMDA and AMPA glutamate receptor labelling at 
synapses in similarly prepared tissue (Fabian Fine et al., 2001; Racca et al., 2000). In effect, 
the intensity of the detected signal has further indicated that the importance of a7-mediated 
nicotinic cholinergic signalling may be far greater than currently recognised.
As reviewed in the present work, activation of nAChR can lead to the modulation of diverse 
cellular tasks. In the particular case of the a7-ERK signalling cascade, we still do not know 
the exact function of ERK activation following stimulation of a7 nAChR. The results obtained 
do not support a role for ERK signalling in nicotine-evoked neuroprotection of hippocampal 
neurones. Alternatively, the activation of ERK following stimulation of a7 nAChR is most 
probably related to the proposed function of nAChR in memory processing (see Chapter 2). 
In effect, given the role that ERK has in the cellular processes of synaptic plasticity, and the 
evidence showing the involvement of nAChR in memory processes, it is probable that a7 
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Fig 5.2 Cell signalling processes activated by stimulation of nAChR in neuronal systems.
Schematic diagram summarising the results obtained, with the three main topics investigated shown 
in red. The generation of complex Ca2+ signals following the activation of nAChR is shown on the left 
side of the panel. Besides the direct influx through a7 nAChR and VOCC, the nAChR can generate 
the activation of Ca2+-induced and IP3-mediated Ca2+ release from internal stores. Interestingly, the 
results might also indicate that a7 nAChR are functionally associated with ryanodine dependent 
stores. On the right side, the diagram shows the specific activation of Ca2+ dependent intracellular 
signalling mechanisms following stimulation of a7 nAChR. These cellular processes are capable of 
activating trophic cascades that will lead to neuroprotection against excitotoxicity. However, the 
precise signalling cascade is still unknown. Although the nAChR mediated ERK signalling might not 
be involved in the neuroprotective properties of nicotine, it may have a role in the processing of long 
term signalling in neurones (note: the location of nAChR in the neuron diagram is arbitrary).
5.3 Future Perspectives
The study of the complex organisation of neuronal function should be closely associated 
with the understanding of the specific signals that are generated following synaptic activity. 
The understanding of how neurones are able to assimilate these signals constitutes one of 
the main objectives for the future. In the case of a7 nAChR the integration of synaptic inputs 
is further complicated by the ability of choline to activate and/or inactivate the receptor. It is 
in fact possible that ACh release from an activated cholinergic terminal could result in a7 
mediated facilitation of synaptic transmission at simultaneously activated glutamatergic 
synapses close to the activated terminal, where the local ACh/choline concentration would 
be transiently high. As a result of diffusion, synapses farther from the cholinergic terminal 
would experience inactivating choline concentrations. However, the real significance of this
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hypothetical cholinergic transmission is still far from being understood. In order to obtain a 
more precise understanding of nAChR function, it will be critical to determine the specific 
localisation of a7 dependent Ca2+ signals in synaptic dendritic boutons, and to analyse their 
interaction with other excitatory transmitter systems. The ability to integrate various Ca2+ 
sources must be also explored in the context of signalling activation. In particular, it would be 
important to address if the singular Ca2+ influx through a7 nAChR is sufficient to mediate 
ERK activation, or if Ca2+ release from internal stores is part of the signalling process (i.e. 
can stimulation of a7 nAChR activate ERKs after blockade of ryanodine dependent Ca2+ 
stores?). Furthermore, a crucial step in the understanding of nAChR signalling cascades 
must be given by the study (co-immunoprecipitations, yeast two-hybrid screens) of the 
specific scaffolding proteins that are associated to the nAChR.
Several of the cellular mechanisms that regulate neuronal function were investigated during 
the course of this work. In the process of understanding a7-nAChR functions we have 
probably generated more questions than answers. Ultimately, this must be a clear indication 




< Ca2+ sensitive fluorescent dyes >
A1.1 Fluorescent indicators
The development of fluorescent indicators of free Ca2+ that could be loaded into cells in a 
non-disruptive manner initiated a revolution in the studies of cellular Ca2+ homeostasis. In 
terms of ease of use and calibration, fluorescent Ca2+ indicators are the most straightforward 
and accessible of the available techniques for measuring Ca2+.
Fluorescence is the molecular process in which emission of electromagnetic radiation results 
from the absorption of radiation from an extra-molecular source. The excited state of the 
molecule generally has a lifetime in the order of 1CT8 s, and as such, fluorescence does not 
persist once exposure to the excitation source is terminated. Fluorescent radiation has a 
longer wavelength (lower energy) than that of the absorbed radiation (for review on 
fluorescent indicators of cytosolic free Ca2+ see Thomas and Delaville 1991; Tsien 1989) 
Under conditions of constant illumination and in a fixed chemical and physical environment, 
the intensity of fluorescence from molecular species is proportional to its concentration; thus, 
fluorescence intensity can be used as a quantitative tool. However, in order for a fluorescent 
probe to provide useful information about its environment, it is necessary that its 
fluorescence properties be altered in a suitable manner by the parameter to be measured. In 
general, any of the following three property changes are appropriate:
- A change in fluorescence yield (fluorescence output as a function of excitation 
intensity)
- A shift in the excitation spectrum
- A shift in the emission spectrum
The measurements of fluorescence intensity changes resulting from alterations in 
fluorescence yield at a single wavelength are the most straightforward to carry out. However, 
calibration of these signals requires some measure of the absolute amount of probe present. 
In general, these dyes do not allow the determination of intracellular Ca2+ concentrations. 
This problem is overcome by carrying out measurements with dyes that give shifts of 
excitation or emission spectra in response to the parameter to be measured, and allow 
fluorescence measurements at two wavelengths (see chapter 1 and Thomas and Delaville, 
1991, for review). Wavelengths are selected to give signals that change inversely in 
response to the variable being measured, while one of the wavelengths can be also selected 
to be an “iso-fluorescent” point, where fluorescence intensity does not change in response to
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the measured parameter. Using the dual wavelength approach (either dual emission or dual 
excitation), it is possible to calculate the proportion of the dye in one of two forms (e.g. Ca2+- 
bound versus Ca2+-free) from the ratio of fluorescence measured at the two wavelengths. 
This then becomes independent of dye distribution or concentration (see Grynkiewicz et al
1985).
The available fluorescent indicators for measuring Ca2+ have been modelled on the widely 
used Ca2+-selective chelator EGTA (see Tsien, 1989). While the tetracarboxylic acid Ca2+ 
binding site is largely unchanged in the fluorescent Ca2+ indicators, additional groups have 
been added to act as fluorescent reporters. Due to the fact that Mg2+ is too small to contact 
more than about half the ligand groups simultaneously, the octacoordinate binding site binds 
Mg2+ about five orders of magnitude more weakly than Ca2+. In the case of monovalent 
cations, they do not form detectable specific complexes probably because their charge is 
inadequate to organise the binding pocket in the face of the electrostatic repulsion of the 
negative carboxylates. In general, most of the indicators are used in an esterified form 
(acetoxymethyl esters being the most commonly employed), which by being uncharged and 
hydrophobic allows the permeation of cell membranes (for review see Thomas and Delaville, 
1991). Once in the cytosol, endogenous esterases “activate” the Ca2+ indicator by releasing 
the free acid form which does not permeate the membrane. This results in the accumulation 
of trapped indicator in the cell cytosol.
A1.2 Fura-2
Fura-2 is currently the most widely used of the fluorescent Ca2+ indicators dyes and is the
one most commonly employed for imaging studies. Fura-2 is about 30 times more
fluorescent than its predecessor, quin-2, has a higher Kd for Ca2+, less Mg2+ sensitivity, and
more importantly, it can be used in the ratio mode (Grynkiewicz et al., 1985). In addition,
fura-2 is normally used at intracellular concentrations in the tens of micromolar as opposed
to the millimolar range used for quin-2, and as a result, has much less Ca2+ buffering effect.
With a Kd for Ca2+ of about 225 nM, fura-2 is suitable for Ca2+ measurements up to several
micromolar. The fluorescence excitation maximum of fura-2 shifts to a lower wavelength on
Ca2+ binding, with negligible shift in the emission maximum (Grynkiewicz et al., 1985). This
allows fura-2 to be utilised as a dual excitation indicator. For optimal separation of
fluorescence due to the two forms of the indicator, Ca2+-free fura-2 is usually monitored at
380 nm and Ca2+-bound dye at 340 nm (for more details and experiments using Fura-2, see
Chapter 2). Fura-2 has an iso-fluorescence point at 360 nm, which is useful for monitoring
Ca2+-independent fluorescence or for following quenching by heavy metal ions. Perhaps the
only problems that have been encountered with fura-2 relate to the incomplete hydrolysis of
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the acetoxymethyl ester form and the propensity of this dye to become compartmentalised in 
subcellular organelles during loading (Thomas and Delaville, 1991).
A1.3 Fluo-3
The fluorophore component of fluo-3 is based on fluorescein and as a result it is excited in 
the visible range of light rather than the UV required for previously developed indicators, 
such as fura-2 (Minta et al., 1989). Fluo-3 does not undergo a wavelength shift on Ca2+ 
binding and so must be used in a single wavelength mode, being therefore not suitable for 
fluorescence ratio measurements. The Ca2+ affinity (Kd 400 nM) of fluo-3 is two to tenfold 
weaker than those of their UV-excited predecessors. This decrease improves resolution of 
micromolar and higher levels of intracellular Ca2+ concentration, surprisingly, without 
sacrificing resolution of low Ca2+ concentrations. This is due to the fact that Ca2+ free fluo-3 
is almost non-fluorescent, with a fluorescence enhancement upon Ca2+ binding of about 40- 
fold, the largest change of any of the available indicators (Minta et al., 1989). As a result, it 
allows the detection of significant signal changes for even relatively small Ca2+ variations at 
the low end of the intracellular Ca2+ concentration range. In addition, the comparatively low 
affinity for Ca2+ means that bound Ca2+ could be expected to dissociate relatively rapidly and 
not artificially prolong the Ca2+ signal that is observed. This property is particularly useful 
when measuring sustained Ca2+ signals (see results of Chapter 3). Fluo-3 is similar to fura-2 
in its selectivity for Ca2+ over Mg2+ and is essentially insensitive to pH above 7.0 (Minta et al., 
1989). As with the other Ca2+ indicators, heavy metal ions such as Mn2+ and Zn2+ bind the 
dye with high affinity. Apart from the lack of ratio capability, the only drawback of fluo-3 is the 
rather small separation between excitation and emission wavelengths, which necessitates 
the use of relatively narrow band filters or monochromators. In general fluo-3 can be excited 




< nAChR mediated dopamine release in the 
substantia nigra >
A2.1 Introduction 
A2.1.1 The basal ganglia
The basal ganglia consist of five extensively interconnected subcortical nuclei: the caudate 
nucleus, putamen, globus pallidus, subthalamic nucleus and the midbrain structure called 
substantia nigra. The caudate nucleus and putamen develop from the same telencephalic 
structure and as a result they are composed of identical cell types throughout. The two 
nuclei are called the neostriatum (or striatum) and serve the role of input nuclei for the basal 
ganglia. The globus pallidus (or pallidum) is divided into external and internal segments and 
derives from the diencephalon, lying medial to the putamen and lateral to the internal 
capsule, while the subthalamic nucleus lies below the thalamus at its junction with the 
midbrain. The substantia nigra lies in the midbrain and has two zones, the pars compacta 
and pars reticulata. Together with the globus pallidus they constitute the major output nuclei 
of the basal ganglia.
Almost all afferent connections to the basal ganglia terminate in the striatum, which receives 
input from two major sources outside the basal ganglia: the cerebral cortex and the 
intralaminar nuclei of the thalamus. The corticostriatal projection contains fibres arising from 
the entire cerebral cortex, including motor, sensory, association, and limbic areas. The basal 
ganglia, together with the cerebellum, constitute the major components of two important 
subcortical loops of the motor system. Both receive major projections from the cerebral 
cortex and both project back to the cortex via the thalamus. However, there are three 
important differences between the connections of the basal ganglia and those of the 
cerebellum. First, the basal ganglia receive inputs from the entire cerebral cortex, in contrast 
with the cerebellum, which receives inputs only from the sensorimotor cortex. Second, the 
output of the cerebellum is directed back to the premotor and motor cortex, whereas the 
output of the basal ganglia is directed not only to the motor cortices but also to the prefrontal 
association cortex. Finally, the cerebellum receives somatic sensory information directly 
from the spinal cord and has major connections with many brain stem nuclei. In contrast, the 
basal ganglia have relatively few connections to the brain stem and no direct connections at
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all to the spinal cord. These differences suggest that the cerebellum directly regulates 
execution of movement, whereas the basal ganglia are involved in higher-order, cognitive 
aspects of motor control. In spite of the good anatomical knowledge of the basal ganglia 
connectivity, this does not answer several questions, such as: what do the basal ganglia do? 
or why do lesions of the basal ganglia and the motor cortex or cerebellum result in 
distinctively different motor disturbances? A great insight into the function of the basal 
ganglia is provided by the study of several diseases affecting the neurons of these nuclei. In 
this regard, it has been proposed that the basal ganglia selectively facilitate some 
movements and suppress others, analogous to the inhibitory surround characteristic of 
receptive fields in the sensory systems. It would do this by focusing activity from widespread 
regions of the cortex onto the motor areas. Alternatively, the basal ganglia may compare 
commands for movement from the pre-central motor fields with propioceptive feedback from 
the evolving movement. Finally, the basal ganglia may be involved in the initiation of 
internally generated movements. This possibility is consistent with the striking inability to 
initiate movement (akinesia) exhibited by patients with Parkinson’s, one of the major 
diseases of the basal ganglia.
A2.1.2 Substantia Nigra
The substantia nigra (SN) lies in the midbrain and can be divided in two zones. A ventral 
pale zone called pars reticulata that resembles the globus pallidus cytologically. A dorsal, 
darkly pigmented zone, the pars compacta, comprised of dopaminergic neurons whose cell 
bodies contain neuromelanin. This dark pigment, a polymer derived from dopamine, gives 
the substantia nigra its name (Latin: black substance), considering that in humans this part 
of the brain appears black in cut sections. Because of the striking similarities in cytology, 
connectivity, and function of the internal segment of the globus pallidus and the substantia 
nigra pars reticulata, these two nuclei can be considered as a single structure arbitrarily 
divided by the internal capsule, serving the role of major output nuclei of the basal ganglia.
In spite of its role as output nucleus, the SN plays a fundamental role in the internal basal 
ganglia circuitry. The projecting axons from dopaminergic neurons that constitute the main 
cell type of the substantia nigra give rise to the nigrostriatal pathway. These neuronal path 
ends by synapsing in the striatum, where it has a fundamental role in the modulation of 
basal ganglia connectivity. In effect, the loss of this pathway gives rise to severe motor 
disruptions and the clinical manifestations of Parkinson’s syndrome in humans. This disease 
may include numerous motor impairments, including the difficulty in the initiation of 
movement and paucity of spontaneous movements (akinesia), slowness in the execution of
movement (bradykinesia) and postural reflex impairment.
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A2.1.3 Somatodendritic release of neurotransmitters in the 
substantia nigra
As described above, the nigrostriatal DA pathway is an important component of basal 
ganglia circuitry, which has been postulated to play a fundamental role in the initiation and 
maintenance of motor behaviours. When studying the function and activity of the basal 
ganglia, much of the emphasis is placed on the actions of dopamine in the striatum, where it 
can regulate the descending pathways to both the substantia nigra and globus pallidus 
(Gerfen, 1992). However, it is believed that DA may also contribute to basal ganglia output 
through its actions within basal ganglia nuclei other than the striatum. The notion that 
nigrostriatal dopamine neurons might release transmitter at the somatodendritic level as well 
as from axonal nerve terminals emerged more than 20 years ago, when early biochemical 
investigations provided evidence that the DA localised to dendrites was certainly stored and 
released (Geffen et al., 1976; Cheramy et al., 1981). Indeed, a functional role for 
somatodendritic DA release in the autoregulation of the electrophysiological activity of SN 
dopaminergic neurones was suggested by early studies (Bunney, 1973). More recently, it 
has been shown that somatodendritically released DA can modulate SNc cell firing and 
subsequent DA output in the striatum (Santiago and Westerink, 1991). In addition, through 
the modulation of y-aminobutyric acid and/or glutamate release within the SN pars reticulata, 
DA may regulate nigral output to the thalamus and cortex (Abarca, 1995; Aceves, 1995).
At present, the potential functional importance of somatodendritic DA release in the SN are 
not matters of dispute, and several investigators have implicated this phenomena as a key 
factor in the regulation of various motor behaviours (Robertson and Robertson, 1989 and 
references therein). However, due to the small size and low tissue content of the SN, the 
measurement of somatodendritic release has been a difficult task. As a result, there are still 
many aspects of SN dopamine release that remain unanswered. Some investigations into 
the mechanisms of DA release within the SN have led to the suggestion that the 
somatodendritic release of DA differs from the release observed at striatal synapses 
(Hoffman, 1999). These observations strengthen early studies by Groves and Linder (1983), 
which indicated that much of the DA stored within the SN is not contained within classical 
synaptic vesicles and may involve an important Ca2+ independent component. However, 
other authors have suggested that the biochemical properties of somatodendritic DA in the 
SN are indistinguishable from those of the dopaminergic nerve terminal in the striatum 
(Heeringa and Abercrombie, 1995). As a whole, it appears that somatodendritic release is 
dependent on vesicular accumulation (Heeringa and Abercrombie, 1995; Jaffe, 1998), 
sensitive to depolarisation (Geffen, 1976; Cheramy, 1981; Robertson et al., 1991), and that it
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is mostly Ca2+ dependent, consistent with an exocytotic mechanism (Geffen, 1976; 
Cheramy, 1981).
Nicotinic receptors in the CNS are localised both on cell bodies and/or their dendrites, as 
well as on axon terminals (Sorenson, 1998 and references therein). In the past, most of the 
attention regarding nAChR has been focused on the presynaptic type of receptors and its 
role in regulating neurotransmitter release (for review see Wonnacott, 1997). This was partly 
due to the scattered distribution of nAChR-containing targets through cortical, limbic and 
central autonomic structures and the complexity of stimulating specific cholinergic nerves in 
the brain. In spite of these difficulties, there is now evidence for the presence of functional 
somatodendritic receptors in the SN and ventral tegmental area (VTA), where the cell bodies 
of the two major dopaminergic pathways (nigrostriatal and mesolimbic) are located (Yin and 
French, 2000; Reuben, 2000a, b).
nAChR have been extensively studied in their role of modulators of the basal ganglia 
circuitry. Much of this function has been attributed to the capacity of nAChR to modulate 
dopamine release at the striatum. On the contrary, their role as modulators in the substantia 
nigra has been largely overlooked. In spite of the limited number of studies reported in the 
literature, it has been shown that systemic or ionotrophic application of nicotinic agonists 
increases the firing rate of SN DA neurons (Lichtensteiger, 1982; Clarke, 1985; Grenhoff,
1986) and stimulates the release of dopamine in the striatum (Blaha and Winn, 1993). 
Immunohistochemical studies complemented the mentioned reports, indicating that SN 
neurons make synapses with cholinergic terminals (Sorenson, 1998). On the whole, there is 
strong evidence suggesting an active role for nAChR at the SN. However, there are almost 
no data reporting the putative action of these receptors in regulating the release of DA at the 
somatodendritic level.
It has been previously proposed that nAChR can have a modulatory role in the function of 
the CNS, and this has been mainly associated with their presynaptic location and ability to 
promote neurotransmitter release at nerve terminals. The fact that nAChR can also be found 
at cell bodies and dendrites suggested other functional aspects of the activation of nAChR. 
Some of the intracellular mechanisms triggered by nAChR stimulation where illustrated and 
discussed in the previous chapters of this work. However, an important modulatory aspect of 
nAChR function could involve the release of neurotransmitters at the somatodendritic level, 
where they can also act as modulators. Considering the importance of DA release in the SN 
for the control of basal ganglia circuitry, and pondering the lack of data regarding the role of 
nAChR in the modulation of this phenomenon, we decided to investigate the action of 
nicotinic agonists upon DA release in SN superfused slices.
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The particular aims of this part of the project were:
- To establish and characterise an in vitro experimental assay for the study of 
somatodendritic dopamine release in the SN.





Male Sprague-Dawley rats were obtained from the University of Bath Animal House 
breeding colony. Nomifensine, citalopram and 4-aminopyridine were purchased from Sigma 
Chemical Co. (Poole, Dorset, UK). Epibatidine and (±)-anatoxin-a (AnTx-a) were obtained 
from Tocris Cookson (Bristol, Uk). Culture media and media supplements were purchased 
from Gibco BRL (Paisley, UK). All other chemicals used were of analytical grade and 
obtained from standard commercial sources.
A2.2.2 Superfusion of substantia nigra slices for [3H]DA release
Male Sprague-Dawley rats (weighing 240-250 g) were killed by cervical dislocation and
decapitated. After rapidly removing the brain, a coronal section from the mesencephalon 
was obtained and the left and right substantia nigra (15-20 mg of wet tissue weight per rat) 
were rapidly dissected for the preparation of the slices. Superfusion experiments were 
performed in Krebs bicarbonate buffer of the following composition: 118 mM NaCI, 2.4 mM 
KCI, 2.4 mM CaCI2, 1.2 mM MgS04, 1.2 mM K2HP04, 25 mM NaHC03 and 10 mM glucose, 
buffered to pH 7.4 with 95 % 0 2/5% C 02 and supplemented with 1mM ascorbic acid and 8 
pM pargyline.
Substantia nigra slices were prepared based on the method previously described by 
Soliakov and Wonnacott (1996) for striatal slices, using a Mcllwain tissue chopper. SN slices 
from four rats were washed once with 3 ml of Krebs buffer and loaded with [3H]DA (0.1 pM, 
0.132 MBq/ml) for 15 min at 37°. After two washes, slices were resuspended in Krebs buffer 
and loaded into six closed superfusion chambers (200 pi and ~15 mg of slices per chamber). 
Superfusion experiments were performed as previously described for striatal slices (Soliakov 
and Wonnacott, 1996), in a Brandel apparatus using Krebs bicarbonate buffer at a flow rate 
of 0.5 ml/min. After 24 minutes of perfusion wash, 2-min fractions were collected (3 samples 
before and 12 samples after the stimulus). All drugs were applied for 40 s, separating the 
pulse of drug from the bulk buffer flow by 10 s air bubbles.
Fractions were counted for radioactivity in a Tri-Carb 1600 liquid scintillation counter 
(counting efficiency, 48%). Stimulation-induced overflow of radioactivity in excess of 
baseline efflux was calculated and expressed as the percentage of total radioactivity present 
in the nigral slices at the onset of the stimulation. To estimate the radioactivity remaining in 
slices at the end of the experiment, superfusion was continued for 30 min with 10 mM HCI,
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to lyse the slices. Aliquots (1ml) of the lysates were counted for radioactivity. Total 
radioactivity was calculated as the sum of released [3H] DA plus that found in the lysate.
A2.2.3 Superfusion data analysis
The baseline was derived by fitting the following double exponential decay equation to the 
data, using the Sigma Plot (v. 2.0) program for Windows: y = ae'bx + ce*dx, where a, b, c and 
d are the curve parameters and x is the fraction number. Evoked [3H] DA release was 
calculated as the area under the peak after subtraction of the baseline. Data are presented 
as percentages of the corresponding controls, assayed in parallel, and are mean ± SEM 
values of at least three independent experiments, each consisting of two replica chambers 
for each condition. For comparison between different experiments, superfusion profiles were 
normalised as percentages of the fitted baselines. Student’s paired t test was used to 




A2.4.1 Dopamine release from SN slices
Each dissected SN weighed 8 mg and tissue from four rats was needed in order to attain a 
clear baseline of transmitter release in six independent perfusion chambers. This animal 
requirement more than doubles the one for striatal slices experiments, where striata from 
three rat brains allows a 12-chamber superfusion experiment.
The basal release of the SN slices was determined after 24 minutes of washout perfusion 
and previous to the addition of the stimulus. On average, each fraction represented 1.8 ± 0.2 
% of the total [3H] DA present at the beginning of the experiment (Fig A1).
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Fig A.1 Time course and profile of ^HJ-dopamine release in the substantia nigra 
Representative results of fractional release of ^HJ-dopamine after stimulation with (A) buffer, 
(B) 4-AP (1mM), and (C) KCI (20 mM). All drugs were perfused for 40 seconds, starting at 
fraction 4, and fractions were collected every 2 min, with a 0.5 pl/min perfusion flow.
Since our experiments regarding the DA release from SN slices were performed after 
loading the tissue with [3H] DA, it was important to characterise the relative contribution of 
the different catecholaminergic uptake systems at the SN. As well as the dopaminergic 
neurons containing the DA transporter molecule, the SN receives an important input of 
serotonergic terminals from the Raphe nucleus. Therefore, in order to demarcate the relative 
contribution of the serotonin transporter in our experiments we used citalopram, a selective 
inhibitor of the serotonin uptake molecule. When the [3H] DA loading and superfusion 
experiments were carried out in the presence of citalopram (50 nM), the basal release of 
transmitter was reduced in nearly 30 % (Fig A2), indicating that in the presence of the 
inhibitor a decrease in the uptake of transmitter was observed. The further addition of 
nomifensine (5 pM), a typical selective inhibitor of the DA transporter, produced a significant 
reduction in the basal release of approximately 75 % (Fig A2). This latter result showed that, 
in spite of the relatively significant influence of the serotonin uptake system, the main
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contribution to the [3H] DA being taken up and released comes from the dopaminergic cell 
bodies.
control citalopram 50 nM
nomifensine
5 (j.M
Fig A.2 Effect of uptake inhibitors on the basal release of ^HJ-dopamine
Two cathecolaminergic uptake inhibitors, citalopram (50 nM) and nomifensine (5 pM), were present 
in the 15 min incubation with [3H]-dopamine. Subsequent basal release was estimated as described 
in the methods section. Data represent the mean ± SEM of at least 3 independent experiments, each 
consisting of two replica chambers for each condition. Significantly different from control (*, p < 0.05, 
Student’s t test).
After elucidating the relative contribution of the main cathecholaminergic uptake systems 
reported to be present in the SN, we initiated the study of [3H] DA release after different 
depolarising stimulus. The perfusion of KCI 20 mM generated a significant increase of DA 
release when compared with the effect of buffer, which normally produces a small non­
specific increase (Fig A1). When 1 mM 4-AP was perfused, an even more pronounced effect 
was observed, nearly doubling the increase in DA release evoked by KCI (Fig A1, A3).
Considering the significant input of serotonergic axon terminals to the SN, and the 
observation that a significant part of the [3H] DA may be uptaken by these terminals, the 
depolarisation-evoked release of [3H] DA was examined in the presence of citalopram. 
When the inhibitor was added to the incubation and perfusion buffer, the increase in [3H] DA 
release after 4-AP was reduced to 50 % of the original effect (Fig A3). Interestingly, the 
addition of citalopram did not affect the KCI evoked [3H] DA increase (Fig A3). In addition, it 
is important to mention that the relative increase in [3H] DA after KCI or 4-AP, expressed as 
a percentage of total [3H] DA uptake, was not significantly different from that observed in 
striatal slices (Fig A4).
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KCI 20 mM 4-AP 1mM
citalopram citalopram
Fig A.3 Effect of depolarising agents on ^Hj-dopamine release in the substantia nigra.
Substantia nigra slices were stimulated with KCI (20 mM) or 4-AP (1 mM). Where indicated, 
stimulated slices were incubated with [3H]-dopamine in the presence of citalopram. Data represent 
the mean ± SEM of at least 3 independent experiments, each consisting of two replica chambers for 
each condition. Significantly different from 4-AP and citalopram (*, p < 0.05, Student’s t test).
To test the action of nicotinic receptors in the modulation of DA release from the SN, two 
different nicotinic agonists were tried. The perfusion with (±)-AnTx-a (1 uM), an agonist of 
the nicotinic receptor, failed to give any significant response on [3H]DA release (Fig A4). 
When epibatidine (100 nM), a more potent and more efficacious nicotinic agonist of striatal 
release was tried, it produced only a small augmentation in the [3H] DA release at the SN 
(Fig A4). However, after several experimental repeats (n = 8, with 2 replicates each) the 
increase observed with epibatidine was relatively inconsistent, with low and variable results. 
Unlike KCI and 4-AP stimulations, the effect of nAChR agonists differed markedly when 
comparing results from SN versus striatal slices (Fig A4). The lack of a clear effect of 
nicotinic agonists on the DA release in the SN precluded a quantitative and pharmacological 
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Fig A.4 Effect of depolarising agents and nAChR agonists on ^Hl-dopamine release in the
substantia nigra.
The effects of depolarising agents (as described in previous figure) and nAChR agonists, anatoxin-a 
(Antx, 1 pM) or epibatidine (Epi, 100 nM) on [3H]-dopamine release, were compared in the substantia 
nigra and striatum, as estimated using the superfusion technique. Data represent the mean ± SEM of 




The existence, importance and potential functional relevance of somatodendritic DA release 
in the SN are well-accepted facts. Various authors have reported that DA containing cell 
bodies within the SN can synthesise, store and release locally, thereby regulating nigral 
output (Bjorklund and Lindvall, 1975; Cheramy et al., 1981). It has been shown that DA 
released at the SN can act through D2 receptors to regulate nigrostriatal output and may act 
via Di and D2 receptors when regulating the nigrothalamic tone (Elverfors and Nissbrandt, 
1992; Abarca et al., 1995; Aceves et al., 1995; Martin and Waszczak, 1996). Accordingly, 
and considering the SN as part of the basal ganglia circuitry, several investigators implicated 
the release of DA within the SN as a key factor in the regulation of various motor behaviours 
(Robertson and Robertson 1989 and references therein).
In spite of the growing interest in nigral DA release, the regulation of DA levels at the SN has 
not been fully elucidated. Moreover, some contradictory results have been found regarding 
the role of the DA transporter molecule (DAT) in the SN. The DAT, the serotonin transporter 
molecule (SERT) and the noradrenaline transporter (NAT) are related members of a 
superfamily of Na+ and Cl2' dependent neurotransmitter transporters. In fact, biochemical 
measurements of [3H]DA transport have suggested that a significant amount of DA may be 
taken up by other transporter systems (Kelly et al., 1985; Simon and Ghetti, 1993), and 
predominantly the SERT. On the contrary, in vivo electrochemical studies have 
demonstrated that DA within the SN is primarily removed by DAT, and not by the SERT or 
NAT (Hoffman and Gerhardt, 1998). The contradictory results observed might be partially 
due to the different target accessibility and physiological states that results of comparing in 
vivo versus in vitro results. Moreover, the relatively high concentration of tritiated transmitter 
utilised for [3H]DA loading in in vitro experiments may saturate the DAT, then allowing other 
transporter systems to play a larger role in the uptake of [3H] DA. Our results seem to 
confirm this latter hypothesis. We have found that the incubation of SN slices with [3H]DA in 
the presence of citalopram, a selective inhibitor of SERT, diminished the basal release of DA 
in 30 %. Even considering the lack of full specificity for the SERT, thus opening the 
possibility for DAT inhibition with citalopram, it has to be said that a significant proportion of 
the DA taken up in our system seem to be loaded into serotonergic terminals. This latter 
result emphasizes the particular relevance of employing selective inhibitors of SERT when 
studies involving [3H]DA loading into dopaminergic neurons are carried out in the SN. 
Finally, it is important to note that after being loaded into the cell, studies using reserpine- 
induced DA depletion have shown that the dopaminergic cell bodies of the SN are capable 




The release of DA from the striatal axon terminals has been extensively characterised, being 
well accepted that it occurs through depolarization-induced exocytosis (Wonnacott, 1997). In 
the SN, the somatodendritic release of DA also appears to be sensitive to depolarization, 
according to reports by different authors (Cheramy et al., 1981; Robertson et al., 1991). This 
was confirmed in the present work with the use of two different depolarising agents that 
increased the release of [3H] DA in the SN. In spite of producing the same qualitative effect, 
KCI and 4-AP largely differ when considering the functional ways in which their assert their 
goals. While K+ acts in a direct way, depolarising the cell body by affecting the fine balance 
of charges inside the cell, 4-AP acts in a more indirect way, blocking the K+ channels 
present in the cell membrane thus increasing the number of intracellular positive charges 
and causing depolarisation. When experiments were carried out in the absence of 
citalopram the effect of 4-AP was higher than the one observed with KCI. However, when 
citalopram was added to the perfusion buffer the increase observed after 4-AP was 
dramatically decreased, while leaving almost invariant the KCI evoked release of [3H] DA. 
This was an unexpected result and it probably indicates that both depolarising agents have 
divided targets depending on the cellular mechanisms that they affect. Depolarisation by KCI 
seems to be influencing mainly the dopaminergic cell bodies, in view of the similar results 
observed with or without citalopram. On the other hand, the effect produced by 4-AP seems 
to have a divided target, affecting the [3H] DA stored at either dopaminergic cell bodies 
and/or the serotonergic axon terminals.
The significant increase in somatodendritic DA release after stimulation with depolarising 
agents clearly demonstrates that [3H] DA is loaded into neurones and can be released upon 
depolarisation, most probably through an exocytotic process. Of particular importance is the 
fact that the relative increases over basal levels of DA release after KCI or 4-AP were 
quantitatively similar in both the striatum and the SN (Fig A4). It appears that, although the 
absolute amount of transmitter is higher in the striatum, the dopaminergic cell bodies in the 
SN and the axon terminals in the striatum are capable of storing and releasing DA in a 
surprisingly similar manner.
Nicotine has been shown to increase the firing rate (Lichtensteiger et al., 1982) and bursting 
activity of mesenchephalic DA neurons (Grenhoff et al., 1986). Moreover, nicotine injected in 
the SN can modulate the release of DA in nigrostriatal axon terminals (Blaha and Winn, 
1993). Also in the SN, Kayadjanian et al. (1994) demonstrated that nicotine can increase the 
release of GABA and that a partial blockade of this evoked-effect was observed after the 
addition of a D1-like DA receptor blocker. Although the certain involvement of ACh was not 
established, these authors postulated that cholinergic terminals were the most probable 
candidate for the evoked increase of DA in the SN, and the subsequent modulation of GABA
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release through DA receptors. Indeed, it was previously demonstrated that substantia nigra 
neurones receive cholinergic innervation mainly from the pedunculopontine nucleus in the 
rat (Clarke et al., 1987). The results reported here do not support the hypothesis of a strong 
influence of nicotinic receptors in modulating the release of DA at the SN level. Contrary to 
the effects observed in the striatum, where a potent and clear modulation is observed, the 
role of nicotinic receptors in somatodendritic DA release seem, at least, less convincing. 
This is clearly demonstrated by comparing the release data from the present study with 
results of striatal [3H] DA release obtained in this laboratory with an identical methodology 
(Fig A4). In effect, the clear and pronounced action of nAChR agonists in striatal 
preparations contrast radically with the effect observed with the same agonists in the SN.
During the course of this study, Reuben et al (2000a, b) reported a very modest increase in 
dopamine release from SN dendrosomes after nicotine stimulation. Although similar to the 
synaptosomal preparation in the methodological prodecure, dopaminergic dendrosomes are 
obtained from the SN and ventral tengmental area, instead of the striatal terminal region. 
Although their study shows a small significant increase in DA release after nicotine 
stimulation, it still demonstrates the apparently minor role of nAChR in the modulation of 
somatodendritic dopamine release. In accordance with our results, Reuben et al. (2000a) 
also reported a considerable difference when comparing nicotine’s effects in the striatum 
and SN.
The lack of effect after nicotine stimulation in SN slices can be argumented as the 
incapability of reaching the methodological requirements for detecting very small levels of 
somatodendritic DA release. However, the fact that a dendrosomes preparation also gave a 
very modest increase of DA release after nicotine, suggests that, unlike their counterparts in 
the striatum, nAChR are not major regulators of DA release in the SN. It appears as if the 
role of nAChR will be determined not only by the receptor per se, but also by its location on 
the structure of the cell. Accordingly, when located at the axon terminals the nAChR can 
have a fundamental role in modulating the release of a variety of neurotransmitters in 
different brain areas. However, the function of nAChR should not be solely circumscribed to 
that role. In effect, the presence of nAChR in somatodendritic areas seems to be fulfilling a 
different and far more complex purpose. The results presented in the main body of this 
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